CA2175587A1 - Synthesizing and screening molecular diversity - Google Patents

Synthesizing and screening molecular diversity

Info

Publication number
CA2175587A1
CA2175587A1 CA002175587A CA2175587A CA2175587A1 CA 2175587 A1 CA2175587 A1 CA 2175587A1 CA 002175587 A CA002175587 A CA 002175587A CA 2175587 A CA2175587 A CA 2175587A CA 2175587 A1 CA2175587 A1 CA 2175587A1
Authority
CA
Canada
Prior art keywords
beads
synthesis
tags
reaction
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002175587A
Other languages
French (fr)
Inventor
Jeffrey H. Sugarman
Richard P. Rava
Haim Kedar
William J. Dower
Ronald W. Barrett
Mark A. Gallop
Michael C. Needels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymax Technologies NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/149,675 external-priority patent/US5503805A/en
Priority claimed from US08/146,886 external-priority patent/US5639603A/en
Application filed by Individual filed Critical Individual
Publication of CA2175587A1 publication Critical patent/CA2175587A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00281Individual reactor vessels
    • B01J2219/00286Reactor vessels with top and bottom openings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00308Reactor vessels in a multiple arrangement interchangeably mounted in racks or blocks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00389Feeding through valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00389Feeding through valves
    • B01J2219/00409Solenoids in combination with valves
    • B01J2219/00412In multiple arrangements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00418Means for dispensing and evacuation of reagents using pressure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00423Means for dispensing and evacuation of reagents using filtration, e.g. through porous frits
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00459Beads
    • B01J2219/00466Beads in a slurry
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00479Means for mixing reactants or products in the reaction vessels
    • B01J2219/00484Means for mixing reactants or products in the reaction vessels by shaking, vibrating or oscillating of the reaction vessels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00495Means for heating or cooling the reaction vessels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/005Beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00545Colours
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00547Bar codes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00554Physical means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00572Chemical means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00572Chemical means
    • B01J2219/00574Chemical means radioactive
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00585Parallel processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/0059Sequential processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00592Split-and-pool, mix-and-divide processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00596Solid-phase processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00686Automatic
    • B01J2219/00689Automatic using computers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00695Synthesis control routines, e.g. using computer programs
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00698Measurement and control of process parameters
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00725Peptides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00731Saccharides
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/12Libraries containing saccharides or polysaccharides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

A device and method for efficiently synthesizing diverse molecular products on substrates. A parent vessel (200) contains a suspension of substrates. The suspension is pressurized with argon and transferred to a plurality of reaction vessels (201-209) in one or more reaction vessel banks where monomer addition reactions take place. Optionally, the substrates may be tagged with a tag monomer. A vortexing motor (300) vortexes the contents of reaction vessels (201-209) during monomer addition reactions to enhance synthesis. After the desired monomer and/or tag monomer addition reaction, the suspension is pressurized with argon and transferred back to parent vessel (200) for mixing. Thereafter, the suspension may be pressurized with argon and reallocated among reaction vessels (201-209) for further synthesis.

Description

~175587 WO 95112608 PCT/US9~1123~7 SYNTTTF-~T7r~G AND SCl~FFNT~G MOr FCUL~R DIVFRSITY
RELATED APPLICATIONS
This application is a rnnfin~ nn-in-part of U.S. Application Serial Nos.
08/146,886 and 08/149,675, both filed on November 2, 1993, each of whieh is ill~,ulpl ' herein by reference for all purposes.
COPYRIGHT NOTICE
A portion of the disclosure of fhis patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile lc~JluJucLiull by anyone of the patent document or the patent disclosure as it appears in the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.
FIELD OF THE INVENTION
The present invention relates generally to methods and devices for ~yllLll~ g very large collections of diverse molecules and for identifying and isolating ,uu .-l~ with useful and desired activities from such enllPrtinnc The invention also relates to the illl,Ull~Ul~iUI. of i~f ~ ;.." tags in such collçctions to facilitate i~lPntifir~tinn of .-. .l~u~ with desired properties.
BACKGROUND OF THE INVENTION
Ligands for II~f~lu~l~ol_ ulfu receptors can be identified by screening diverse collections of peptides produced through either molçcular biological or synthetic chemical Rf~-~o,.,~ peptide libraries have been generated by inserting degenerate 30 nli~ ' " ' into genes encoding capsid proteins of fil~nnP~n~lc 1.- ~ .g~ and the DNA-binding protein Lac I. See Cwirla et al., 1990, Prûc. Natl. ~a~. Sci. USA 87:
6378-6382; Scott & Smith, 1990, Science ~: 386-390; Devlin et al., 1990, Sciencç 249:
4.14-4û6; Cull et a~., 1992, PrQc. Natl. Acad. ~Çi. USA 89:1865-1869; and PCT
publication Nos. WO 91/17271, WO 9111981B, WO 93/08278, each of which is 35 illCUl~JI ' ' herein by reference. These random libraries may contain more than 109 different peptides, each fused to a larger protein sef~uence that is physically linked to the
2 ~ 7 5 5 8 7 PCTIIJS9J1123.17 genetic material encoding it. Such libraries are efficiently screened for inîeraction with a receptor by several rounds of affinity purification, the selected exposition or display vectors being amplified in E. coli and the DNA of individual clones sequenced to reveal the identity of the peptide responsible for receptor binding. See also PCT publication Nos.
WO 91/05058 and WO 92/02536.
Chemical approaches to generating peptide or other molecular libraries are not limited to syntheses using just the 20 genetically coded amino acids. By expanding the building block set to include unnatural amino acids and other molecular building blocks, the accessible sequence and structural diversity is tlr~ y increased. In several of the strategies described for creating synthetic molecular libraries, the reaction products are spatially segregated and the identity of individual library members is ~ ly defined by the nature of the synthesis See Geysen et al., 1984, Proc. ~. ~. Sci.USA 81: 3998 4002; Geysen et al, 1986, in Synthetic Peptides as Antieens; Ciba Foundation Symposium 119, eds. Porter, R. & Wheelan, J. (Wiley, New York) pp.
131-146; Fodor et al., 1991, Science 251: 767-773; U.S. Patent No. 5,143,854; and PCT
patent publication Nos WO 84/03564; 86/00991; 86/06487; 90/15070; dnd 92/10092, each of which is i~. u~uld~d herein by reference.
Libraries of more than 30 million soluble peptides have been prepared by the "tea-bag" method of multiple peptide synthesis. See Houghten, 1985, ~. ~1.
Acad. Sci. II~ 82: 5131-5135; and U.S. Patent No. 4,631,211, each of which is ;.., u.~ ' herein by reference. Each library is ,yll~ .l and screened as degenerate peptide mixtures in which individual amino acids within the sequence are explicitly defined. An iterative process of screening (e.g., in a ~ i.", binding assay) andresynthesis is used to fractionate these mixtures and define the most active peptides within the library. See Houghten et al., 1991, Nature 354: 84-86; Pinilla et al., 1992, Pe~tide ~h _: 351-358; Blake, J. & Litzi-Davis, 1992, B;u~ullju~dt~ m. 3: 510-513; and PCT patent publication No. WO 92/09300, each of which is ;-.w-~u-~. l herein by reference.
Using the split-synthesis protocol of Furka et al., 1988, ~. 14th ~.
~n~. Biochem., Prague, Czech. 5: 47 (see also Furkd et al., 1991, In~ 1. ~ Prot~in ~- ~Z: 487~93; and Sebestyen et al., 1993, Bioor~. Med. Chem. Lett. ~: 413-418),Lam and coworkers have prepared libraries containing-- 106 peptides attached to 100-200 ~m diameter resin beads. See Lam et al., 1991, Nature ~: 82-84; Lam et al., 1993, ~ WO 95/12608 2 ~ 7 5 5 8 7 PCT/US9~/123.17 Bioor~ . Chem. I~. 3: 419-424; and PCT paterlt publication No. WO 92/00091, each oF which is il~,o-,uuldL~d herein by reference. The bead library is screened by incubation with a labeled receptor: beads binding to the receptor are identified by visual inspection and are selected with the aid of a mi~ ~ullldlli~uJl_~vl . Each bead contdins 50-200 5 pmol of a single peptide sequence which may be d~t~rminp~l directly either by Edman ~1. ~,..,.I~;r.,. or mass :,Ue~L~ul,l~ L-~ analysis. In principlel one could create libraries of greater diversity using this approach by reducing the fiim~-ncinnc of the bedds. The sensitivity of peptide sequencing techniques is limited to ~ I pmole, however, placing a cledr limitation on the scope of direct peptide ~PqllPnrin~ analysis. Moreover, neither 10 analytical method provides for ~LIdi~llLrulwdld and ~ sequence analysis when the library building block set is expanded to include D- or other non-natural amino acids or other chemical building blocks.
High throughput screening ûf collections of chemically synthesized molecules and of natural products (such as microbial fPrmPnt~ir,n broths) has traditionally 15 played a central role in the search for lead ~ for the dcv~lul of new I,~...i, nlr.~ agents. The ~ dbl~ surge of interest in cul~lb 1 chemistry and the associated ~Prhnr,ln~iPc for generating and evaludting molecular diversity represent significant milestones in the evolution of this paradigm of drug discovery. See Pavia et 1-, 1993, ~iQ~e. ~. ~h~m. I~t. ~: 387-396, illco.pu-dL~d herein by reference. To20 date, peptide chemistry has been the principle vehicle for exploring the utility of .,,,.1.;,~ u... ;~1 methods in ligand idPntifir~tinn See Jung & Beck-Sickinger, 1992, ~Q.
m. Inl. Ed. En~l. 31: 367-383, I ' herein by reference. This may be ascribed to the availability of a large and structurally diverse range of amino acid mnnnm~rc a relatively generic, high-yielding solid phase coupling chemistry and the 25 synergy with biological approaches for generating .e~ peptide libraries.
Moreover, the potent and specific biological activities of many low molecular weight peptides make these molecules attractive starting points for therapeubc drug discovery.
See ~irc-hm~nn, 1991, ~ m. InI. Ed. ~gl. 30: 1278-1301, and Wiley & Rich, . 1993, ~. Res. Rev. 13: 327-384, each of which is ;llCOl~JuldL~ herein by reference.
30 U~rdvu~dbl~ pll~ul.ld~od~rnamic properties such as poor oral bioavailability and rapid clearance ~ yivû have limited the more widespread dc~luull~..,L of peptidic ~ u,....l~ as drugs however. This realization has recently inspired workers to extend the concepts of Cùlllb I organic synthesis beyond peptide chemistry to create libraries of known WO9~/12608 2 1 7 5 5 8 7 PCTIS91/123~7 ~
r~ c~ like h~n7n~1io7rrinrC (see Bunin & Ellman, 1992, I Amer. Chem. Soc.
114: 10997-10998, illcul,uol~ herein by reference) as well as polymerie molecules sueh as oligomeric N-substituted glyeines ("peptoids") and uli~;u~-du~a~ See Simon et al., 1992, proc. Natl. Acad. Sci. USA 89: 9367-9371; 711rkl~rm:~nn et al., 1992, l. Amer.
Chem. Soc. 114: 10646-10647; and Cho et al., 1993, Science 261:1303-1305, each of which is i~cvluùldLed herein by reference.
Despite the great value that large libraries of molecules can have for identifying useful c~ ,u~ or improving the properties of a lead eomrollnrl~ the difficulties of sereening sueh libraries, Lldl~iuul~ly large libraries, has limited the impaet aecess to sueh libraries should have made in reducing the costs of, e.g., drug discovery and dcv~ lu,u"~ . Cv~l~uc~llLly~ the d~iclv,u"l~ of methods for generating and screening libraries of molecules in which each member of the library is tagged with a unique identifier tag to facilitate i~lrntifinA~inn of, .,..,~ (see PCT patent publieation No. WO
93/06121, ill~Ull~Vl~t~ herein by referenee; see also U.S. patent application Serial Nos.
946,239, filed September 16, 1992, and 762,5æ, filed September 18, 1991, 5~) metwith great ~-n~h-~ci lcm In the method, produets of a chemieal synthesis procedure, typically a ~.~.,.I,;,,-I..,iAl synthesis on resin beads, are explieitly specificd by attachment of an identifier tag to the beads coincident with each coupling or othe} product generating reaction step in the synthesis. Each tag specifies what happened in a reaction step of interest, e.g., which amino aeid monomer was eoupled in a partieular step of a peptide synthesis proeedure. The strueture or idenvity of a eompound, e.g., the sequenee of a peptide, on any bead can be dedueed by reading the set of tags on that bead. Ideally, sueh tags have a high i,-r~ eontent, are amenable to very high sensitivity detection and deeoding, and are stable to reagents used in the synthesis. The concept of an olignnl~nll~ot~ encoded ehemieal synthesis was also proposed by Brenner and Lerner, 1992, ~2Ç ~. Aead. Sci. USA 89: 5181-5183, i~l~u~ùldL~d herein by reference.
The encoding method has been employed to show that, starting with an orthogonally differentiated diamine linker, parallel ~ A~ ;Al synthesis ean be used to generate a library of soluble ehimeric peptides comprising a "binding" strand and a "coding" strand. See Kerr et al., 1993, l- Amer. Chem. Soe. 115: 2529-2531, ullJvl~L~d herein by reference. The coupling of either natural or unnatural amino acid monomers to the binding strand was recorded by building an amino acid code comprised of four L-amino acids on the "coding" strand. Compounds were selected from equimolar WO95/12608 2 1 75587 PCT/US9J1123~7 peptide mixtures by affinity ~u~ ;.." on a receptor and were resolved by HPLC. The sequence of the coding strand of individual purified molecules was then A~t~rmin~A by Edman .1.~;"..1-l;..., to reveal the structure of the binding strand. An analogous peptidic coding scheme was also recently reported by Nikolaiev et al., 1993, Peptide B~ç~h _:
161-170.
Cnnetr~inte on the sensitivity and throughput of the Edman procedure will ultimately restrict the scope of tbis aspect of the encoding method to analyzing libraries of limited diversity. The use of ~"~ ' '- tags offers greater promise, but imp}ovedmethods for ~J ' ~ llig~.. l~.ll;.l. -tagged molecular libraries are needed.10 Moreover, there remains a need for altemate m~thnAl-l~gy for ~y~ ;Liilg and screening very large tagged molecular libraries.
Where it is desirable to synthesize diverse collections of molecules on a plurality of solid supports such as beads, additional problems can arise. Examples of the use of beads with diverse molecular products ~y~ ;L~J thereon are disclosed in, for 15 example, the following ~1.~.1;~-li~ , ' herein by reference for all purposes:U.S. Application Serial No. 07/876,792, filed on April 29, 1992; U.S. Application Serial No. 07/762,522, filed on September 18, 1991; and U.S. Application Serial No.
07/946,239, filed on September 16, 1992.
While meeting with substantial success, the techniques described above have also met with certain lin it~ti~-nc For example, when the synthesis of diverse products takes place on beads, many manual . of such beads become necessary. For example, in U.S. Application Serial No. 07/876,792, filed on April 29, 1992, ;l~by reference herein for all pum. oses, one must suspend a collection of beads in a carrier, divide the beads, perform monomer addition reactions on the divided sets of beads, sometimes redivide and selectively recombine the beads thus ~ l~iL~l, mix the .l ' beads, and repeat the process. When large numbers of monomers are involved and when the reactions involve many monomer addition steps, manual techniques become extremely tedious. In addition, the "accounting" for the many products that have been ~ ' ' becomes a daunting task.
From the above, it is seen that improved methods and devices for ~J ' ' and screening very large tagged molecular libraries are desired. The present invention meets these and other needs.

wo 95/12608 ~ ~ 7 5~ 8 7 PCT/US9~1123.17 SUMMARY OF THE INVE~TION
The present invention provides improved methods for generating and screening molecular libraries in which the individual molecules in the library are tagged with unique, easily decoded identifler tags. Also provided is an apparatus and method for 5 rapidly and efficiently synthesi~ing diverse molecular products.
In one . ."l.o.~ the present invention provides methods and reagents for tagging the products of C.,..~ chemical processes to construct encoded syntheticchemical libraries. In an important . .~.l.o~ the invention provides a method for p~.rul",~ peptide and ,~l jg~"",~ synthesis on Illi~,~U:~,UIJic beads through an10 alternating and compatible synthetic procedure. The large ~ ..".. lff)~;~encoded synthetic peptide library produced by this ~ulllb;~ Lul;dl synthesis is composecl of many beads, each of which contains many copies of a single peptide (with a defined sequence) and a single-stranded DNA tag whose se~quence artificially and ~ ly codes for the structure of the associated peptide. The library can be efficiently illt~ llu~ ~i for 15 interaction with lluu~ ,lLly-labeled biological receptors by flow cytometry, and individual beads selected by exploiting the ability of FACS il.aLIul--~.,Ld~ion to sort single beads. The DNA tag on a sorted bead is amplified by the PCR and sequenced to determine the structure of the encoded peptide ligand. The library can be used, for example, to find high affinity (~l~lu~l~ol~u) ligands for a receptor such as an anti-peptide LO m~nru-lr)n~l antibody.
A synthetic molecular library of the invention can be produced by ayllLi.~;L;l.g on each of a plurality of solid supports a compound, the compound being different for different solid supports. The compound is ayllll~ ;L~i in a process cûmprising the steps of: (a) dlJ~)Uli' ' ,, the supports in a stochastic manner among a 25 plurality of reaction vessels; (b) exposing the supports in each reaction vessel to a first chemical building block; (c) pooling the supports; (d) apportioning the supports in a stochastic manner among the plurality of reaction vessels; (e) exposing the supports in each reaction vessel to a chemical building block; and (fl repeating steps (a) through (e) from at least one to twenty times. Typically, substantially equal numbers of solid supports will be 30 ~IJUlLiull~d to each reaction vessel. In one ~ bodilll~l,L of the method, the chemical building blocks are chosen from the set of amino acids, and the resulting compound is a peptide oligomer.

WO 95/12608 2 1 7 ~ 5 ~ 7 PCT/US9.11123-17 More particular~y. the invention relates to certain improvements in the coupling l l- ";~ c associated with such methods. One such illl~)lU..,~ relates to the chemistry used to remove the Fmoc protecting group from the alpha-amino group of a bead, linker, or growing peptide chain in such syntheses. Preferably, such removal is effected by treatment with 5 to 15%, preferably 105~o, piperidine for 5 to 60 minutes, preferably 5 to 10 minutes, although other conditions may be employed, e.g.. 15 to 30%
piperidine for 5 to 30 minutes. Other improvements relate to the activation chemistry of the peptide coupling reactions, in that when cenain automated i~ ulll~..lLdtiOn is used to perform the synthesis of an r~ r~nl~riPrJti~lP tagged peptide library, the invention provides 10 for a simple mixture of HOBVHBTU to reduce reagent supply bottles.
In another aspect, the present invention relates to methods of synthesizing a tagged molecular library. wherein each molecu~e in the library is covalently attached to a solid suppOn and is tagged with one or more different chemically inert hydrocarbon tags, wherein said tags comprise a variable l~ydlu~l/ull region and a molecular hook.
15 Preferably, such tags comprise a cleavable linker attaching said tag to said solid suppon, a molecular hook, and a variable length lI,~I.hU~UIJUII chain linking said molecular hook to said cleavable linker. More preferred are those PmhrriimPn~c wherein said tag comprises the formula:
20 wherein n is from I to 10 or more, X is a cleavable linker and R is a molecular hook.
Such molecular hooks are preferably selected from the group consisting of biotin, a of a hi~h association peptide pair and a protected activatable group, such as a phu~u.l~LivdLdble group. Preferred cleavable linkers are photocleavable linkers Also provided is a method of detecting the presence of such chemically inen 25 llydlU~ .lUII tags. The method comprises cleaving the one or more different tags from the solid support, followed by immohili7in~ the tags to a second solid suppon. The immo~hili7Po tags are then treated with an olipf n~ PoririP sequence whereby theoli~ ' ' sequence selectively binds to the immr~hili7P~ tag. The r~ nllrlpoti~ipsequence is then amplified, and its presence is detected, wherein the presence or absence 30 of the ~"~ ' ' sequence is indicative of the presence or absence of the tag.

21 755~7 WO 95/12608 PCT/US9~/123-17 Another ~ .o.~ of the present invention provides a method of d~....;,l;.~g the sequence of synthesis steps for a synthesized molecule attached to a solid support in tagged molecular library, tagged with chemically inert llydlu~ulJull tags. The method comprises individually detecting the presence of one or more different tags on said 5 solid support, the presence or absence of said individual tags being indicative of the occurrence of a particular synthesis step in the synthesis of said molecule.
In another aspect, the invention relates to methods and il.~L ul..~ ,.~Liù.l forencoded synthetic chemical libraries on beads too smaU to be separated on cull~ "iunal flow cytometry ill:~LIu~ Such small beads aUow the resulting library size to increase from the more typical range of 109 to 10'3 for bead based libraries up to a size of 1013 members for bead-free libraries. The invention also relates to methods for screening such libraries.
The invention also relates to methods for screening encoded synthetic libraries to identify useful ~~ ~ In one important aspect, the invention provides 15 important advances in the field of natural product screening relating to methods for generating, tagging, and screening natural product libraries to, l".,,.. t. . I'~ and identify .u l~ with useful activity.
In another aspect, the invention relates to an improved process for rapidly and efficiently identifying a pool of cu"~l,u~ from a molecular library of the invention.
20 In this method, the oli~u~u~ lcA Lide tags from a pool of tagged ~ that exhibit a desired property (e.g., binding to a receptor) are ..)....~...,.. ;.. A and cloned to facilitate sequencing of a plurality of tags in a single sequencing reaction. If the tagged cu~
are peptides, and an encoding scheme based on the genetic code is employed, then one can subclone individual tags from the u u..~,..t~ "~ . into other selection and expression systems, 25 such as the plasmid and phage-based systems described in the ~ ;lUUII,I section above, for further analysis of the peptide.
In another . 1~o-~ the present invention provides an apparatus and method for rapidly and efficiently ~ "iLill~ diverse molecular products. According to specific aspects of the invention, diverse polymers are synthesized on substrates such as 30 glass beads. Optionally, the beads may be ~ ln~ ly "tagged" during the synthesis reactions with a molecular tag. Merely by way of example, the syl.~ll~iL~ molecules on the beads may comprise peptides, while the molecular tags may comprise olig~ i Of course, other molecular products may also be synthesized using the techniques ~ wo 95/12608 2 ~ 7 5 5 ~ 7 PCTNS9 1/12317 described herein whenever a molecule has a basic "building block" common to other related molecules. Examples include l.~ ibl~ r~ , and beta turn mimetics.
According to one r.llllO/1;ll~rlll of the invention, a parent vessel is used to 5 mix bead ~"~ The mixed beads are distributed through a common manifold to a plurality of separate reaction vessels. In the reaction vessels, the beads are exposed to different, selected mnnnmrrc, which react on the beads to be coupled thereto, preferably covalently The beads may, optionally, be exposed to chemical "tags" which also couple, covalently or otherwise, to the beads. The beads are then ~ d through the 10 manifold back to the parent vessel and mixed. The mixed bead suspension is then again divided among the plurality of reaction vessels, and the process of monomer addition, bead mixing, and ~ L~ tioll continues. The process results in the formation of a collection of beads or other substrates with a diverse set of molecules formed on the surfaces thereof.
According to one aspect of the invention, the invention includes an apparatus 15 and a method for ~yll~h~siLil.g diverse molecules on substrates. The substrates are distributed to selected reaction vessels from a parent vessel. Reagents are then introduced into the reaction vessels to synthesize a portion of the molecules. The substrates are then moved to the parent vessel for mixing. The substrates are then lrA,~l,il...lr~l to the reaction vessels for further synthesis. The cycles continue until a desired set of molecules are ~yllLll~iL~ During synthesis, the entire synthesizer is sealed from the external dLIllU;llJIl~lt:.
In general, the invention provides apparatus and improved methods for generating and screening molecular libraries in which the individual molecules in the library are tagged with unique, easily decoded identifier tags.
A further l---d~ ~L~ of the nature and advantages of the invention may be had with reference to the description and drawings below.
DESCRIPI`ION OF THE DRAWINGS
Fig. I shows a schematic diagram of the synthesizer of the present invention;
Fig. 2 shows a schematic diagram of a reagent reservoir;
Fig. 3 shows a 3-port valve used in the synthesizer;
Fig. 4 shows a 2-port valve used in the ~yllLll.~

~VO 95112608 2 1 7 5 5 8 7 PCI`IUS9~11123 17 ~
Fig. 6A shows an alternative ~ al.~ lL of a reaction vessel bank having a rotatable carousel holding a plurality of groups of reagent reservoirs;
Fig. 7 shows the among a lower manifold valve, an injcction valve, a reagent reservoir, and a reaction vessel;
Fig. 8 shows a ~ iC agitator;
Fig. 9 shows the upper portion of a reaction vessel bank;
Figs. lOA and IOB show a lower reaction vessel bracket;
Fig. llA-1 lD show an optical alignment block for use with optical sensors to detect the presence of a liquid within a substantially translucent tube according to one aspect of the present invention;
Fig. 12 shows a reaction vessel according to one aspect of the present invention;
Fig. 12A shows a ~ r controlling jacket around the reaction vessel of Fig. 12;
Fig. 12B shows a cross-sectional view of the jacket and vessel of Fig. 12A;
Fig. 12C shows an alternative; ' ~ " of reaction vessel having a lLulc controlling jacket;
Fig. 12D shows a cross-sectional view of the jacket and vessel of Fig. 12C;
Fig. 13 shows a parent vessel;
Fig. 14 is a simplified diagram of the electronic hardware for controlling the ~y~ ,.;~"
hg. 15 shows a simplified diagram of the controller circuit;
Flg. 16 shows the steps taken by the control computer to drain the reaction vessels of all liquids;
Fig. 17 shows the steps taken by the control computer to clear the bottom manifold of material;
Fig. 18 shows the steps taken by the control computer to agitate the contents of the parent vessels;
Figs. I9A through 19D show the steps taken by the control computer to reallocate the bead suspension from the parent vessel to the reaction vessels;
-~UBSTlTUrE SHEET (RULE 261 ~ wo gS/12608 2 i 7 5 5 ~ 7 PCT/US9.1/123~7 Fig. 20 shows th~ steps taken by the control computer to fill the reaction vessels with reagents from the ~ cd delivery system;
Figs. 21A-21D srhpmqrir~lly illustrate the steps taken by the control computer to fill the reaction vessels with reagents from the ,ul~ cd delivery system;
Fig. Z2 shows the steps taken by the control computer to introduce amino acid monomers into the reaction vessels;
Figs. 23A-23C 5rhPmq~irqlly illustrate the steps taken by the control computer to introduce amino acid monomers into the reaction vessels;
Fig. 24 shows the steps taken by the contro', computer to transfer the bead suspension from the reaction vessels to the parent vessel for mixing;
Fig. 25 ~rhPi~ir~lly illustrates the data flow among the major modules of the control software;
Fig. 26 srhpm~rirqlly illustrates the command interpreter structure;
Fig. 27 crhPrrq~ir~lly illustrates the scheme used to access valve data; and Fig. 28 crhPm~tir~lly illustrates the scheme used to access sensor data.
Fig. 29 shows a device for ~yilLll. ~;~;llg cu.,.l, I chemica', libraries on IlI;~lUi~.Ui~;C beads. The device is composed of a vacuum manifold or magnetic plate attached to a solid substrate having a synt,~,esis surface having an arr~,y of reaction sites at which cù...l~uu~ can be ~yl-L~ cd. The partition block is composed of an array of 20 reaction wells Cullc~uul..'i;.lg to said reaction sites and is used to partition library members after each mixing step. The device can a-,so be used to aid the synthesis of tagged chemica-, libraries.
Fig. 30 illustrates the use of 13C NMR to monitor the stability of ll,;~ .,li.l;"~ . . Panel C shows the 13C NMR spectrum of support bound i .
25 which has been doubly labeled with a 13C atom at the position 2 of the ring and at the position a'ipha to the carbonyl of the ,inker (labeled positions are indicated with a "*").
Panel B shows the 13C NMR spectrum of support-bound doubly labeled rhi~7r,li~1inn~nP after treatment with 95% TFA for 1 hour. Panel A shows 13C NMR spectrum of support bound doubly labeled II.;r ~ ..J ~ after 40 cycles of DNA synthesis.
Fig. 31 further i,lustrates the use of 13c NMR to monitor the stability of thi~7~ nl-nPc Panel C shows the 13C NMR spectrum of support-bound thi~7r.1i~' -which has been doubly labeled with a 13C atom at the position 2 of the ring and at the position aipha to the carbonyl of the linker (labeled positions are indicated with a "*").

WO 95/12608 ` PCT/US9.1/123~7 Panel B shows the 13C NMR spectrum of support-bound doubly labeled thi:;7~1ifiin~nP after 90 minute photolysis in PBS buffer. Panel A shows 13C N~IR spectrum of support bound doubly labeled ~ l;,-.",f after 3 hours of photolysis in PBS buffer.
Fig. 32 shows an HPLC trace for the reaction mixture produced by S subjecting a support-bound ~hi~7f~ innnf to 40 cycles of DNA synthesis and 3 hour photolysis in PBS buffer.
Fig. 33 illustrates a graphic user interface ("GUI") as ;,,,~ ,t -~ on the control computer. As shown, the GUI includes a rect~ngular window 1301 with a workspace 1303. At the top of the window is a menu bar 1305 with user command choices 1306-1313. Each of these command choices include additional submenus forcontrolling the operations of the synthesizer. A user can program the synthesizer by selecting the ~ " command choice with the mouse.
Fig. 34 depicts the GUI, showing the submenu options in the Macro menu.
Fig. 35 depicts the dialog box for running a macro.
Eig. 36 depicts the GUI, showing the submenu options in the Groups menu.
Fig. 37 depicts the GUI, showing the submenu options in the Variables menu.
Fig. 38 depicts the GUI, showing the submenu options in the Diagnostics menu.
Fig. 39 depicts the valve diagnostic screen.
Fig. 40 depicts the sensor diagnostic screen.
Fig. 41 depicts the GUI, showing the submenu options in the File menu.
Figs. 42-44 show the dialog boxes involved in setting up a synthesis, allowing the user to select the reaction vessels to be used in the synthesis (Fig. 42), select the start, loop and end macros (Fig. 43) and enter the amino acid symbol and olig~,,, " l~,l;,l~ code for each reaction vessel (Fig. 44).
Fig. 45 depicts the GUI, showing the submenu options in the Synthesis menu.
Fig. 46 depicts the status display during a synthesis or macro execution. ,-Fig. 47 depicts the User Abort dialog box.
Fig. 48 depicts the GUI, showing the submenu options in the Edit menu.
Fig. 49 5~hPm~ti~ y illustrates the data flow among the major modules of the control software in a Windowsn' environment.

WO95112608 587 PCTIIlS91/123.17 DESCRIPTION OF THE SPECIFIC EMBODIMENTS
The present invention relates generally to improved methods for generating and screening tagged chemical libraries. The present invention also relates to a device useful in synthesizing collections of diverse molecules, such as the described tagged 5 chemical libraries.
To appreciate the value of the improved methods, one must understand not only the basic mr-thnrlr~logy for making and using tagged libraries but also how the various steps of synthesis and screening interact and how the selection of reagents impacts the results achieved. Tagged chemical libraries are often ~y~ iLcl on a solid support, and 10 the choice of support and linker is critical to success. A linker can be used to attach the support to the tag, to attach the support to a library molecule, or, in an . .,.l-o.l;, where there is no solid support, to attach the tag to a library molecule. The choices relating to chemical building blocks, tags, and synthesis methods can be ef~ually critical and are also impacted by the nature of the solid supports and linkers available. The assays and 15 ~ dLi~l~s for which the tagged libraries are intended also impact these choices, as well as the il~ LdLiul~ and reagents available.
Although the apparatus and methods of the present invention are illustrated primarily with regard to the synthesis of oli~ c and peptides, the invention is not so limited. The invention will find application in the synthesis of materials such as 20 pol~ f ~ lCI~ r~ UI~LIIcLl~ f i, ~ , and beta turn mimetics, and other materials. Cyclic materials may be formed as disclosed in U.S.
Patent No. 5,242,974 (Holmes), i.,.~ dL~d herein by reference.
The use and synthesis of diverse materials such as .~ c and peptides is disclosed in further detail in the following copending applications, which are 25 i~c~ )oldl1d herein by reference for all purposes: U.S. Application Seria~ No.
07/876,792, filed on April 29, 1992; U.S. Application Serial No. 07/762,522, filed on September 18, 1991; and U.S. Application Serial No. 07/946,239, filed on September 16, 1992.
The description of the invention is provided as indicated by the following 30 outline:
OUTLINE
I. Overview of a Synthesis of a Tagged Chemical Library -2 1 755~7 WO 9~;/12608 PCTI~S9~/123~7 Il. The Solid Support A. Types B. Linkers C. Molecular Supports S III. The Chemical Building Blocks A. Oligomers and Monomers B. Other Building Blocks IV. The Tag V. Synthesis Methods A. Ol j~""~ Tagged Peptide Libraries B. Improved Method for SyllLll.,;Lillg Oligonucleotide-Tagged Peptide Libraries C. Small Molecule Synthesis D. Methods for Generating Soluble Libraries 15 V~I. Assay Methods A. Screening Assays for Bead-based Libraries B. Screening Soluble Molecules C. Screening Natural Product Libraries VII. I,l~Llu,,,~llLG~ion and Reagents 20 VlII.Apparatus for Parallel Coupling Synthesis Redctions Examples End of Outline In addition to the outline abûve, the following glossary is provided to 25 facilitate the description of the invention, and a number of abbreviations and terms are defined to have the general meanings indicdted as used herein to describe the invention.
Abbrevi~ n~ HBTU, O-QJ~,IlLULlilLOI-I-yl)-l,1 ,3,3-tetramethyluronium dnuu~ u~ HOBt, l-hy~ u~.y~ HATU, [0-(7-dL~b~.LUll;dLul-l-yl)-1,1,3,3 t~.ldUII~lllylUI~ n"~ r' ', TFA, L inuul~ua~Lic acid; TCA, 30 trichloroacetic acid; DIEA, dii~u,ulu~ylc;Lllyldlllill~, DMF, dimethylformamide; Fmoc, 9-fluorenylmethyloxycarbonyl; DMT, dimethoxytrityl; Trt, trityl; Bz, benzoyl; Pmc, 2,2,5,7,8-pentamethylchroman-6-sulfonyl; 'Boc, rer~-butyluAy, dubu--yl; PBS, I ' ,' buffered saline; BSA, bovine serum albumin; mAb, mnno~ l antibody.

~ wo 9~/12608 2 ~ 7 5 5 8 7 Pcrluss~ll23~7 C~ f. ~ rl~ or Allhctf~nti~lly ~v~ llrll~ . These terms refer to the ability of one compound to bind to another, e.g., as a ligand binds to its c,~,l,l,l.. ~I ~y receptor. Typically, these terms are used in connection with a description of base pairing between nllrlPntiflPc of nucleic acids, such as, for inshnce, between the two strands of a 5 double stranded DNA molecule or between an nli~nnllrlPoti~p primer and a primer binding site on a single stranded nucleic acid to be sequenced or amplified. "C~ ,l. .llrlll- y"
: ' are, generally, A and T (or A and U), and C and G, but there are a wide variety of synthetic or modified "". lr.JIif'f; with binding properties Icnown to those of skill in the art. "Subshntial ccmnrlf.~ ;ly" exists when an RNA or DNA strand will 10 hybridize under selective hybridization conditions to a ~ ,lf.~r~ ,y nucleic acid.
Typically, llyblidi~Liu~ will occur when there is at least about 55% 1 ~",,1,1 ...... ~1 .l ily over a stretch of at least 14 to 25 I,,,,I..ll;rlf c but more selective hybridization will occur as CUII.I.I .1- I~ y increases to 655~o, 75%, 9û%, and 100%. See Kanehisa, 1984, ~Çl.
~ Res. 12:203, illCul,~)l ' ' herein by reference. Highly selective l~yblidi~Li 15 conditions are Icnown as "stringent hybridization conditions", defined below.Epitope: This term is used to describe a portion of an antigen molecule delineated by the area of interaction with the subclass of receptors Icnown as antibodies.
IdPntifiPr t~ In the most general sense, this term is used to denote a physical attribute that provides a means whereby one can identify a chemical reaction, such 20 as a monomer addition reaction an individual solid support has ~ PCI in the synthesis of an oligomer on that solid support. The identifier hg serves to record a step in a series of reactions used in the synthesis of a chemical library. The identifier hg may have any rPcog~i7~hlP feature, including for example: a microscopically or otherwise ~ 1;. g,.;~ ,lf shape, size, mass, color, optical density, etc.; a differential dbSVl~ G or emission of 25 light; chemically reactivity; magnetic or electronic properties; or any other distinctive mark capable of encoding the required i,~rvl,lld~iull, and llf ;1~ at the level of one ~or a few) molecules. A preferred example of such an identifier tag is an f~l,g~"..fl. Jl;flf, because the nucleotide sequence ûf an l.li~ lf,JL;~l~P is a robust form of encoded ;,lr..,... l;.~" An "identifier tag" can be coupled directly to the oligomer ~ .iL~d, 3û whether or not a solid support is used in the synthesis. In this latter ...,1,.,.1;,.,...1 the identifier tag can ccmrPrtl~lly be viewed as also serving as the "support" for oligomer synthesis.

WO 95112608 2 ~ 7 5 5 8 7 PCT/US9~1123.17 L~: This term is used to denote a molecule that is recogni~ed by, typically by binding to, a particular receptor. The agent bound by or reacting with a receptor is called a "ligand", a term which is ~iPt`initionqlly meaningful only in terms of its ~UUIIt~ UI receptor. The term "ligand" does not imply any particular molecular size or 5 other structural or ~.~."~ 1 feature other than that the substance in question is capable of binding or otherwise interacting with the receptor. Also, a ~ligand" may serve either as the natural ligand to which the receptor binds, or as a functional analogue that may act as an agonist or antagonist. Ligands that can be investigated by this inYentiOn include, but are not restricted to, agonists and antagonists for cell membrane receptors, toxins and 10 Yenoms, viral epitopes, hormones, sugars, cofactors, peptides, enzyme substrates, cofactors, drugs (e.g., opiates, steroids, etc.), and proteins.
Monomer: This term is used to denote any member of a set of molecules that can be joined together to form another molecule or set of molecules, such as a set of oligomers or polymers. Sets of monomers useful in the present invention include, but are 15 not restricted to, for the example of peptide synthesis, the set of L-amino acids, D-amino acids, or synthetic amino acids. As used herein, "monomer" refers to any member of a basis set for synthesis of an oligomer. For example, dimers of L-amino acids form a basis set of 400 "ll~olloll~ " for synthesis of polypeptides. Different basis sets of monomers may be used at successive steps in the synthesis of a polymer. Those of skill in the art 20 will recognize that a "monomer" is simply one type of "chemical building block" and that any type of chemical building block can be employed in the present method, regardless of whether one is synthesizing an oligomer or a small organic molecule or some other molecule.
Oli.~omer or Polymer: These terms are used to denote molecules that are 25 forrned by a process involving the chemical or enzymatic addition of monomer subunits.
Such oligomers include, for example, both linear, cyclic, and branched polymers of nucleic acids, poly~ hqri~lr~ pt.~ and peptides having either alpha-, beta-, or omega-amino acids, hct~luuolyll,~l~, polyul~LI,~ , polyesters, polyu~ubul,~t~, polyureas, pol~lll";J~, polyethylrn~imin~ polyarylene sulfides, polysiloxanes, polyimides, 30 polyacetates, or other polymers, as will be readily apparent to one skilled in the art upon review of this disclosure.
Pe~tide: This term is used to denote an oligomer in which the monomers are alpha amino acids joined together through amide bonds. A "peptide" can also be Wo 9S112608 2 ~ 7 5 5 8 7 PCTlUS9~ill23~7 referred to as a "polypeptide." In the context of this invention, one should appreciate that the amino acids may be the L-optical isomer or the D-optical isomer. Peptides are more than two amino acid monomers long, but more often are more than 5 to 10 amino acid monomers long and can be even longer than 20 amino acids, although peptides longer than 5 20 amino acids are more likely to be called "polypeptides." Standard single letter .~ abbreviations for amino acids are used (e.g., P for proline). These abbreviations are included in Stryer, Bio~ liaLly. Third Ed. (1988), which is i,.~o.~o.~L~ herein by reference.
Oli~ vl;d~s This term is used to denote a single-stranded DNA or 10 RNA molecule, typicaLIy prepared by synthetic means. Oliennl~rlpoti~ipc employed in the present invention will usually be 50 to 150 nllrlPotir;Ps in length, preferably from 80 to 120 nl~rlPnîi~iPc although r,li~nnllrlP~ti iPc of different length may be .IL.~,u~ L~ in some For instance, an olig.~ PI~I;fiP tag can be built nucleotide-by-nucleotide in coordination with the monomer-by-monomer addition steps used to synthesize the 15 oLigomer. In addition, very short, i.e., 2 to 10 rlllrlPnti~i~c~ nlig~.,..l. l.'.~l;~iPC may be used to extend an existing .~i;~...,..,l~.,li~P tag to identify a monomer coupling step. Suitable oligrnllrlt oiiriPc may be prepared by the IJI .~L.llUI"".; iitP method described by Beaucage and Carruthers, 1981,1~51. Lett. _: 1859-1862, or by the triester method, according to Matteucci et al., 1981, I. Am. ~m. Soc. 103:3185, both il~u~L~u~LPd herein by 20 reference, or by other methods such as by using commercial automated r,l;~" ~ P
Operably linked: This terms refers to a functional l~.L.lic.,l~l,iLJ between onesegment of a nucleic acid and another. For instance, a promoter (or enhancer) is"operably linked" to a coding seouence if the promoter causes or otherwise positively 25 influences the l..,..~ .L;~ of the coding sequence. Generally, operably linked means that the nucleic acid segments or sequences being linked are contiguous and, where necessary to join two protein coding regions, contiguous and in reading frame.
p~r~llPI Cou~lin~: This phrase refers to the ~i""lll~ coupling of two building block ~ u.~ to separate distinct points on a substrate. Such a substrate may 30 be a solid support having distinct groups to which these building blocks are attached, or may constitute another chemical compound possessing two distinct groups where each building block ;~ ..lly attaches. Sim~lt~nl OllC coupling refers to the coupling of two c~ o~ c to such distinct points prior to the addition of a new building block compound WO 95/12608 2 T 7 ~ 5 8 7 PcTlu59~l1123~J7 ~

to the first coupled building block. Thus, the term "cimlllt~n~n~ as used in this context is not strict in the sense that the two building blocks are coupled with precise ~ rlll e.
Rece~tor: This term refers to a molecule that has a specific affinity for a given ligand. Receptors may be naturally occurring or synthetic molecules. Receptors can 5 be employed in their unaltered natural or isolated state or as aggregates with other species.
Receptors may be attached, covalently or noncovalently, to other sllhctAnrpc Examples of ,.
receptors that can be employed in the method of the present invention include, but are not restricted to, antibodies, cell membrane receptors, mnnnrlnnAl antibodies, antisera reactive with specific antigenic .Irlrl,...,.- ,l~ (such as on viruses, cells, or other materials), 10 ~oly.,... 1~ C, nucleic acids, lectins, poly~ C, cells, cellular ~ U~ S~ and organelles. Receptors are also known as "anti-ligands." A "ligand-receptor pair" is formed when two molecules, typically Ill,~ ""nl~. "lPc, have combined through molecular I~U~ iUl. to form a complex. Other examples of receptors include, but are not restricted to specific transport proteins or enzymes essential to survival of l";..luùl~;Auli",.s for which 15 antibiotics are needed; the binding site of any enzyme; the ligand-binding site on an antibody molecule; a nucleic acid; a catalytic polypeptides as described in Lemer et al., 1991, Science 252: 659, incorporated herein by reference; and hormone receptors such as the receptors for insulin and growth hormone.
Substr-AtP or Solid Support: These terms denote a material having a rigid or 20 semi-rigid surface. Such materials will preferably take the form of small beads, pellets, dislcs, or other convenient forms, although other forms may be used. In some clllbùdilllcllL~, at least one surface of the substrate can be sllhctAnti~ y flat. A roughly spherical shape is preferred.
Strineent llylJli~ iul~ conditions: This phrase refers to highly selective 25 hybridization conditions in which nucleic acids remain stably bound in association with other nucleic acids (or other segments of the same nucleic acid) only if the associated sequences are perfectly or highly (i.e., greater than 80%) ~u..,l~l ,.,. .llAly. Such conditions typically include salt rr~nrPntrltinnC of less than about I M, such as less than 50û mM, and will often include salt ..~ ;n.~c of less than 200 mM. The hybridization l~,lll~ldLulc ,-30 for oligomers will typically be greater than 22 C, such as greater than about 30'C, andwill often be in excess of about 37 C. Longer fragments may require higher hybridization t~ Lulcs for specific hyhririi7AAtinn As other factors may dramatically affect the stringency of hybridization (such factors include base ~I.Ull}lO~i~iOl~, length of the ~ wo 95/12608 1 7 5 5 8 7 PCT/US9~/12347 .y stlands, presence of organic solvents, and extent of base mi~m~rhin~), Lhe ~u".l,~ ;.." of factors is more important than the absolute measure of any one factor alone.
Synthetic: A compound is "synthetic" when produced by in vitro chemical 5 or enzymatic synthesis. The synthetic libraries of the present invention may be contrasted with those in viral or plasmid vectors, for instance, which may be ~ ' in bacterial, yeast, or other living hosts.
I. Overview of the Synthesis of a Tagged Chemical Library The present invention relates generally to methods for ~ -Lh~;,iLil-~ and screening tagged chemical libraries. In essence, each "book" of a chemical library of the invention consists of a chemical or molecule of interest, a tag identifying the chemical or molecule of interest or some important aspect thereof, and a linkage between the chemical 15 or molecule of interest and the tag. In one important ~mho~iiml nt~ the chemical or molecule of interest is an oligomer such as a peptide, the tag is an oligomer such as a nucleic acid, and the linkage is a solid support or particles, from which oligomers and tags may optionally be cleaved, e.g., to facilitate detection or to provide a soluble library.
Such libraries can be screened to isolatc individual oligomers that bind to a receptor or 20 possess some other desired property. A general method for producing a tagged chemical library is illustrated by the production of a large, highly diverse collection of oligomers, in which each different library member is an oligomer with a unique monomer sequence relative to other library members (although the library will typically comprise duplicate "books"). Such a library or collection may contain, for example, all ~ ;.."c of X
25 different monomers in a set of monomers assembled into length n oligomers yielding, X' different o"~l,u,. ~1~ The collection may also contain oligomers having different monomer units at, for example, only one or a small number of positions, while having an identical sequence at all other positions.
A general method for syllLl~ such collections of oligomers typically 30 involves a random ,.~",1.;",.1...; ~l ("stochastic") approach and the chemical andtor enzymatic assembly of monomer units. One process comprises the steps of: (a) dl"JulLi~..i.~g a plurality of solid supports among a plurality of reaction vessels; (b) coupling to the supports in each reaction vessel a first monomer and a first tag using 2i 75587 Wo gS/12608 PCTIIIS9~/12 different Flrst monomer and tag ,o...l,i"~iu-.~ in each different reaction vessel; (c) pooling the supports; (d) ~IUUUlLiUllillg the supports among a plurality of reaction vessels; (e) coupling to the first monomer a second monomer and coupling to either the solid support or to the first tag a second tag using different second monomer and second tag 5 ~ c in each different reaction vessel; and optionally repeaùng the coupling and ulLullillg steps with different tags and different monomers one to twenty or more times.
Typically, sl~hcrSm~ y equal numbers of solid supports will be ~yyulLiull~d to each reaction vessel. Those of skill in the art recogmze that the same chemical building block can be employed in different coupling steps and that the same chemical building block can 10 be employed in more than one coupling reaction (reaction vessel) of a single coupling step.
To visualize the method more readily, one might first consider the stochastic synthesis of an untagged library of all oligomers three residues in length, assembled from a monomer set of three different monomers: A, B, and C. Three aliquots of beads are .I,Up~ iUII~ among three reaction vessels, and monomer A is coupled to the beads in the 15 first reaction vessel, B is coupled in the second, and C in the third. The beads from all the reaction vessels are then pooled. The pool contains ~ lu,.illl..t~ly equal numbers of three different types of beads, with each type . ~ by the monomer coupled to thebead. The pool is mixed and l~ I to the separate monomer reaction vessels, each containing A, B, or C as the ne~t monomer to be coupled~
2û Following this coupling reaction, each reaction vessel now has beads withall three different monomers in position one and the monomer contained in each particular second reaction vessel in position 2. All beads are pooled again, producing a mixture of beads each bearing one of the nine possible dimers. The pool is again distributed among the three reaction vessels and coupled to the three different monomers, producing the complete set of all trimers of the three monomers (33 = 27). As can be readily -luy~ L~I, the use of a ~u~rc;~-lLly large number of synthesis beads helps to ensure that the æt completely represents the various comhin~irmc of monomers employed in this random, stochastic, ~ ";~l synthesis scheme.
Mo.l;r. ~ of this completely random approach are also possible. For 3û example, the monomer æt may be expanded or contracted from step to step; or the monomer set could be changed completely for the next step (e.g., amino acids in one step, ~' ~ ' in another step, ,~bollydl_'~,, in another step), if the coupling chemistry were available. A monomer unit for peptide synthesis, for example, may include single amino ~ wo g~/1260g 2 ~ 7 5 5 8 7 PCTIUS9~1123~7 acids or larger peptide units, or both. One variation is to form several pools of various sequences on solid supports to be distributed among different monomer sets at certain steps of the synthesis. By this approach, one can also build oligomers of different lengths with either related or unrelated sequences, and one can fix certain monomer residues at some 5 positions whi~e varying the other residues, to construct oligomer r.d..l~ ~.Jll~ wherein certain residues or regions are altered to provide diversity.
The synthesis of a tagged chemical library often involves such . ' synthesis steps. Because the identifier tag can be easily decoded to report the identity of each oligomer, however, tagged chemical libraries can be cienifi~ntly larger and more 10 complex than untagged libraries. In fact, the present methods for syllLI~ g encoded synthetic libraries of ~u,.~l,uu~ makes possible the screening of large collections of non~ u. ~1,1~ ~ul~lpuullJs produced by multi-step synthesis.
In particular, the use of oliennllrlPo~ p tags and olignnllrlpori~1p encryption provides a powerful nn.~h~nicnn for recording the structural identity of every member of 15 vast library of tethered co"~ull-~J~, especially peptides, generated through a synthesis. The methods are broadly applicable to encoding the ~u~ l assembly of other non-peptidic structures, providing the parallel synthetic schemes remain orthogonal and comr~ihlP The net outcome of a culllb;llalulidl synthesis is ~ ly def~ned only for a sequence of reactions that each proceed in very high yield to afford single 2û products. This situation is ~ u~Jlll~t~J with standard peptide and DNA synthesis , and the resulting product structures are explicitly specified by the order of the building blocks andtor coupling reactions used in the synthesis.
However most synthetic organic reactions are more idiu~ LLi-, giving variable yields and frequently multiple products (such as regio- and st~l~
25 structures). Using such chemistry to synthesize ~",~);",.1",;~l libraries on solid supports yields a mixture of products on each bead in the library. In the most general case, the encryption of a synthesis may not uniquely specify the chemical structure of an associated entity. Rather, the encryption process may more accurately be viewed to encode the exact synthetic protocol (e.g., reagents, reaction conditions, etc.) by which a member of the 30 library was constructed. The library is screened to identify "active recipes" that then can be ~c~luJuucd on a plc~ Livc scale and r.~. I;n..,-t .1 (if necessary~ to isolate the bioactive ~iclll~iln~ (s)~ The encoded library ~Prhn~ giP~ have c~nci~lpr~hle potential to expand the Scope of ~ul~ Luli~l chemistry and its applications to drug discovery and the WO 95112608 2 i 7 5 5 8 7 PCTIUS911123.~7 ~
dc~lv~ and isolation of a wide variety of useful ~ Jr~ With this overview of the synthesis of tagged molecular libraries, one can better appreciate important aspects of the invention, such as the use and choice of solid supports in library synthesis.
5 II. The Solid Support A. Types Typically, the tagged chemical libraries of the invention are composed of a collection of "solid supports", such as beads or particles. Such solid supports may be of 10 any shape, although they will preferably be roughly spherical. The supports need not necessarily be l~ r.". ,.- ~ in size, shape, or romr~Cit;rm although the supports usually and preferably will be uniform. In some e...l~oJi~ , supports that are very uniform in size may be particularly preferred. In another ..~ , however, two or more distinctly different p,.l~ul-';",.~ of solid supports may be used for certain purposes, i.e., the 15 solid supports may be composed of a single particle, or two or more linked particles.
Solid supports may consist of many materials, limited primarily by capacity for derivatization to attach any of a number of chemically reactive groups and comr~tihility with the chemistry of oligomer or other molecular synthesis and tag :Itt~hmr-n~ Suitable support materials include glass, latex, heavily cross-linked 20 polystyrene or similar polymers, gold or other colloidal metal particles, and other materials known to those skilled in the art. Except as otherwise noted, the chemically reactive groups with which such solid supports may be derivatized are those commonly used for solid state synthesis of the respective molecule or oligomer and thus will be well known to those skilled in the art. The term "solid support" as used herein embraces a particle with 25 d,u~luulid~e sites for oligomer synthesis and, in some ~."I,orli",. ~ , tag attachment and~or synthesis. There are various solid supports useful in ~lC~dUdLiUII of the synthetic oligomer libraries of the present invention. Solid supports are commonly used for solid phase synthesis of, for example, peptides and nucleic acids and other oligomers as;
above, and thus are well known to those skilled in the art. The solid supports of the ' 30 present invention do not include living cells, viruses, or cloning vectors such as phage vectors or plasmids. Mon~bP~icTY (commercially available from Pharmacia Fine Chemicals AB, Uppsala Sweden) or their equivalent, are udlLicul~ly useful as solid supports for the various aspects of the present invention. MonobeadsTY provide good size ~ wo 95/1261~8 2 1 / 5 5 8 7 PCT/US9~/123.f7 I-f ~ ~,. Iy and a small size, 10~m. Further, these MonobP~srA do not clump in eitber organic or inorganic solvents, and provide a suitable support for both olieon~clf-otiflP and peptide synthesis. Finally, M.. ~ provide very high loading of primary amines (100 nmolelmg).
S One important aspect of the particular solid support chosen for practicing the invention is the size of the support. With enough solid supports and efficient coupling, one can generate complete sets of cert,~in oligomers, if desired. In general, the solid support size is in the range of 1 nm to 100 ~m, but a more massive solid support of up to 1 mm in size may sometimes be used. The ~ IUIJl;..'~, size of the solid support depends 10 on (1) the number of oligomer synthesis sites and identifler tag attachment sites desired;
~'2) the number of different ~ u l~ to be ~yl~ J (and the number of solid supports bearing each oligomer that are needed for screening); and (3) the effect of the size of the solid supports on the specific screening strategies [e.g., nuulc.. ~.~c~-activated cell sorters ~'FACS)] to be used.
As a specific example, solid supports of 1 ~m in diameter may be used in the method. If each reaction vessel contains ~ 'y 0.2 mL of solid supports, and the oligomers are ~yllLII~;~ from a set of 50 monomers (50 parallel reactions), then a total of 10 mL of solid supports, or .,~ / 10~3 solid supports, would be re~uired.
If one wishes to make hexamers with these 50 rf~nnnmpr~ then there are over 1.5 x 10 20 possible se~uences, and each specific se~uence would be ~ t~ on about ld3 solid supports. An estimated capacity of each bead, based on the capacity of commonly used peptide syllth~.~iJ.g resins, is about 0.1 pg of peptide per bead. By this estimation, then, each solid support would have about 100 amol or 10~ oligomer chains.
To improve washing . r,~ r - C, one could employ nonporous beads or5 other solid supports less porous than typical peptide synthesis; however, for certain of the invention, quite porous beads or resins work well and are often preferable. Nonporous supports will have a lower density of growing chains, but even with a decrease in ~apacity of several orders of magnitude, sufficient oligomer densities '~ can be produced for efficient screening. With the less porous supports, a greater 30 proportion of the oligomers will be accessible for binding to the receptor during the screening process. Also, the less porous supports will reduce the carryover of tags from one reaction to the next, thus improving the accuracy of reading the dominant (correct) tags.

WO 95112608 2 ~ 7 5 5 ~ 7 PCT/US9-11123-17 As noted above, another . ,l-o~ involves the use of two solid supports, such as beads, that are physically linked together, one with synthesis sites (or linkers) for the molecule or oligomer and one with attachment sites (or linkers) for the identifier tag(s). This ..",~ allows the sc~;,C~"lLiul~ of molecules or oligomers and identifier tags into discrete "zones" and permits the use of widely different chemically reactive ~roups and nhpmic~rips for :~t~rhmrnt The solid supports can be derivatized sepaMtely and then linked under conditions where all or nearly all of the synthesis solid supports will have a tag-attachment solid support in tow. The solid supports can be of different sizes, as for example a large synthesis bead with several (or many) smaller tag-attachment beads linked. In one ~ o~ the first solid support will have at least one attached amino acid and the second solid support will have at least one attached nucleotide.
The mode of linking the two beads is constMined by the chemistry of oligomer synthesis. The most obvious means of linking the beads is with a h~.t~ 1ubirullctional cross-linking agent (for examples of such agents, see Pierce ImmunoTechnolo y Catalo~ and Handbook pp. E10-E18 (1991)) inteMcting with the dominant chemically reactive groups on each species of solid support. Such cross-linking agents can serve a variety of purposes, as indicated by the following section.
B. Linkers When bound to a solid support, the oligomer and its associated tag arc usually attached to the support by means of one or more molecular linkers. The linker molecule, prior to ~t~rhm~n~. has an a~ lUp functional group at each end, one group a~ Upl for attachment to the support and the other group àplJ1UIJ1id1C for attachment to the oligomer or tag. In some ~ o~l;,.,. .11~, cleavable linkers will be used to facilitate an assay or detection step.
Given the wide availability of diverse linking reagents, one can link the identifier tags either to the oligomer or other libMry compound of ;nterest or to the solid support or to a pre-existing tag. For instance, the identifier tag may be attached to a monomer il1- u1~Ju1~cd into an oligomer or to a building block illCUI~l ' ' into a ,' non-oligomeric compound. For peptidic oligomers, the side chain of a cysteine residue provides a convenient site for tag ~t~f~hmrnt In other instances, the tag could even be attached so as to cap a small number of the oligomer chains, providing the decreased amount of net synthesis of the desired oligomer could be readily tolerated. One can attach ~ WO 95/12608 2 ~ 7 5 5 8 7 PCT/US9~1123J7 the tag directly to the linker that binds the oligomer (or other compound of interest) to the solid support. In this ~ bodi~ , the linker has, pnor to ~tt~rhmPnt a third functional group dyyLUylidt- for the attachment of the identifier tag.
One can of course illCuluOIcl~ a wide variety of linkers, depending upon the 5 application and effect desired. For instance, one can select linkers that impart llydluyllobi--iLy~ hydrophilicity, or steric bulk to achieve desired effects on properties such as coupling or binding efficiency. In one aspect of the invention, branched linkers, i.e., linkers with bulky side chains such as the linker Fmoc-Thr(tBu), are used to provide rigidity to or to control spacing of the molecules on a solid support in a library or between 10 a molecule and tag in the library.
As noted abûve, cleavable linkers can be employed to useful effect.
Preferred photocleavable linkers of the invention include 6-nitrov~ lyluAy~l,ullyl (NVOC) and other NVOC related linker .~ u~ (see PCT patent publication Nos. WO
90/15070 and WO 92/10092; see also U.S. patent application Serial No. 9?1,181, filed 2 15 Nov. 1992, ill~ ulyOI.ll~d herein by reference). In another ~ budil..e~L, the linkers are nucleic acids with one or more restriction sites, so that one portion of a library member (either the tag, the oligomer or other compound of interest or both, or the solid support) can be selectively cleaved from another by the dyylUyli,lL~ restriction enzyme. This novel nucleic acid linker illustrates the wide variety of linkers that may be employed to useful 20 effect for purposes of the present invention.
C. Molecular Supports As noted above, the invention can also be carried out in a mode in which there is no solid support, and the tag is attached directly (typically through a linker) to the 25 oligomer or other molecule being ~yllL~ ~. Alternatively, the oligomer or otber molecule and its associated tag can be ~yllL~ on a solid support and then cleaved or otherwise removed from the solid support prior to screening or other use. Such methods are described more fully below. Regardless of whether a solid support is present, the size ~ and . u.. ~ .,. of the library will be determined by the number of coupling and mixing 30 steps and the monomers or other building blocks used during the synthesis.

WO 9S112608 2 1 7 5 5 8 7 pCT~lJss~llu~7 ~

m. The Chemical suilding Blocks A. Oligomers and Monomers The wide applicability of the present inventions is perhaps most readily S grasped by ~ ;"~ the synthesis and screening of large libraries of diverse oligomers and polymers. Oligomers are polymeric c.""l,u,~ composed of monomers; for biological polymers, the sequence of the monomers in an oligomer often specifiesimportant biological properties. Preferred oligomers of interest include peptides, olig.."l, ~ , oligo N-substituted glycines, and poly~,~ul,d~dL~. As noted above, for 10 purposes of the present invention a monomer is any member of a set of molecules that can be joined together to form an oligomer or polymer, i.e., amino acids, carbamates, sulfones, sulfoxides"l ~ ,dlbOllydldlc~ ureas, ~ , lipids, esters, - c~ of the same, and the like. Thus, the monomers may be of any type that can be ~ lUl~lidt~,ly activated for chemical coupling or accepted for enzymatic coupling.
This method of assembling oligomers from many types of monomers requires using the d~ u~ L~ couFling chemistry for a given set of monomer units or building blocks. Any set of building bloctcs that can be attached to one another in a step-by-step fashion can serve as the monomer set. The attachment may be mediated by chemical, enzymatic, or other mcans, or by a cnmhin~tinn of any of these means. The 20 resulting oligomers can be linear, cyclic, branched, or assume various other cullrullllaLiulls as will be apparent to those skilled in the art.
B. Other Building Blocks The invention is described herein primarily with regard to the lu-c~ -Liu-~ of 25 molecules containing sequences of amino acids, but the invention can readily be applied to the ~ J~dLiu.~ of other oligomers and to any set of cnmrolln~c that can be ~YII~ ;L~ in a component-by-component fashion, as can be ~ idt~ by those skilled in the art. For instance, rnmro~n~lc such as t.. ~ 5, hydantoins, and peptidy'~' .' can be prepared using the present methods (see U.S. patent application Serial No. 08/119,700, ,' filed 9 Sept. 1993, which is a n nn~in~l~tinn-in-part of Serial No. 081,577, filed 21 June 1993, now ~h~n~lnnPri, which is a cnntinll~tinn-in-part of U.S. Patent No. 5,339,115, each of which is i~l~,ul~u~dl~d herein by reference.

WO 9S/12608 L~ 1 7 5 5 8 7 PCTIUS9~/123 17 In one embodiment, the present method can be used to create libraries of branched polymers. While in many instances libraries of lincar polymers, such aspeptides, are quite useful, with more than 3-4 residues, the shape of these linear molecules becomes long and narrow. Most drugs do not have such an extended shape, perhaps due 5 in part to the high degree of flexibility of the molecules. Branched backbone polymers can result in molecular shapes similar to known drugs. Thus, in one ~ bodilll~,.lL, the present invention relates to the incorrJoration of monomers with at least three functional groups to which other monomers ca~n be attached.
If one uses such monome}s exclusively, however, then the fully branched 10 synthesis will always result in a high ratio (relative to the other monomers used in the synthesis) of the last monomer coupled. One could of course illuul~uldlr mixtures of different branching monomers to alter this ratio, but then one might have more difficulty in identifying the structure of a compound of interest, i.e., the more complex the mixture of branched mt-nrnn~rC, the less i.lrull~ iull the tag may provide about the particular 15 compound syllLllQiL~I. In an improved method of the invention, one il~,Ul~lUI...I~ a mixture of two monomers -- one capable of branching and one not -- at each monomer coupling step, producing a library COIll~ g a great diversity of shapes with highly informative tags. In this case, the tag would specify the monomers present at each coupling step but not whether the monomer was capable of branching. However, a simple 20 resynthesis using only those monomers contained in the selected set of ~ u~ ,u .1~ from the first library would readily identify the structure of those . ~.."I,u~
IV. The Tag The identifier tag has a ~rl,u~ iLdblc feature that is, for example, u~U~ ly or otherwise distinguishable in shape, size, mass, charge, or color. This Ir~ug.~ r feature may arise from the optical, chemical, electronic, or magnetic properties of the tag, or from some combination of such properties. In essence, the tag serves to label a molecule and to encode illrull~ldLiùl~ at the level of one (or a few~ molecules or solid supports. By using identifier tags to track the synthQis pathway that each member of a chemical library has taken, one can deduce the structure of any chemical in the library (i.e., the sequence of monomers of any oligomer) by reading the identifier tag.

2' 75587 WO 9S/12608 PCT/1)59-11123-17 One can construct Illi-,lU~,U,UiCdlly ir::~n~ifi:~hl~ lags as small beads o~
.~u~ ly different sizes, shapes, or colors, or labeled with bar codes. The tags can be "machine readable" l~.,..;nr~ 1 or radioactive labels. The identifier tag can also be an encodable molecular structure. The i~rO~ Liull may be encoded in the size (the length of S a polymer) or the c~rnCitinn of the molecule. Perhaps the best example of this latter type of tag is a nucleic acid sequence, i.e., RNA or DNA assembled from natural or modified bases.
To illustrate the role played by the tag in the,synthesis and screening of a chemical library, consider for example, the use of ~ lu~u~i~lly l~cu~l~i~blc, 0 -~i 'r tags that are attached to each bead in an oligomer synthesis. The tag "A1"
means that a bead participated in the A-monomer reaction at step 1, "C2" means that a bead ~?dlt; l ' in the C-monomer reaction at step 2, and "B3" means B-monomer was added in step 3, and so on. At the end of a 3-step synthesis, one bead would have three tags attached, e.g., A1, C2, and B3, indicating that the sequence of the peptides on the 15 bead is ACB. This scheme requires a number of distinct identifier tags equal to at most the product of the number of different monomers and the number of synthesis steps (nine in this example). The number of identifier tags is reduced if the symbols are attached to one another in the order of the steps: A, A-C, A-C-B, in which case only as manyidentifier tags are needed as monomers, and the identifier tag is assembled in a way that 20 preserves the record of what monomer was added, and in which addition step.
In another example, the tag is comprised of a variety of light-add~ dl,lc molecules, such as fluorescent or ,?I~,*,I.ul.~"~ cornrolln~c~ the spectral properties of which can be changed (e.g., ~ b~ g) and therefore used to store ,l.l-l., .,..l;...,.
which are used to mark each bead or other solid support in the library. In one such mode, 25 a bead i,.. .,l~ t ~ a variety of lluolu~llu~a, each of which can be selectively ~h .~ 1, and so rendered incapable of nuulu~i~ ..l, e or of diminished fluorescence.
During each coupling or chemical reaction step, the bead is irradiated (or not) to 1 (or not) one or more particular types of lluulu~Jhol~, thus recording the monomer identity in the oligomer synthesized. See Science 255: 1213 (6 Mar. 1992), A-~UI~.~i herein by reference.
The identifier tags therefore identify each monomer coupling or other reaction step that an individual library member or solid support has ~A~J~Ih,ll~,V,i and record the step in the synthesis series in which each monomer was added or other chemical 2 ~ ~5587 WO 9~112608 PCT/US9-ill23-17 reaction performed. The tags may be attached i.~ before, during, or after the monomer addition or other reaction, as convenient and compatible with the type of identifier tag, modes of lltt:lrhmr~nt, and chemistry of oligomer or other molecular - synthesis. As noted above, the identifier tag can be associated with the oligomer through a S variety of ,~ n.i~ , either directly, through a linking molecule, or through a solid ,~ support upon which the oligomer is synthesized. In the ~atter mode, one could also attach the tag to another solid support that, in turn, is bound to the solid support upon which the oligomer is ~y~ d. The identifier tag is added when the solid supports that haveundergone a specific monomer addition or other chemical reaction step are physically 10 together and so can be tdgged as a group, i.e., prior to the next pooling step.
In some cases, of course, when only a small number of monomer units of an oligomer are varied, one may need to identify only those monomers which vary among the oligomers, as when one wants to vary only a few amino acids in a peptide. For instance, one might want to change only 3 to 6 amino acids in peptides 6 to 12 amino 15 acids long, or one might want to change as few as 5 amino acids in polypeptides up to 50 amino acids long. One may uniquely identify the sequence of each peptide by providing for each solid support an identifier tag specifying only the amino acids varied in each sequence, as will be readily ~ ,id~-i by those skilled in the art. In such cases, all solid supports may remain in the same reaction vessel for the addition of common monomer 20 units and d~lJuilh)1~e~ among different reaction vessels for the addition of rii~
monomer units.
Synthetic olig~d~u7.y,i~ f~11irlr-s are especlally preferred i~ru1111d~iull-bearing identifier tags. Oli~on~ ti~ c are a natural, high density i r .. -~-~1i. ." storage medium. The identity of monomer type and the step of addition or 25 any other i..ru~ LiU11 relevant to a chemical synthesis procedure is easily encoded in a short r,li~ rif.J~ sequence. Oljgrm--rl~-oti ir-c, in turn, are reddily amenable for attachment to a wide variety of solid supports, oligomers, linkers, and other molecules.
For example, an nli~nnllrlPrltjde can readily be attdched to a peptide synthesis bead.
One ~ advantage inherent in using an rlligr~m~lrlPI~ti~iP-based coding 3û scheme is the ability to achieve tremendous levels of target ~mrlifir~tir~m through the pOI,ylll~.~d;~l; chain reaction (PCR, see PCR Prûtûcûls; A Guide tû MPthori~
~7~1ic~tion~ (Innis, M., Gelfand, D., Sninsky, J. and White, T., Academic Press, San Diego 1990); see also U.S. Patent Nos. 4,683,202 and 4,965,18g, each of which is Wo 9~112608 ~ ~ 7 5 5 ~ 7 PCT/USg~/123 ~ uluu ' herein by reference) and other nucleic acid replication and ~ iri. -~;.."
techniques. Although the most commonly used irL vitro DNA :~mrlifir~tirln method is PC~, suitab~e alternate ~mrlifir:ltion methods include, for example, nucleic acid sequence-based amplification (Compton, 1991, Nature 350:91-92, il~Cu,L,ulAt_i herein by 5 reference) and amplified antisense RNA (Van Gelder P~t al., 1988, Proc. Nat. Acad. Sci.
~l~ 85:7652-7656, il.~Ul~Ju-dL~d herein by reference), and the self-sustained sequence replication system (3SR, see Guatelli et al., 1990, Proc. Nat~. Acad. Sci. USA 87:
1874-1878, i,.~ul~u-~d herein by reference). Only tiny quantities (with highly selective and efficient methods, even a single copy is sufficient) of DNA template is required for 10 PCR, enabling one to use solid supports of microscopic dimensions and obtain larger libraries.
The use of nucleic acid tags facilitates the construction and screening of synthetic libraries that far exceed the diversity accessible through other tethered library techniques. Moreover, these libraries employ manageable quantities of bead material and 15 can therefore be assayed for receptor binding using practical volumes of biological reagents. One improved method of the invention relates to a limiting step in theprocessing of ESL libraries with oli~.-"~ ,Li~p tags ~ the ~ , strand separation, and sequencing of tags from individual beads. The method increases sequencing efficiency by at least an order of magnitude, and relates to the i...,u,,uu,~Liu-- of 20 a tag ~ ",~, ;,,.~;nn (, ' " ) step, in which a number of different tags typically amplified from a selected set of library members are ligated together prior to either cloning or sequencing of the oligonucleotide tags.
In one ~ ,ll of the method, the amplified tags are ' and then cloned as linear arrays of 10 to 20 (or even more) tags in a cull~ Liu.l.,l sequencing 25 vector. Preferably, ~ ulu~)~;dl~: restriction sites are installed adjacent to the "coding regions" (sequences with information content) of the ..lic""",~ idP tags; after amplifying the tags on a group of beads. the restriction sites are cut, and the fragments ligated to form . The concatamers are then cloned into an dlJplupli.lt4 sequencing vector.
Each template can then be used for bidirectional sequencing of a total of, for example, 500 to 800 bases, allowing tlle identification of more than at least 10 tags per template. This approach will also provide the option of avoiding the isolation of individual beads with FACS. Beads or tagged compûunds can be sorted into pools, the pool of tags amplified, c- i, and cloned for C~q~ n~in~. In addition, because the l~uil~ t to WO 95/12(~08 ~ 1 7 5 ~ 8 7 P -r/US9J/123-17 manipulate individual beads is relieved, one can use beads smaller than l ~Lm (typically, this size is too small for conventional FACS analysis) for library construction and screening. The selection can be conveniently Arcf mrli~hPA by affinity ,~ irlcALiull methods (panning, magnetic beads, etc.) and the enriched pools of beads then amplified 5 and cloned as above.
Oligrln~lrlpotifip identifier tags can be assembled base-by-base before, during, or after the ,.~, l~ ~l,.,.,.l;,.~ monomer coupling (for oligomer synthesis) or other chemical reaction step. In one case of base-by-base synthesis of an f~ f nllrlrl~tiflP tag, the tag for each step is a single nucleotide, or at most a very few ~ lPU~ (i.e., a block 10 of 2 to 5 nllr1P/~tif~Ps) In the block-by-block approach, encoded sets of nucleotides ("codons") of 2 to 5 to 10 or more bases are added as protected, activated blocks. Each block carries the monomer-type or other inff.~rmqtif n, and the order of addition of one tag ~-block to the next represents the order of the monomer addition or ûther reactions.
AI~ lALiY~;ly, the block may encode the oligomer synthesis or other reaction step number 15 as well as the monomer-type or other building block ;,.r." ",_ti"" This strategy preserves the order of the steps in the linear Al IAII~ of the r~liennllrlPotifip chain grown in para]lel with the oligomer. To preserve the chemical compatibility of the parallel synthetic steps (oligonucleotides and peptides, for example), one can modify the standard synthesis rhPmictriP~, an important aspect of the present invention discussed in further detail below.
20 One can also attach protected (or u.. ~lu~e.,~td) f~l;g~ . .,Lides containing A",~,liri. -li.", primer sites, monomer-specific i.,r."", ~ ", and order-of-reaction information, from 50 to 150 bases (lll.. lf,Jl;fi. ~) in length, at each step. At the end of a senes of n oligomer synthesis (monomer coupling) or other chemical synthesis steps, there would be n differently encoded sets of oli~.. ,l, If.,lifif identifier tags associated with each ~5 oligomer sequence or other chemical in the library. After identifying the oligomers with ligand activity, the associated oligul,uclcuLides could be amplified by PCR and sequenced to decode the identity of the oligomer or other compound.
As discussed more fully below, the choice of bases used in an oligu~ -lifl,P identifier tag is dictated by the chemistry of oligomer synthesis or other 30 chemica] reaction conditions to which the tag will be exposed. For example, the use of strong acid can depurinate nucleic acids. Therefore, when . ~ l l if-~ requiring the use of strong acid are employed, the use of an f~lie~mllr~pl~tide composed of only the pyrimidines C and T and a binary code can prove of value. In similar fashion, the lability of purine WO 95/lZ608 2 7 7 5 5 ~ 7 PcrluS9=i/lU=i7 ~
nucleotides to strong acid may be overcome through the use of the purine nucleoside analogs, such as 7-dea~a-2'-dcuA~a~ osil-~ and 7-deaza-2'-deu~y~,ùaulo~ e (see Barr _ 1., 1986, BioTechniques _:428-432, and Scheit, Nucleotide Analogs: Svnthesis andBiolo~ical Function pp. 64-65 aohn Wiley and Sons, New York), both of which are 5 i,~cul~oldtcd herein by reference). Use of these or other anaLogs would permit the use of a quaternary or other, as opposed to a binary, encoding scheme. Thus, in a preferred ,.
t,~ c~l;",r"l, the identifier tag will be an oligrmllrit~nt~ about 50 to 150 nllrltr)tiri~ in length and composed of pyrimidines or ~J~lillli~ill~i and punne analogs or any type of nucleoside that will not degrade under the coupling conditions used to assemble the lû oligomer library. The oligr~n~rlPnti~ir identifier tag may contain a 5' and a 3' :~mriifir~ti~n site, and optionally a DNA sequencing primer site, which may be specific for each step of the oligomer synthesis.
Encoding a, L I synthetic procedure with nli~on~lrll oti(i~ provides a mechanism for addressing the major limitations of ambiguity and sensitivity encountered 15 in the direct structural analysis of minute quantities of ligands isolated from large libraries.
The high capacity of DNA for information storage can be exploited to archive the precise details of a library's coll~LIu~Liul-. In Example I below, a "codon" structure of 2 contiguous nucleotides comprising three bases (c7dA, dC, T), capable of encoding a synthesis ill~UllJUl.lLil~g up to 32 = 9 amino acid building blocks was used (only seven 20 building blocks were used in the synthesis of this library). If c7dG was also included in the coding template, then a ~ l. ., ;,d synthesis employing 1000 different monomers could be ~rcrlmmnfi~tf (i by using a "codon" size of iuSt 5 ~lu-,leuLidcs (45 = 1û24).
Information may be encoded in the length rather than, or in addition to, the sequence of the olig~n~rl~nti~i~, or for that matter any other polymeric or oligomeric, tag.
25 If only length is utili~ed to represent each specific monomer addition to the oligomer, then the identity of the oligomer can be decoded by, for example, amplifying an oligu,luclcu~ide tag, as described above, and identifying the tags through any of a variety of size-separation techniques, including polyacrylamide gel or capillary gel elc~lu~ u.csis. Each different monomer added at a given step in an oligomer synthesis or each different chemical ~' 30 reaction step is Ir~Jlc~llt~i by an olig-""l~ IrlJL;~ir tag of unique length. The uli~ullu~l~olide tag contains àlll~Jlirl~à~iull sites, such as PCR priming sequences, the sequences of which are designed to be (.IIAI~I t~ of the given step-number in the oligomer or other chemical synthesis. Drlrl ",;"-~;",, of the oligomer composition a~ any given position in the secLuence then involves amplifying the tag using the PCR priming sequence rhqrq~fPricti~ for that step in the synthesis and size-separating the amplification products utilizing techniques well known in the art, such as gel or capillary electrophoresis (using the tagging f)li~ rl~--Litil~ as standards) This ~",l~ is particularly useful 5 when one desires to make a library of ~..,..l.~"",,i~ related to a lead sequence. One need only tag during steps in which a site being analoged is ~y~ ,d.
In addition to length, oligomer sequence informqti~n can also be encoded in the sequence of bases comprising the oliE-)n~rlP~-titlP tag. This type of encryption is of value not only in the ~ hot~ l in which one attaches a different oligt~n~ lpoti~ip tag at 10 each coupling step but also in the ~ 1;",. ~1 in which one extends a pre-existing ;~,..",.~l. ..l,,i~ tag at each coupling step. For example, one may use oligrmll( l~oti~ip~ of up to about 100 bases (or somewhat longer), each having seven (or more) regions, as described below.
Region I is a 3'-PCR primer site (20 to 25 bases). This site is used in 15 ~-,-,ju,--,Liu~, with another PCR site (at the 5'-end of the oliEnnll~ lP~ti~iP) to prime q~mrlifirqtion by PCR. Other ~",~ l,.,,. methods may also be used.
Region 2 is a "step-specific" DNA sequencing primer site (15-20 bases).
This site is specific for the particular numbered step in the synthesis series. All the .,ii~....,l.-,~;~i. ~ added to all the beads at a particular step will have this sequence in 20 common. Each numbered step will have a highly specific primer site representing that step.
Region 3 is a spacer (20-30 bases). A spacer segment of variable length, but preferably 20 to 30 bases long~ places the coding site ~u[rlci~ Lly distant from the sequencing primer site to give a good "read" through the monomer encoding or 25 i~iPntifi~qtir)n region.
Region 4 is a monomer i~ " region (8 bases). In this illustrative , each base in the 8-bit string represents one bit of binary code, where, for exarnple, T = 0 and C = 1. Each set of step-specific identifier tags consists of 8 bases ~ with a 1 (C) or a O CI') at each of the 8 positions. These may be thought of as switches 30 set to "on" or "off" at the different positions. Each monomer type is encoded by a mixture of 1 to 8 of these "switches."
Region S is a step number . . ,. ,1; ", - ~ " region (4 bases plus 2 bases on either side for region distinction). Four bits in this short stretch encode the step number.

WO 9~i/12608 2 1 7 5 5 8 7 Pf'T/US9-1/1~3-i7 This is redundant to the sef~uencing primer but can be used to csnfirm that the proper pnmers were used and that the right step is decoded.
Region 6 is a repeat of the monome} i if ntifir~irln region (8 bases). This region has the same information as region 4, and is used to confirm monomer identity.
S Installing this second monomer encoding region also increases the probability that a good se ~uencing "read" will be obtained.
Region 7 is a 5'-PCR primer site (20 to 25 bases). This site serves as a site for annealing the second PCR primer for ~ ,lir-- -~i..., of the se~uence. The length of nli~fmllf lf ntides witll all seven of these features, some of which are optional, will commonly be between 75 and 125 bases.
An 8 bit format can encode 256 different monomer types. The number of steps that can be encoded is determined by the number of step-specific sets (8 per set) of .li, .. ,.ll,lf~ , on hand. With 10 sets (80 nli~.. l~ ~li.l. ;~ one can encode up to 256 different monomers assembled into oligomers up to 10 units long (thus providing encoding capability for up to 2561 = 1.2 x 1024 oligomer se~uences). The coded identif~er tags may be used so that each monomer is assigned a speciftc binary number (e.g., Ala =
00000001, Gly = 000001~0, etc.). The ~ u~ iflf'C are combined to give the correct binary code.
To facilitate l-l;~ lrJ~Iiflf- tag i~ iri, -li..." one has a variety of options.20 For instance, one could read the tag directly from the bead by sef~uencing or hybridi~ation.
One can also amplify II;g.. ,. lf.J~;tif~ tags to facilitate tag iflf-nfifir~rinn The oligonllr~ identifier tags carried by a single solid support or oligomer can be amplified in vivo, by cloning, or in vitrs, e.g., by PCR. If the limit of detection is on the order of 100 molecules, then at least 100 or more copies of each oligsn~rlfr,~ifif~ tag on a 25 bead would be ref~uired. Copies of the tag are produced, either as single stranded Uli~ lf-~-iiflPC double-stranded nucleic acids, or mixtures of single and double-stranded nucleic acids, by any of a variety of methods, several of which are described below, and the amplified material is se~uenced. In the ~ ..l of the invention in which a separate and distinct olig.-.~ tag is added at each monomer addition step (as ~' 30 opposed to extending an existing tag at each step), one can amplify all tags at once and then divide the amplified material into as many separate se~uencing reactions as there were oligomer synthesis steps (employing a different se~uencing primer for each type of tag).
In this embodiment, one could also design the tags so that each tag could be amplified WO 95/12~108 2 1 7 5 5 8 7 PCT/US9~/123-17 separatf ly from the other tags by .~ U~ . choice of primer sequences. The sequencing reactions are performed and run on a standard sequencing gel, and the oligomer sequence is deduced from the code revealed in the resulting sequence informatiûn An altemative strategy is to use common PCR primers and common 5 sequencing primers (the sequencing primer may even overlap completely or partially with . a PCR primer site) and identify the step by hybridization to oli~""~ i iP probes that are comr~l~nnPntqry to each step-specific se~uence in the nli~nnllrlfntides from the bead. A
single set of sequencing reactions is performed on all of the amplified oli~nnllrlfotides from a single bead, and the reaction products are run in a single set of lanes on a gel. The 10 reaction products are then transferred to a suitable hybridization membrane and hybridized to a single step-specific probe (see Maniatis et al., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1982), which is i~-,ull~ui4l~d herein by reference). After detection of the resulting signal, the probe is washed from the membrane and another step-specific probe is hybridized. One could also use the procedure described in EPO publication No.
237,362 and PCT publication No. 89/11548, each of which is incorporated herein by reference.
Parallel hybridization provides an altemative to sequential hyhri ii~inn The sequencing reactions are divided into a number of aliquots ef;ual to the number of peptide synthesis steps and run in a separate set of lanes for each on the sequencing gel.
After transfer of the reaction products to a suitable membrane, the membrane is cut to separate the sets of lanes. Each lane set is then hybridized to one of a plurality of step-specific ulig.,,,. lf~,Li l probes (see "Uniplex DNA ~ ;" and "Multiplex DNA
cf~ Pnring"" in Plex 1~ .; Kits Product Cqtqin~. Bedford, MA, 1990, i~ull~ul~d herein by reference).
As noted above, a single synthesis solid support (or an attached bead beanng a tag, or in solution in a "well") may only comprise a few hundred copies of each f~1l;df tag These tags may be amplified, e.g., by PCR or other means well known to those skilled in the art, to provide sufficient DNA to be sequenced accurately.
. The ability to decode the oligomers depends on the number of available olignnllrlf Oti~if identifier tags. the level of :~mr~ifir~tinn that can be achieve~i from the available tags, and the accuracy of sequencing that amplified DNA.
If PCR :~mrlifir~tinr of an oli~ lf~ if identifier tag is employed, one may encounter "PCR product ~ ",;".l;~.,. " caused by the product of one PCR reaction wo 9~ 608 ~ ~ 7 5 5 8 7 PCT/US9~ 3~7 ...,.~,.,;..AI;~ a sU~sef~uent PCR reaction mixture designed to amplify other tags having the same PCR primer binding sites. One may prevent this problem by ill~l.JJU~illg lability into the product secluences and treating subsequent reactions so as to destroy potential carried over from previous reactions. A specific example of this strategy, 5 for which commercial kits are sold by PECI and Life T~ c-gi~, is to introduce dUMP
into the product. Treating each new PCR reaction with uracil-N-glycosidase degrades any r dU-containing DNA present, preventing :~mrlifir~fifm of the ~ lrl~ The template DNA, which contains no dU (only dT) is not affected. Of course, the ~;ly~ .,siJd~e is removed or inactivated before ~ ,. is begun.
Some of the tags described above for peptide synthesis have the unusual of containing only L~Y ' This means that the uracil glycosidase strategy (Perkin Elmer Cetus Il~LIU--I~I.L~ (PECI) Catalog, Alameda (l99l), incorporated herein by reference) will work on only half of the strands produced-- those containing T's (or U's). One cannot introduce dUMP into the ~1. j,l..,....~- y, purine-only strand;
15 however, the purine strand is highly vulnerable to acid fiPr~lrin~if n and alkaline-mediated scission of the backbone. The ~llli. -1;l-ll of these treatments can greatly reduce problems with product ~1Illl_ ll;ll_l;lll~ Another approach to preventing carryover f-,,-t~ ;l, l;flll involves incorporation of a restriction site (~I could be used for polypyrimidine tags) into the f~ rntide tag and digestion with the u u~ JIldil-grestriction enzyme prior to ~mriifit~tif n of a reaction suspected of being l ~ lf~
with the tag. This method only works if the tag to be amplified will not be cleaved by the en~yme, as would generally be the case for a single stranded f,~ ,lif~f- tag.
For sequencing amplified DNA, one usually desires to generate sin~le stranded templates. This generation may be ~ 1...1 by any of several means. One such means is ~y"l,l,e~lic PCR, where an excess of one of the primers is used to amplify one strand to a level 10 to 100-fold higher than the other (see, for example, U.S. Patent No. 5,066,5~4, incorporated herein by reference). Another means of providing a single stranded template is to by biotinylate one of the primers and purify or remove the resulting strand by adsorption to immobilized streptavidin (Pierce Tmmllnot~prhnolo~y Cataloa and ~.
~n~ks2~ 1991, ill.oll,~,ldt.d herein by reference). Yet another means involves generation of RNA transcripts (I~l~ illg only one of the strands) from an RNA
UOlylll.~ promoter and sequencing the transcripts with reverse Ll~l~ JL~c (Sommer et 1-, Chapter 25, In PCR Protocols A Gllif~P to Methods and Applications Supra.

WO 95/12608 2, 7 :~ 5 ~ 7 PCT/IIS9,-ill23.17 ill~ UlUUl_t~i herein by reference). If the tags dre cûmpûsed ûf only pyrimidinen-lrlf~tifiPc then all purine strands can be eliminated by acid/base treatment7 leaving the pyrimidine strand for Cf~/plf~nrin~, O The use of separate sequencing primers for each step-specific olignnl.rl~otifi~ requires a separate, conventional sequencing reaction for each step-speci~lc primer. Using primers that are differentially labe~ed would allow the identifier tags frûm a single solid support to be sequenced in a single reaction and run in a single lane set (2 lanes if only polypyrimidines are used; 4 lanes if 4 different bases are used) on a gel.
There are now l U~ ,idlly available primers labeled with ~ ,Al)le fluorophores that are suitable for this purpose (ABI Catalog, ill~.Ul,~l ' I herein by reference). Sets ûf rhf-mil"l";"~ labels now distributed commercially may also be used (Bronstein et al., BioT~rhnicues 8: 310-314 (1990), illCUI~ herein by reference).
The amplified product can be easily sequenced or otherwise identified to decode the identity of the peptide or other molecule on the bead or otherwise attached to the oligr,n~lclf Q~ifip tag. For this purpose, one can use any of a variety of sequencing methods, including sequencing by sequence-specific probe lIY~ DNA secuencing enzymes which may be employed in the present invention include Taq DNA polymerase, E. CQLL DNA pUIylll~ld~ I (or the Klenow fragment), T7 IJUIyll.~.d~C, Sequenase~ and Sequenase Ir (Modified T7 DNA ~uly~ Ld~. ~), ~ DNA polymerase, and reverse 11dll~ )Ld5t~ (from AMV, MMLV, RSV, etc., see USB ~n7ymes foF DNA Se~ lpnrin~
U.S. l~irrhfmir-Al Corp, 1991, Cleveland OH, illCUI~ herein by reference). The sequence of an olig~..,l, l~ ,~;fir tag may also be identified by a high f~delity DNA
hybridization technique. To this end, very large scale immobilized polymer synthesis with oligrln~lrlf oti~if c may be useful (see PCT patent publication Nos. 92/10587 and 92/10588, each of which is i.lcul},uld~cd herein by reference).
The choice of tag, whether the tag is an oli~nnllrlro~i~if or some other molecular structure, depends upon the nature of the molecules of which the library is composed and the method by which those molecules are to be ~yllLllcsi~cd, as discussed in 'A the following section.
Where synthesis rhf-nnic~rif~ involve the use of reagents and reaction conditions incompatible with the above described ~ .,.",~ l;fif tags, it may be desirable to utilize an alternate tagging method. Thus, the methods for synthesizing a tagged molecular library of the present invention also envision utilizing chemically inert wo gSrl2608 2 1 7 5 ~ 8 7 PCTrusgl/l23~7 hydrocarbon tagging molecules which are discretely resolvable by a variety of methods, such as ~ methods.
The use of such inert l..y~ilu~l,on tags in molecular libraries has been described. See, Michael H. J. Ohlmeyer, et al., Proc. Nat'l. Acad. Sci. 90:10922-26 -_ (December 1993), and published PCT Application No. WO 94/08051, both references .r~,l herein by reference for all purposes.
The tags described utilize a binary coding scheme like that described herein.
Specificaily, a binary code is assigned to each chemicai building block, i.e., an amino acid, to be added in the synthesis. The length of the code may be dependent upon the total number of building blocks to be added. For example, where only seven totai building blocks are to be added, a three bit binary code may be used. This ailows for seven separate specific codes, 001 through 111, each one being assigned to one of the seven building blocks, e.g., Iysine=001. Where the number of building blocks is greater, a larger code can be utilized, e.g., an eight bit binary code, as described herein.
A number of tags are prepared, each having a different resolution or separation pattem from the others using ~.1..~ ,. ,' - methods. If a particuiar tag is present, it will represent a "1" in each position of the final tag code for a given ~ ' ' molecule. Thus, where a molecule has four building blocks and is coded in a three bit coding system, there are 12 potentiai code digits, each building block having three bits. For each step in the synthesis, the solid support upon which the molecule is to be ~y~lLh~ ~;~i is tagged so as to indicate not oniy the building block added, but aiso the step at which it was added. For example, the presence of tag no. 1 or "Tl" indicates that there is a " I " in the ftrst position of the binary tag code for the building block added at the first step. Similarly, the presence of T7 indicates that there is a " 1 " in the seventh position of the overall code, which, in a three digit code, would also correspond to the first position of the third added buiiding block. Thus, the building block assigned the code 111, if added at position one, would be encoded by the presence of tags Tl, T2 and T3.
Altematively, if added in step 2, the same building block would be encoded by the presence of tags T4, TS and T6.

WO 9~/12608 392 1 7 5 5 8 7 PCT/U59S/123 i7 The specihc l~y iluwb~ll tags described by Ohlmeyer have the following structure:
Linkcr Electrophoric Tar HOO~ \~/ Ar t NOC
Cl Cl Cl H Cl H
Ar = ~cl ~ci ~F ~
Cl Cl C H Cl H
where n is from I to 10. The varying length of the llyuiluwl,u., chain and the varied S h~lnEJPn~tPA group allow physical separation or resolution of the tags by met}tods, specificaily, electron capture gas .,;..~ ,y~ y.
Detection of these lly~ u~bull tags is, however, limited by t'ne sensitivity of the detection method. Thus, to ensure detection of the tags, larger amounts of tag must be used. This requires larger sized beads, thus reducing the size of the overall library 10 which can be ~yllLII~,~,;~, and increased reaction times to ensure maximum coupling of the tags to the solid support. Finally, where larger molecules are screened, more IIY~iIU~LtbUII
hgs are added to the solid support. The i~.u~yvl<lLiun of large amounts of l~yui~uwlJul.s on a solid support, e.g., for large synthetic ~n~ ull l l~ having numerous tags, will likely have adverse effects on continued synthesis and/or screening of the compound on t~ e solid 15 support due to steric, lly~ilu~h~;c or ionic nte problems of detectability, tagging time, and screening or synthesis ' associated with these lly~ilu~bull tags may be ~ . ' ' utilizing the methods of the present invention. Specifically, the present invention, in one I --~i;,- ~, provides a method of tagging using l'I,y~'ilU~LllJUII tags wherein such tags have a "molecular 2 t 75587 Pcr/uss~/l23~7 wo 95112608 hook," instead of a detectable electrophore as described in Ohlmeyer, et al.. This "molecular hook" is defined herein as a functional group on the tag which allows for the attachment of an dlllt lir,~d,le, detectable group, thus permitting detection of smaller amounts of tag on the solid support. The hook will generally comprise a stable functional 5 group or molecule which will either form a covalent linkage with the amplifiable, detectable group, or will have a high affinity for a portion of that group. Examples of , such hooks include, e.g., biotin, to which a streptavidin linked amplifiable, detectable group may be bound or one i-"~ "~ of a high associahon peptide. Such high association peptides generally comprise a ~u",~ .y pair of peptides each ha~/ing a 10 high affinity for the other. Thus, one, ",11~ .". .1 denotes one peptide of such a pair.
High association peptides are generally described in U.S. Application Serial No.08/321,933, filed October 12, 1994, which is a nnntinll~rinn-in-part of U.S. Application No. 08/067,387, filed May 24, 1993, each of which is i.l~u.~o.~l~d herein by reference for all purposes. Alternatively, the hook may comprise a protected activatable group, which may be activated to covalently attach the ~ Jlirl(lblc, detectdble group to the tag.
Phu~vlJlvLe~ l activated groups are particularly useful in this ~rpli~inn Activated groups are generally well known in the art, and include such groups as carboxyl,hydroxyl, amino, thiol and the like. These groups may be protected using photolabile protecting groups such as those described in published PCT Application No. WO
93/22680, i~ul~u~lL~d herein by reference for all purposes. The resulting group is photoactivatable .
In addition to the above, the molecular hooks may comprise .~ lir ~
groups. For example, the molecular hook may comprise two or more different functional groups capable of being coupled to two separate entities. This may be the case where for example, it is desirable to recouple the tag to another solid support for detection purposes, e.g., a reaction well in a microtiter plate. The first functional group may be used to selectively bind a ~nmrl~mf~nr~ry group on the solid support. Once coupled, the second functional group may be used for selective coupling of the amplifiable detectdble group.
Such hooks may generally comprise ~vlllb;~ Livl~ of the functional groups described herein, or other groupS which are capable of being selectively bound to another such group. As an example, such a hook might comprise both biotin and digoxin, orthogonally linked to the lly-l-v-~ul,v,, tag. Once separated, these tags may be contacted with a solid support, e.g., a microtiter well, which is coated with a group capable of binding to one of Wo 9~/12608 2 1 7 5 5 8 7 PCT~S9~1l23~7 the functional groups on the tag, e.g., an anti-digoxin antibody, and allowed to bind thereto. After repeated washing steps, the solid support is contacted with the oli~ ul;~i~ coupled to a group capable of binding to the second functional group, e.g., streptavidin linked olig-",~ as described previously. The bound oligl~ o~ is 5 then detected as previously described. The synthesis of the llydlu~ull tags of the present invention may be carried out by methods well known in the art. See, e.g., March, Advanced Organic Chemistry (John Wiley & Sons, 3rd Ed., 1985), Larock, Cu~ lcll~.laive Organic Tl~l,ru~ Lions (VCH Publishers, 1989).
Because the inert l~ydlu~lJul~ tags of the present invention provide for more lû sensitive detection of the l~ydlu~lJull t;igs, the amount of ~ particular tag on a solid support may be reduced without affecting its detectability. Further, by reducing the amount of tag on the solid support, time required for the cûupling of the tag to the support may be reduced.
Tags useful in the present invention will generally comprise a variable 15 llydlu~dlbull region and a molecular hook. More preferably, such tags will comprise a cleavable linker attaching the tag to the solid support, a molecular hook as described, and a varied length lly~lu- ~u~oll chain connecting the molecular hook to the linker. Different tags will have a different length l~ydlu~bull chain, or a different molecular hook, so as to allow for their physical sepa;ation and detection.

WO 95/12608 PCTI~S9`1/123 17 Tags having the following general structure are preferred:
!~ / \~/ ~ R
where n is from 1 to 10, or more, X is a cleavable linker and R is a molecular hook.
Preferred molecular hooks comprise, e.g., biotin, a high association peptide, and S activatable groups, such as a yllU~Uà~,LiVdLdble group, or a combination thereof.
Examples of cleavable linkers which are useful in the present invention include, for example, the yllvLucl~,avablC linkers describcd in U.S. Application No.
08/265,090, filed June 23, 1994, and ;IICul~ ~ herein by reference for all purposes.
Examples of such ~lluLuCI~,ava~lC linkers include those having the following structures:
0_'~0~ ~ ~~
~,,NOz ~$~No2 ~N~ O~N~ ~--N~
H H
~0~ ~_ ~o, ,¢,NOZ o ~ N~

WO 95/12608 PCT/US9~/lU-17 Follow;ng synthesis and tagging, the tags are removed from the solid support, e.g., by photo~ysis of the linker. The tags are then separated from each other using a method which preserves the separation pattem of the tags, e.g., HPLC with fraction collection, or other ~ .;r methods, such as gel or capillary 5 ~ u~ ;s. Because the tags are generally present in amounts lln~l~pt~prt:~hlp by normal means, e.g., absorbance, etc., they must be separated in a manner which allows subsequent detection and correlation to their separation pattern. As an example, the tags cleaved from a solid support, are separated on an HPLC column and collected in a fraction collector. When the tags are eventually detected, as described in further detail below, the 10 fractions which indicate the presence of a tag are correlated against the known elution profile, or separation pattem, for all of the tags used in the tagging/synthesis.
The separated tags are then immnhili7PA according to their separation pattem. Such immobili7ation may take the form of spotting individual fractions, blotting for gel based CPp~r~tion~ or immohili7:~tirn within reaction wells, i.e. on a microtiter 15 plate.
Once ;mm~-bili7PA the tags may be "hooked" to an a.l.~Jlirlablc, detectable group. Amplifiable/detectable groups generally include a compound or structure which is capable of being amplified, or produces a signal which is capable of being amplified.
~~omro~ln~ic capable of PYrnnPnh~l ~u ~ i,... are preferred. A ~dlLil ulculy useful amplifiable, detectable group is an ~li~.,.. -lrlJI;rlf sequence. Hooking of the amplifiable, detectable group may take a variety of fomms. For example, where the hook comprises a biotin group, the ..li~...".. I~ ;AP may be coupled to streptavidin which will tightly bind the biotin. Alternatively, the ~Ll~Ldvidin may be added in an ;"t . ".~ tr step followed by addition of b;.)~ ' ' 1 nl;~ J~ P In altemative ....~.o~ , the tag may comprise 25 a ..,,1ll 1 .1l .1 of a high association peptide. In this case, the ol;L~ Lide is linked to the other comrlPmPnt to that peptide so that the ~li~....l.~ I~.~l;~IP may tightly bind to the tag. In yet another Clllb~dill.._.lL, where the tag comprises an activated group protected by a photolabile protecting group such as thos~ described in published PCT Application No.
wo 93/æ680, previously il~uul~uldl~d by reference, this group may be activated, i.e., by 30 photolysis of the photolabile group, allowing the oli~..,... I~.J~;~P to then be coupled to the tag by methods well known in the art. Where this is the case, it may be desireable to select a photolabile protecting group having different photolysis, ~ lr~ from a the WO 95112608 ~ ~ 7 5 5 8 7 PCTII~S9~/1231 photocleavable linker, if one is being used. This will allow selective cleavage of the tag from the solid support without activation of the molecular hook.
Once hooked to the tag, the uli~;v~uclcvLi l~ sequence may be amplified using the PCR techniques descnbed herein. Where the imml~hil;7:~fi(1n is in a blotting S format, the ~mrlifi- :~tinn must be carried out so as to preserve the local concentration and avoid diffusion of the amplified o~ r, thus allowing its detection and correlation to the separation pattern. This may be ~comrlic~ A by performing the ~mrlifil ~ti~n reaction in, for example, a gel overlay of the blot.
Detection of the hooked .,I;r,..-- ~ l..,l;A,~, and thus the tag, may be carried10 out by ill-,Ul~J(Jld~ g a label into the amplified olignnll~lrnfiA~ or by probing for the amplified ~ ide sequence where such sequence is known. Detection of a tag is correlated to the known separation pattern for the tags. A tag so identified is then i-lcul~u~ d in the overall tag code for the syl~Lll~.,i~d molecule. For example purposes only, if following HPLC separation, hooking, ~mplifir:~finn and probing, fraction #17 15 indicates the presence of a tag, this is correlated to the tag which is known to separate into fraction #17. If, for example, this is tag # 5, then a "1" may be assigned to position # 5 of the overall binary code for the molecule ~yllLl,~ d on the particular support. The coding schemes described herein are for example purposes, and those of skill in the art will recognize that a variety of coding schemes may be applied to the methods of the ~0 present invention.
Those of skill in the art will also recogni2e that there is no ~Luil~,l,c..L that the code reporting the sequence of a ~ h~5i~ molecule be contained in a single polymeric sequence of individual tags. Instead, the code may be embodied by the presence or absence of individual different tags on the solid support. While these tags may ~5 potentially be coupled sequentially to each other, those of skill will recogni2e the benefit of having each different tag individually attached to the solid support. Specifically, only a single coupling chemistry would be required for any and all tagging steps. Further, complex protocols of protecting\~luL~Li--g reactions for tags having different reactive groups may be avoided.

WO 95/12608 2 1 7 5 5 ~ 7 PCT,US9~/,23~7 V. Synthesis Methods The method of the present invention can be applied to any set of synthetic chemical reactions performed in a sequence to generate diverse cu~ uu-~do. While the 5 invention is typical~y illustrated using chemical building blûcks, more typically monomer building blocks, the general nature of the invention should be d~ The majority of synthetic chemical reactions proceed quite differently than the typical monomer coupling reaction; the typical ûrganic chemical reaction gives variable yields and leads to multiple products, such as regio- and ~Irlr~ structures. The present invention can be used 10 to identify useful products of such series of chemical reactions, because one can practice the methods so that the tag encodes the protocol for sy~ ,Oi~i,.g the compound instead of explicitly specifying the structure of the reaction product.
To simpliFy discussion, however, the.invention is most readily viewed as a series of monomer coupling steps. Because the various coupling reactions of the present 15 method can be carried out in separate reaction vessels at separate times, even building blocks, such as monomers, with very different coupling . ~ ;rC can be used to assemble the ~ u.. A~ of interest in a library. While the invention can be practiced by exposing solid supports to a building block and an identifier tag at the same time, or sequentially (either building block and then tag or tag and then building block), the 20 sequential approach allows one additional flexibility with respect to coupling ~
In any event, the preferred ~ lrlll for conducting coupling reactions is one in which the diverse coupling reactions are carried out in paraLiel.
After each parallel series of coupling steps is performed, the solid supports on which the oli~omers or other ~,u~ uu~Jo of the library are or~ . i are pooled and 25 mixed prior to re-allocation to the individual vessels for the next coupling step. This shuMing process produces a large library of c~ v~ with each distinct member of the library on a distinct solid support. If each synthesis step has high coupling efftciency, then sl~hcf~ti~lly ail the cu~ ,vull~is on a single solid support have the same structure or, if the c are oligomers, monomer sequence. That structure or sequence is determined 30 by the synthesis pathway (type and sequence of monomer or other building block coupling reactions) for any given solid support at the end of the synthesis. The maximum iength of oligomers is typicaily less than about 20, usualiy from 3 to 15 monomers in length, but in some cases a length of 8 to 12 monomers (residues) is preferred.

WO 95/12608 2 ~ 7 5 5 ~ j~ PCT/[)S9.1/123~7 ~

Given the diverse numbers of tags and building blocl~s suitable for use with the present invention, there are a number of chemical methods by which one can prepare chemicaL libraries of the invention. However, one must ensure that each coupling step, whether of tag or o~igomer, does not produce unacceptable levels of unwanted reactions or 5 destroy tags or oligomers already present on the support. In one embodiment, one ensures that only desired reactions occur by using solid supports with chemically reactive groups ,.
for tag and oligomer attachment that are protected using two different or "orthogonal"
types of protecting groups. The solid supports are exposed to a first d~lut~lio,~ agent or activator, removing the first type of protecting group from, for example, the chemically reactive groups that serve as oligomer synthesis sites. After reaction with a first monomer, and after any optional blocking steps, the solid supports are then exposed to a second activator that removes the second type of protecting group, exposing, for example, the chemically reactive groups that serve as identifier tag attachment sites. The tag is then coupled, and these steps are repeated, typically from one to about 20 times.
A. Oli~,vllucl~Lide Tagged Peptide Libraries In one important ~ \o~ the present invention relates to the synthesis of Itlrge libraries of diverse peptides. While many other c~ u~ and oligomers can be made by the method (see Gait, Olil~onl~clf otid~ Synthesis: A Practical Approach. IRL
Press, Oxford (1984); Friesen and Danishefsky, 19~9, I- Ame}. Chem. Soc. 111:6656 and Paulsen, 1986, ~Ç~. Chem. Int. Ed. En~l. 25:212, all of which are il-~u~lJuldL~d herein by reference), techniques for solid state synthesis of peptides are particularly important and well Icnown (see Merrifield, 1963, I ~m Chem. Soc. 85:2149-2154, u~dL~d herein by reference), and peptide libraries are highly useful for a variety of purposes. Ln the Merrifield method, an amino acid is covalently bonded to a support made of an insoluble polymer. Another amino acid with an alpha-amino protecting group is reacted with the covalently bonded amino acid to form a dipeptide. The protective group is removed, and a third amino acid with an alpha protectiYe group is added to the dipeptide. This process is continued until a peptide of a desired length and sequence is ~' obtained. Protective groups known to those skilled in the art may be used to prevent spurious coupling (see The Peptides, Vols. I & 3 (eds. Gross, E., and J. Meinhofer, Academic Press, Orlando (1979 & 1981), which is il~,UI~ ,' herein by reference) or to allow one to control coupling. Phûtolabile, base-labile, and acid-labile protecting groups, ~ wo gs/12608 ~ 1 7 5 5 ~ 7 PCT/U59.11123.17 and ~.. ,l,;",,l,.",~ of the same can all be employed for various purposes of the present invention.
Additionally, both L and D forms of arnino acids may be employed in peptide synthesis methods described herein. ~mploying D-amino acids may be useful in 5 the synthesis of `'retro-inverso peptides," as described in U.S. Application Senal No.08/309,451, filed September 21, 1994, ill~,UI~ ' ~ herein by reference for all purposes. Such retro-inverso peptides will comprise the same amino acid sequence, but having reversed ~ILlt~O~,ll.llli~Lly from a peptide which is ~y~ ~ using L-amino acids.
When the present invention is used to make and screen peptide libraries, the 10 tag of choice is a nucleic acid. There are a variety of compatible ~ c for peptide synthesis and round by round attachment of ~' g ' '- identifier tags. However, to maintain the integrity of an o~ p tag during peptide synthesis, one may need to use different cù.~ la~io.ls of protecting groups and/or synthetic nl~rlPI-ti-iPc to avoid "~ of the tag or the oligomer ~y~Lh. ,;~. In general, uolyAuy~ li-le 15 nlip""~ P tags are relatively stable under typical peptide synthesis conditions, as opposed to olieonl~lP{ltidP tags that contain natural purine nllrl~oti~p~ but a pOIy~uy~illli~i,lC nucleotide tag may be somewhat refractory to ~mrlifi~tinn by PCR. One may need to illcUl,u, purine bases, or analogs such as 7-deaza-deoxy~ Pm~cinP, and 7-deaza-d~y~uallu~;..c, tested for ability to withstand peptide coupling (and d~:~lu~c~iull) 20 conditions, into the tag to achieve a desired efficiency of .' ~ For purposes of the present invention, the tag optionally may contain from 10 to 90%, more preferably 35 to 50%, and most preferably 33 to 35%, purine or purine analog nllrlPoti~iPs Theoligonll~lpoti~lp tags may optionally ill~UllJI ' a biotin ûr other reporter group to facilitate U~.~;1;. .1,l~l~ hybridizdtion, ~ nrlifi~ti-~n, or detection (see p;Prce Imm~nnTechnoloey 25 ('s~t~lo~ and T~n~honl~ 1991, iUl~ Ul,UOldt~ herein by reference).
Thus, in selecting the ~ used to create an .~ ~lrvl;~p-tagged peptide library of the invention, one must (1) select a solid support with ~plu~JIiaLt:
functional groups; (2) select the amino acid coupling chemistry; (3) select the nlit ll...,. l~U~ ,; tag coupling chemistry; (4) select the protechng groups for the various 30 tags, monomers, and oligomers; and (5) select the d.~lul~Lioll and, in some l-mho~limPn cleavage chemistry (for either the tag or peptide). Those of skill in the art recognize that not all of the above selections need be made in every case, as some applications may not present the same issues as others. For instance, one or more protecting groups may not be WO 95/12608 2 ~ ~ 3 ~ PCT/US91/123.17 required for all applications. In the generaL case, however, each of these selections is important.
To consider factors relevant to the selection of coupling chemistries and protecting groups for the synthesis of nli~nnllrlf~otiA~ tagged peptide libraries, consider a S synthesis in which commercially available Fmoc protected amino acids are coupled using standard Merrifield chemistry, and the . li~.""~ ,L;~I~ tags are coupled using standard IIAI~ chemistry. The process can be viewed as having the following steps: (1) removal of the amino-terminal Fmoc protecting group from the linker or peptide attached to the bead; (2) coupling an Fmoc protected (the side chains may be protected as well) amino acid to the free amino group produced in step (1); (3) optional capping of unreacted free amino groups; (4) removal of the D~T protecting group from the hydroxyl group on the bead or tag to which the nucleotide tag is to be attached; (S) coupling a nucleotide ,l"-,A,~idi~f~ with a 5'-DMT protecting group as well as protecting groups on the phosphate and exocyclic amines of the bases; (6) optional capping of any unreacted free hydroxyl groups; (7) oxidation of the ~l~u~ oluu~ of the nli~on~ o~id~ tag; and (8) deprotection of the peptide and nlig,-"", 1 .J~ tag. Each of these steps is discussed below.
(I) P~emoval of the amino-terminal Fmoc protecting group from the linker or peptide attached to the bead is necessary prior to the attachment of the next amino acid monomer. Typically, treatment with 30% piperidine in DMF for about one hour is used to achieve this d.~luL~iull (see also step 8), but one aspect of the present invention relates to the use of reduced ~ IC of piperidine or reduced d.,~-ut~iu~ times for the synthesis of olignnl~nl~n~ tagged peptide libraries. Piperidine may cause deprotection of methyl triester protected ~ " ~ Lid~ tags, and O-methyl phosphate protecting groups have greater base stability tban the standard beta-cyanoethyl group, known to besusceptible to piperidine cleavage. Preferred Fmoc deprotection conditions of the invention are 5 to 15%, preferably 10%, piperidine for 5 to 60 minutes, preferably 10 to 20 minutes, and 15 to 30% piperidine for 15 to 30 minutes. Another treatment known to effect Fmoc removal is treatment with DBU (1,8-diazabicyclo[5.4.0]undec-7-ene), e.g., ~' 5% DBU for 5 min. However, a report by PaLom et al., Tetr. 1~- 34: 2195-2198, uldlcd herein by reference, suggests that such treatment can result in methylation at N-3 of thymidine. While DBU-mediated Fmoc removal can be effective in some A~ C, the potential for base mnt'ifi~A~in~ should be recogni~ed.
_ ~ Wo 9~12608 2 1 7 5 5 ~ 7 PCT/US9~ 7 (2) Coupling an Fmoc protected amino acid to the free amino group on the bead or peptide can be achieved using standard BOP coupling chemistry (see ~
Peptides, supra~. Typically, a mixture of an Fmoc protected amino acid (l l0 mM), - HBTU (l00 mM), HOBt (l00 mM), and DIEA (300 mM) in a solution composed of l:l DMF/DCM is employed to effect amino acid coupling. Other activation chemistnes may ¢ also be applied in this instance, for example ~ " of HBTU/HOBt with HATU. In one rmhl~rlimrnl of the invention, however, the reaction mixture is composed of 55 mM
Fmoc-protected amino acid, 50 mM HBTU, and 150 mM DIEA in a solution composed of3:1 DMF/DCM; this ~",1,o,1;",~"1 is preferred for use with ill~LIu..lcllL~ where reagent delivery bottles may be limited. The side chains may be protected as well; Fmoc/'Bu protection is preferred for most purposes, due to the commercial availability of building blocks. Other useful amino acid building blocks with side chain protection included Arg(Pmc), Gln(Trt), His(Trt), Asn(Trt), Asp(O'Bu), Glu(O'Bu), and Lys('Boc) and amino acids with side chain protecting provided by photolabile protecting groups.
(3) Optional capping of unreacted free amino groups can be achieved by treatment with acetic anhydride and l-methyl imida~ole or by other methods known in the art.
(4) Removal of the DMT protecting group from the hydroxyl group on the bead or tag to which the nucleotide tag is to be attached can be achieved by treatment w;th trichloroacetic acid (TCA), i.e., l % TCA in CH2Cl2. If one uses acid-labile protecting groups on phosphates and exocyclic amines of the '~: ' ~ (i.e., deoxycytidine, 7-deaza-deoxyadenosine, and 7-deaza-d~y~ o~l~ ), then those groups should be sufficiently robust to resist the TCA (typically 1-3 %) used in 5'-0-eJcLIiLyldlio.,.
(5) Coupling a nucleotide ~ "",--,-~ with a 5'-DMT protecting group can be achieved using standard ~ ",~ 1;1r chemistry, although one must take into,~,,ci,l. .A1;~... the need for protecting groups on the phosphate oxygen as well as on the exocyclic amines of the bases of the Oli~;ol~uclcuLide_ tags. For photolabile protecting groups for nucleic acids, see PCT patent publication WO 92/10092 and Baldwin et al., ', 1990, :~. L~. 46: 6879-6884, each of which is ;-lw-~ul~l~d herein by reference. As 30 noted above, suitable phosphate protecting groups include the O-methyl and beta-cyanoethyl groups, but O-allyl and/or N-allylù,-y~ 'uùllyl groups (i.e., byillCuluuldLil~g 3-(allyl N,N'-diisopropyl) ~ Ps) can also be used to protect phosphate oxygens and the exocyclic amines of the nucleoside bases, respectively (see Wo 9S/12608 2 1 7 5 5 ~ 7 PCT/liS9~1123~7 ~
Hayakawa et al., 1990, l. Amer. Chem. Soc. 112: 1691-1696, iL-~olL-ul LLt;d herein by reference). Allylic protecting groups can be removed using THF containing tris ,yl;~ (,,.r) ~iir~ m-chloroform complex, LLi~ yl~ r~ and n-butylamine/formic acid, followed by a THF wash, an aqueous sodium S N,N-diethylrlithi~ wash, and a water wash. r~ it coupling is mediated with agents such as lH-tetrazole; 4-~ luyll~.lyl tetrazole; pyridinium .
hydrochloride/imida201e. The latter L~ h ~A~ ;rl;l~ activator leads to se~ectiveS'-O-phu,~ yl,Lliull at the expense of low levels of spurious reaction at nitrogen on the peptide or oli,,u--uclcvLid~ (see Gryaznov and Letsinger, 1992, ~Ii Acids Research 20:
1879-1882, ill- ul~Jul LLt;d herein by reference).
(6) Optional capping of any unreactecL free hydroxyl groups can be achieved by treatment with acetic anhydride and l-methyl tetrazole or by treatment with acetic anhydride/lutidine/DMAP.
(7) Oxidation of the ~ luu~ of the ~,l;g~ Lidc tag can be achieved 15 by treatment with iodine and pyridine or by treatment with 12, collidine, MeCN in H20.
Alternatively, by employing the mild oxidant 'BuOOH for oxidation at the phosphorous, one can minimize oxidation of the amino acids m~-thirnin~, tryptophan, and histidine (see Hayakawa et al., 1990, Tetr. Lett. 27:4191-4194, il~,ul~ol_Sd herein by reference).
(8) D~L,LuL~Liull of the peptide and ~lig.. - i~ lr tag can be effected by 20 se~tuential treatment with 1% TCA in dichlul, ' , then with thiophenol/NEt3/d;oxane (1:2:2), then with cLl~yl~ ,..; /EtOH (1:1) at 55 degrees C, to remove the protecting groups from the tag, and then Llill~lulu~c~Lic acid (95:5 TFA/water, with cationscavengers) is used to remove acid-labile amino acid protecting groups. The lability of purine nllrlr~ C to strong acid (e.g., TFA) can be avoided by use of ~ho~,lluldll,idites Z5 of the purine nucleoside analogs 7-deaza-2'-~v,.y~l.u~l.~ and 7-deaza-2'-deoxyguanosine (see Barr et al., 1986, BioT~hni~llpc 4:428-432, and Scheit, Nucleotide Analogs:Synthesis and Biolo~ical Function pp. 64-65 (John W1ley and Sons, New York), both illUUl~J~ ' ' herein by reference).
The next section illustrates one preferred ~:IllI,odilll~ llL for synthesizing ~ tagged peptide libraries.

wo ss/~2608 PCT~vS9~ 7 B. Improved Method for Syl~Ll.~u~g I;v ~ Tagged Peptide Libraries r~ a practical bead-based ~,lie,.",~ .,Lide-encoded peptide library mPthndnlngy demands that several key technical criteria be met. These include (i) the d~lu~ ; of mutually compatible h 1~ for parallel assembly of peptides and 5 rl ' ' " fii) the selectiûn of bead material with d,U~JlUlJlid~: physical ..1,~ (iii) the facile isolation of small beads bearing ligands that bind a t~irget receptor; and (iv) successful reading of the tags from a single bead, i.e., by PCR
a~rlifi--~tinn and sequencing of template tag DNA from single beads. The presentinvention provides an improved method for ~ll~ lg such libraries, as illustrated in this section and Example 1, which show how to use single stranded nl;e~ l. uL;.~ tags to encode a cu~ peptide synthesis on 10 ~m diameter polystyrene beads.
In this improved method, peptides and n~ lPnti~lPc are assembled in parallel.
alternating syntheses so that each bead bears many copies of both a single peptide sequence and a unique ~ identifier tag. The ~ lP~ share common 5 - and 3'-PCR priming sites; the beads can therefore serve as templates for the PCR. Toillustrate the method, an encoded synthetic library of some 8.2 x 105 hepta-peptides was generated and screened for binding to an anti-dynorphin B mnnnf~lnn~l antibody D32.39 (Cull et al., 1992, Proc. ~. Acad. ~. ~ ~:1865-1869"ll~ul~uuld~d herein by reference), using a lluul~.,.,~ activated cell sorting (FACS) instrument to select individual beads that strongly bind the antibody. After PCR ~mrlih~ inn of the o1~ tags on sorted beads, the DNA was sequenced to determine the identity of the peptide ligands, as is described more fully below.
One important aspect of this method, which is described in additional detail in Example 1, below, is the solid support selected for synthesis of the peptide and tag.
Solid supports, i.e., 10 ~m diadmeter beads, fashioned from a macroporous styrene~liviu,~ll,. .~l c copolymer and derivatized with a dOd~lddlllille linker are preferred. The amino group loading of these beads was estimated to be ~ 100 ~lmol/g by exhaustive acylation with Fmoc-glycine, followed by piperidine cleavage of the ~moc group and ~ r- ' 'f' ~ '- " of the released piperidine-dibenzofulvene adduct (e3C2 = 7,8001 mol~l cm~'). With 5 x 109 beads/g, this cu~ ,uul~d~ to a maximum peptide load`ing of--20 L"~ dd. Acylation of the beads with a mixture of an d~Juluulid~ly protected amino acid and an omega hydroxy acid provide orthogonally di~r~l~"~;d~d amino and hydroxyl groups from which the peptide and nucleotide chains respectlvely can be WO 9~i/12608 2 1 7 ~ 5 8 7 PCT/llS9~/123~7 extended. The average ~Ir~ i(""- Iy oFpeptide to n~ f ~ iP per bead is controlled by varying the ratio of amino and hydroxy acids coupled to the initial bead mass (vide infra). Test peptide syntheses (5-mers to 12-mers) on these beads equipped with a Llinuulu~l,Li~ acid-cleavable Knorr linker (F .. i.~ ~1-, 1989, ~. Lett. 30: ;
4645-4648, i--cu,,ul ~ herein by reference) using standard Fmoc chemistry were found to proceed with high fidelity that was i~d~Li~l~ui~ll~lc from syntheses performed on conventionai peptide synthesis resin, as ~iPtPnninP~i by HPLC analysis of the crude cleaved peptide carboxamides.
Parailel synthesis strategies require the use of a set of protecting groups on the amino acids and nucleotide building blocks that are mutually orthûgonal, and that each of the polymer chains be stable to the reagents used in the synthesis and d~JIut~Liul) of the second chain. Although, in principle, a variety of protection/deprotection schemes can be used (as discussed above), Fmûc/'Bu prûtection on the peptide building blocks is preferred, because of the extensive commercial availability of natural and unnatural amino acids protected in this manner. However, the 'Bu-based peptide side chain prûtecting groups require treatment with strong acid (typically Llinuulua~.Lic acid) for removal, conditions that can lead to rapid ,I.I,UI;ll,.Liull of ~ P..I;~iPS containing either 2'-.lcu~ (dA) or 2'-dw~.y~;L.~o~illc (dG) (see Capon, 1969, Chem. Rev. 69:
407-498, i--l ull~u~At~d herein by reference). This problem has been ~ u~ lLed by using 20 7-deaza-2'-d~o,.~ llo~;llf (c7 dA) in place of dA in the template r~ r,n-lrlPntiflP tag. The glycûsidic bonds of fiP~Ar-~rin~P "", ~,~n~..lf~ are resistant to acid-catalyzed hydrolysis (see Scheit, 1980, Nucleotide ~P~ and Biolo~ical E~i~ (John Wiley and Sons, New York) pp. 64-65, i~,ul~J~ ' herein by reference), and oli~f~nllrlPl)tiflP~
UI~oldLi~g these monomers are faithfully copied by ~I,r""--~t~l,lr pOlylll~ t~ used in the PCR (see McConlogue ct al., 1988, Nucl. ~i51 Re,s. 16: 9869, and Barr et ai., 1986, BioTechniques 4: 428-432, each of which is i~u~lJu ' herein by reference).
Acid-resistant guanosine analogs can also be in~ , ' ' into the template DNA.
5'-O--lilll.,Lllu~-yLliLyl 2'-df ~y~lu~l osidf 3'-(O-methyl-N,N-diisopropyl) Al~ were used in all parallel syntheses. The reagent (12/collidinelH2O/aretr,nitri~P) used to convert the nucleotide phosphite intermediates tû
llU~IJllU~ t.l~ in the DNA synthesis protocol was not found to adversely affect either the readily oxidized residues Trp and Met or any of the other protected amino acids.Complete removal of the 5'-O-DMT group from the growing r~iL~ JI;fiP chain was ~ Wo 95/12608 2 7 7 5 5 8 7 PCr~S9~1123~7 achieved in ~ 40 sec using 1% trichloroacetic acid (TCA) in dichloromethane, while a~l of the acid-labile side chain protccting groups used conventionally in Fmoc/'Bu chemistry, excepting thè 'Bu ether derivative of tyrosine, were inert to treatment with 1% TCA for I
hour. Fmoc-Tyr(O-B~) proved a suitable Ir~ in the synthesis of 5 tyrosine-containing peptides, the O-benzoyl ester being robust towards both TCA and the piperidine used for removal of the alpha-N-Fmoc protecting group in peptide synthesis.
Quantitative d~vlu~Liu-~ of the alpha-amino residues required 5-10 minute treatment with piperidine/DMF (10% v/v) and also resulted in partial d~ LI~ .Lion of the prûtected polyl-llclcuLid~ phrlcrh~tri~-forc (tl,2 ~ 45 min). Control rlllrl ;" ..1~ indicated that any 10 aberrant ~11u~1~i~yldLiull of the resulting p~ `t spccies during subsequentnucleotide chain elongation was reversed by the final r~ Lide deprotection steps(see Lehmann et al., 1989, Nucl. ~i~ Bs- 17: 23n-2390, i.l. vl~u.a~e~ herein byreference). At the completion of the parallel synthesis, the DNA was fully d~-u~ L~d by treatment with 11~;"~1,. nvldLl; (phosphate O-d~ l.illyldLiull) then ethanolic ethy1-~11rl1;A"",~P
15 (d~v~ uyldLion of protected cytidine and 7-deaza-adenine residues). These mild, anhydrous aminolysis conditions did not adversely affect protected peptide sequences (see Juby et al., 1991, ~ L~- 3: 879-882, ;II~,UII~u herein by reference), which weredeblocked using TFA under standard conditions.
The carboxy-terminal region of opioid peptide dynorphin B
20 (YGGFLRRQFKVVT) (SEQ ID NO: 1) has been previously shown to represent the epitope of anti-dynorphin B mAb D32.39 (see Cull et al., ~): the soluble hepta-peptide RQFKWT (SEQ ID NO:2) binds D32.39 with high affinity (Kd ~ I nM). A parallel synthesis of this peptide and a 69 base oligodeu;~yllu~le~Lide was performed on orthogonally di~f~ llLidL~ beads bearing an acid-cleavable Fmoc-protected carboxamide '~ (Knorr) linker. After addition of the first 20 n~ Pmti-lPc the beads were treated with piperidine/DMF and the first peptide residue (Fmoc-Thr('Bu)-OH) coupled to the free amines. The beads were then subjected to two cycles of r1~v~ chemistry and coupling of the next amino acid (Fmoc-Val-OH). This process was repeated until the 1~ .Lirlo sequence and nucleotide coding region had been fully elaborated, and then the 3û DNA was extended by a further 35 ., ~1. v~iri ~ to provide a spacer region and 5'-pnming site for the PCR. The beads were finally exposed to full ~ --,1-- lr--li~P and then peptide d~.-ut~Lio-~ conditions, and the TFA ~ 1 containing the cleaved peptide was analyzed by reverse-phase HPLC. The HPLC results showed that the crude peptide from WO 95112608 2 1 7 5 5 8 7 PCTIU59~1123 17 0 the parallel synthesis consists of a single major component (co-eluting with authentic RQFKVVT, (SEQ ID NO:2)) and that this crude product is not significantly different from that generated in a control peptide synthesis in which no ~ "".-lf"~ P chemistryoccurred.
The stability to parallel synthesis chPmistripc of template DNA containing T, dC and c7 dA was compared with an analogous target containing the standard punnenucleotide dA. Using the single bead cloning capability of a FACStar Plus cytometer, individual deprotected beads from the two syntheses were sorted into microfuge tubes and the tethered illig,.",l. 1~ F template amplified through 45 cycles of the PCR. A "clean"
~mrlifjr~tinn product of the expected size and nucleotide sequence was obtained only from template containing the ~ F Thus the integrity of this olignn~lPo~ P was maintained through the course of a parailel peptide synthesis, ~l~".. l,,.li.,~ that template from a single bead can be readily ampli6ed and sequenced.
An encoded library designed to contain 823,543 (77) different hepta-peptides 15 attached to 10 ~m beads was constructed by a ~..,..l.;.. ~ .,iAl synthesis using seven amino acid building blocks Arg, Gln, Phe, Lys, Val, D-Val and Thr.
Alpha-N-Fmoc-Thr(tert-butyl)-o,~yl-~ .l,uLIi~ulc (protected threonine) and succinimidyl 4-O-DMT-u~ybu~yl~lL~; residues were first coupled to all the beads to provide the orthogonally differentiated amino and hydroxyl groups for this synthesis. On average, 20 each bead bore 2û molecules of a single peptide sequence per molecule of DNA tag.
Every amino acid addition was encoded by building a . ~ ;cl;- fiin~lriP~tiriP unit, and after the seventh cycle of peptide coupling the beads were pooled, and the DNA synthesis completed. Starting with a total bead mass of 35 mg (1.75 x 10~ beads) ensured that each peptide sequence appeared on ~ 200 different beads in the library. Peptide 25 micro-sequencing analysis of an aliquot of the library confirmed that the seven amino acids were ctnr~h~ctic~lly distributed among every position of the degenerate hepta-peptide mixture (note that L-valine and D-valine are not .I;~ in the Edman degradation procedure).
The binding of mAb D32.39 to control beads and to the bead library was 30 analyzed by flow cytometry. Beads carrying the positive control sequence RQFKVVT
(SEQ ID NO:2) and a 69-mer nli~r~nllrlPotiriP tag were strongly stained by the antibody whereas blank beads were unstained. By contrast, only a small fraction of the encoded library bound D32.39. Analysis of 105 events indicateci ~ 2~o of the library st~ined above ~ wo 9~112608 2 1 7 ~ 5 ~ 7 PCT~S9VI23~7 background levels. .~ienifi~An~ly, this binding to D32.39 was specific for the combining site as it could be completely blocked by ,~ the mAb with soluble RQ~KVVT
peptide (SEQ ID NO:2). Individual beads from the library having lluu.e~:e.~e intens;ties comparable with the positive control beads were sorted into microfuge tubes for tag 5 ~lmrlifirA~ion by PCR (beads with nUUlG~ ,G in the top 0.17% of the population were collected). The amplification reactions contained dUTP and uracil DNA ~ ly~,usid~sG to prevent carryover ~ ;.." with soluble product from previous amplifications (see Longo ç~aL . l990, Gene ~;125-128, i~l~;u~ ' herein by reference). Nucleotide sequences were obtained from 12 sorted beads and the deduced peptide sequences are lO given in Table 1. R~l.,e~ ,v~ peptide sequences obtained from single beads having IrlUUi~ ,G which was not c,~";l;. - :ly above background are also tabulated for ~OI~ U~I.
:I~I~l High Fluul~ ,G Intensity Beads SeQuence ~I
(SEQ ID NO:3) TFRQFKVT 0.29 (SEQ ID NO:4) TTRRFRVT 4.3 (SEQ ID NO:5) TVRQFKTT 8.8 (SEQ ID NO:6) QvRQFKTT 16 (SEQ ID NO:7) RQFRTVQT 76 (SEQ ID NO: 8) KQFKVTKT 340 (SEQ ID NO:9) QQFKVVQT 370 (SEQ ID NO:10) KQFKVTQT 410 (SEQ ID NO: I l) TQFKVTKT 560 (SEQ ID No:i2) TFRvFRVT 1400 (SEQ ID NO:13) FRRQFRVT not teste~d (SEQ ID NO:14) RQFKQVQT not tested WO 95/12608 2 ~ 7 5 5 8 7 PCTIUS9`1/123.17 Low Fluv~ Intensity Beads Sequence Kd. mM
(SEQ ID NO:15) QTvTvKKT ~1 (SEQ ID NO:16) QQVQRQTT >0 4 S (SEQ ID NO:17) KTQvVQFT not tested (SEQ ID NO:18) QvTQvRVT not tested (SEQ ID NO:19) FVVTVRVT not tested The data in Table I is consistent with earlier studies ~ that the preferred 1~0~ UII sequence of D32.39 is localized to the six amino acid fragment RQFKW of dynorphin B (see Cull et al., supra). The positively charged residues arginine and lysine are strongly preferred in the first and fourth positions of the epitope and phenylalanine appears e.~ ly as the third residue of this motif. ~t the second positiûn glutamine is the favored residue in tbis library, while the aliphahc b-branched 15 amino acids valine (L; only) and threonine are clearly preferred as the flhh and six residues. D-Valine appears to be best tolerated at positions outside of the consensus motif. The range of affinities ûf peptides that were selected ( K~ - 0.3 - 1400 nM) v,as not unexpected given the design of the binding assay: bivalent primary antibody with labeled second antibody detection. r' . l~ n of the binding valency (for example~ by ~0 using directly labeled monovalent receptor) and the stringency of wash conditions will improve the capacity tû isolate only the highest affinity ligands.
C. Small Molecule Synthesis Although primarily described in terms of the synthesis of peptide or other 25 large polymer libraries, as noted previously, the various aspects of the present invention are equally applicable to other chemical syntheses. Specifically, the apparatus and methods of the present invention may be used to carry out a variety of chemical synthesis steps in many synthetic protocols, including, for example, the synthesis of small molecules. The apparatus may be employed in a chemical synthesis scheme to selectively 30 add reagents in, r _ with the synthesis protocol for the particular molecule.Further, different synthesis protocols may be carried out in parallel, as with the p~ptide synthesis described above, where different reagents are added at different steps to yield a diverse library of small molecules on solid supports. These diverse libraries wo ss~l2608 2 1 7 5 5 8 7 PCTi TSg~/123~7 may be screened for desired properties by the methods described herein. Additionally, where such a diverse library of small molecules is desired, the library may be tagged so as to encode the synthesis steps which were involved in the synthesis of each discreie member of the library of molecules.
Examples of the synthesis of such smal~ molecules on solid supports include, for example, fhi~7r~ iinnnP~, mPi~hi~7r~Ti~iin(~nP~, and derivatives thereof, as described in Example 2, included herein, and U.S. Patent Application No. 08/265,090, filed June 23, 1994, and i-lcul~u~ d herein by reference for all purposes.
D. Methods for Generating Soluble Libraries For some ~l,}li~ , one may desire a "bead-free" or "soluble" library of molecules. Soluble molecules, both tagged and untagged, can be useful for a variety of purposes, including assaying the activity of a compound (see Section VI.B, below) and amplifying a tag. There are a variety of ways one to generate soluble molecular libraries, both tagged and untagged, and to solubilize ~u.~ u ~ both tagged and untagged, syllLl-.,;~i on a solid support. Typically, cleavable linkers are employed in such methods.
For instance, and as noted above in Section II.B, cleavable linkers can be used to cleave tagged or untagged molecules from a bead or other solid support, thus ~r~ hili7in~ the molecule of interest. To produce a soluble tagged molecule, the cleavable linker will be attached to the bead or other solid support and have at least two functional groups: one for ~yllLll~ the molecule of interest and the other for synthesizing the tag. Thus, the molecule and tag are ~y~lLh.~i~i attached to a common linker, which, in turn, is bound to the solid support. Once the molecule and tag are ~ylllll.s;~:~, the linker is cleaved to provide a soluble tagged molecule.
A single, planar solid support can be used to synthesize the library, and the members can be cleaved from the support prior to screerling using very large scale immr~hili7P~l polymer synthesis (VLSIPSn') technology. See U.S. Patent No. 5,143,854 <~ and PCT patent publication No. 92/10092, each of which is ill-,ull~ùldL~d herein by 30 reference. In one ~ o,lil" ,1 an array of ~ lig".. 1~ is synthesized on the VLSIPS~ chip, and each ~I;G~ rIr ~ iP is linked to the chip by a cleavable linker, such as a disulfide (see U.S. patent application Serial No. 874,849, filed April 24, 1992, illl,ul~ulal~d herein by reference). The ri;~ lr.JliriP tag has a free functional group, wo 95/1~608 2 ~ 7 5 5 ~ 7 Pc rlUS9~1123~7 such as an amine, for attachment of the molecule to be tagged, which is typically an oligomer and preferably a peptide. The tag may optionally contain only pyrimidine or pyrimidine and purine analog bases. The tag also contains binding sites for amplification, i.e., PCR primer sites optionally a sequencing primer site, and a short section uniquely 5 coding the monomer se~uence of the oligomer to be tagged. Then, the oligomer is synthesized, i.e., from a free terminal amine groups on the tag or a linker linked to the tag, so that each oligomer is linked to a tag. The collection of tagged oligomers can be released from the chip by cleaving the linker, creating a soluble tagged oligomer library.
Other advantages can be realized by generating soluble libraries of 10 molecules. In any bead-based library, the size (mass) of the bead will impose practical limits on the size of the library that can be assembled. For instance, several grams of beads may be required to assemble a library containing 109 different tagged molecules.
The present invention provides an improved method for ,~ g tagged molecular libraries that enables one to obtain much larger libraries much more practically. This 15 improved method provides a means whereby the c~mro~n~ic are released from the solid support prior to the mixing steps but are reattached to the solid support pnor to each coupling step.
In this method, the tagged molecule is imn~hi1i7P~i on a solid support in a reversible manner, allowing one to release the tagged molecule from the support during 20 each of the mixing steps of the method. In one ~ I,o~ ; this reversible binding is provided by an 1~1tr~filtr~itm membrane (for suitable ". ,.1" .". ~, see, e.g., the "Commercial C--mr~tihility Chart" in the Millipore catalogue, which shows ",~ ..,1."~"~ ~
inert to a variety of solvents and chemicals used in synthesis methods). A membrane with a molecular weight cut-off of about 2,000 to 10,000 daltons (such as the Amicon YM5 25 membrane) would be suitable for most libraries. During the coupling steps, the molecules of the library would be retained by the membrane, while the coupling and other reagents would be drawn through the membrane by vacuum suction. The vacuum would be released to allow the molecules to be mixed during the mixing steps.
In another ~ .,\ho.i;-"~,.l of the method, a reversible covalent linkage is used30 to attach the tagged molecules to the support during the coupling steps. Examples of suitable reversible chemical linkages include (I) a sulfoester linkage provided by, e.g., a thiolated tagged-molecule and a N-hydroxy-~ l-idyl support, which linkage can becontrolled by the NH20H ~v,~ t;~ ; and (2) a disulfide linkage provided by, e.g., a wo 95112608 2 1 7 5 5 8 7 PCTr~vS9J1123~7 thiolated tagged-molecule and a 2-pyridyl disulfide support (e.g 7 thiolsepharose from Sigma), which linkage can be controlled by the DIT (diLlliuLlllriL~ .
VI. Assay Methods s s The utility of large: ' I libraries for ligand discovery depends critically on the availability of robust and affinity-sensitive bio- h~mir~l assay m~th~ r,gi~ The present invention provides a number of novel assays for use withencoded synthetic molecular libraries, which in tum have a wide variety ~l~uliu~lLiull~. By way of example, such libraries can be used in assays to identify ligands that bind receptors, such as peptides and nucleic acids that bind to proteins, drugs that bind therapeutic t~rget receptors, and epitopes (both natural and synthetic) recognized by antibodies, as well as to identify a variety of v~ )u~ with ~,1, .""~ ~,11;. ,.1, ~vnr~ lr~l and medical diagnostic ~I,,uli~ Given these diverse ~ , there are a wide variety of assay methods relevant to the present invention. Two important types of assays, albeit with some overlap, include bead-based assays and assays of soluble molecules.
In general, however, such assays typically involve the following steps.
The libraries are screened by assays in each different molecule in the library is assayed for ability to bind to a receptor of interest. The receptor is contacted with the library of synthetic molecules, forming a bound member between the receptor and any molecule in the library able to bind the receptor under the assay conditions. The bound molecule is then identified by rAdlllill~LiUII of the tag associated with that molecule. In one rll,l,,.l;".. .1, the receptûr tû which the library is exposed under binding conditions is a mixture of receptors, each of which is associated with an identifier tag specifying the 25 receptor type, and ~ lly two tags are examined after Lhe binding assay.
A. Screening Assays for Bead-based Libraries When specific beads are isolated in a receptor screening, the beads can be segregated individually by a number of means, including infinite dilution, 30 Illi, l.".,~.~;l",l~tiorl or preferably, flow cytometry. Libraries of tethered ligands are most effectively evaluated in binding assays with soluble labeled receptors. By adopting cell-sized solid supports or beads, one can use flow cytometry for high sensitivity receptor binding analysis and facile bead ~Il- l;ll.llrl;llll WO 95~12608 2 1 7 5 5 8 7 PCT/U59~1123~7 ~

Flow cytometry, commonly referred to as 111,..,, ~ . f- activated cell sortingor FACS should be viewed as equivalent to "fluorescence activated molecular sorting" or "fluorescence activated bead sorting" for purposes of the present invention. One of ordinary skill in FACS methods for cloning mAm~ n oells expressing cell surface S antigens or receptors can readily practice the assay methods of the present invention. In general, these assays involve the binding of a receptor labeled with a fluorescent tag to a mixture of beads displaying the diverse molecules of a molecular library. After washing away unbound or non-specifically bound receptors, one then employs a FACS instrument to sort the beads and to identify and isolate physically individual beads showing high 10 IIUU~ C~ See Methods in Cell Biolo~v~ Vol. 33 (Dar~ynkiewic~, Z. and Crissman, H.A., eds., Academic Press); and Dangl and TT~..,- ..1.~.c, 1982, J. Immunol. Meth.
~:1-14, both il~ulL ' herein by reference. Once the desired beads have been isolated, one identifies the tag to ascertain the identity (or molecular structure, ~ u,.,~ , or conditions of synthesis) of the molecule of interest on the bead.
Standard FACS i~ permits bead (cell) lluul~l en.e analysis rates of ~ 104 events/sec. and, when operated in single bead cloning mode, sort rates that are 5-10 fold slower. In assaying very large libraries (e.g., > > 10~beads) some form of affinity-selective pre-screen can be used prior to individual bead isolation with the cell-sorter. For example, receptor-coated sub-micron sized ~U~ A~A~ c~ particles are frequently used to affinity purify specific cells from large, mixed ~U,U.11A1;11,.C by magnetic activated sorting (see Miltenyi et al., l99û, Cvtometrv 11: 231-238, ill~,UlL~Uld~d herein by reference). To have a high probability of detecting very rare binding events, each different compound in the library should be present on many beads in the librar~. A
practical upper limit for the size of an encoded librdry constructed from 10 llm particles, assuming a hundred-fold l~lullddll~,y, is probably 10~- 109cu.. l,uu ' ayll~ l on ~
101 - 101l beads. Even larger libraries can be preparefi using smaller beads, but conventional cytometers are unlikely to detect or manipulate particles much less than ~ 1 IAm in diameter- Of course, as noted elsewhere herein, the present invention provides a variety of Ar~ innc for such small beads in the synthesis and screening of libraries of 30 molecules. For instance, by using the ~1;c~ f-J~ f tag c~ A~ I- method of the invention, one need not use FACS 1"r~ ^cy to sort the molecules in the library.
~nnP~hP1Pcc, one should not u,.~i. .r~ ^ the power of FACS
Llulll~lltflLion for purposes of the present invention. In one assay method of the 2t 7~5~7 Wo 95/12608 PCTIUS9~ 7 invention, the tagged molecular library is ~yllLl.~iL~ on fluorescent beads. The beads are smaller than cells and composed of a fluorescent material. The library is incubated with a suspension of cells expressing a high level of a cell surface receptor of interest, such as a G-protein-linked receptor. Of course, one can also perform a variety of controls, such as 5 conducting all steps with cells that do not express a high level of the cell surface protein, and use those controls to identify false positives.
In any event, cells expressing the receptor can bind to any library members presenting a ligand for the receptor. Flu~ lly labeled cells can be readily 1 and separated from fluorescent unbound library beads and from unlabeled 10 cells with a FACS instrument based on light-scattering or another fluorescent signal, e.g., from a cell nucleus. After sorting, the tags from the beads attached to the cells are examined to identify the ligands specific for the receptor. Depending on the application, one would sort for cells expressing the highest level of the desired receptor, e.g., by selecting only the brightest cells, and would adjust the binding conditions to maximize 15 specific binding events. To ,~ between ligands specific for the receptor of interest and those specific for other cell surface receptors, one could examine tags associated with beads binding to cells expressing high levels of the receptor of interest and cells that do not.
The methods of the present invention also enable one to use FACS
20 m~LI, ' " to sort tagged molecular libraries ~ ;L~ on beads much smaller thanthe smallest beads current FACS , are capable of sorting. In this method, encoded synthetic libraries are screened for effector activity on signal trAn~ r~ir,n pathways. The synthetic library is c~ Llu~ with several !l.n~ .,,c- (a) the beads are I l~m or smaller and nePd not be sortable in the FACS, allowing rather small beads to 25 be used in some instances; (b) the tags are rl;~"", lr.~ Pc resistant to the in~r~r~ r (most IJcuLi~.ul~ly nuclease resistant), pl.o~L,l,uloLllioates are preferred for this purpose; and (c) the peptides (or other diverse chemical entities) are attached to the bead support via a linker that cleaves in the 'I~ r l,.lVilU..lll_.lL. Such linkers include `- linkers that can be cleaved upon the application of an external factor, such as light, that 30 does not harm the cells and linkers labile to the in~r~rPl~ r Gllvi~ -"~llt, such as a .l,n~ bond or a disulfide bond, but in any case, the cleavable linker must be stable to the parallel synthesis process.

WO 95~12608 PCT/IIS9~/1231 The library beads are introduced into the reporter cells preferably by a rnr rh~nir~l process such as, for example, biolistic projection. In some cases, a hir~rhrmin~lly-mediated process leading to irt nr ~1i7~iinn can be employed, but this route usually results in il,cu.,uu.~lliul~ into an ~ cellular ,UIII~J~U~ (i.e., Iysozomal 5 lnr~li7~tinn). Once the beads are in the cells, the peptides or other cull,puullds of interest are released. Given that 10 llm beads have a ~ i capacity of 10'peptide (or other) synthesis sites, then if the capacity scales with volume, a 1 ~m bead of th~ same material would contain 107 molecules of the ~yllLll~ l peptide. If all of the synthesized peptide is released in a single (spherical) cell of ~ 10 ~m diameter ( a volume of ~ 0.5 10 pL), then a c~ l,u;.", of free peptide of--30 ~lM would result. This ~
would be controllable by the synthesis density on the beads, and a lower loading density could provide for a more stringent screening format (i.e., a screen for more active ~U!'~l'O~ ). The recipient cells are engineered to generate a fluorescent signal upon activation or inactivation of the pathway of interest. The individual cells producing the 15 desired effect are selected by FACS ill ,LI~ and the tags, which are still attached to the beads and contained within the cells, are amplified and sequenced to identify the active synthetic ~u..,l~r,~
In another r ,l~bud;~ , large beads are employed and used to screen a population of cells that express a receptor (i.e., the enzyme beta-g~ rtn~ ) capable of ~0 generating a fluorescent or other detectable signal, i.e., by cleavage of a substrate to produee a detectable eompound. The beads are then mixed with a population of the cells, which are allowed to attach to the beads. If the receptor on the cell surface is stimulated by the compound on the bead, then the detectable compound is produced, providing a basis for sorting activated cells attached to the beads from u-l~ Liv~Lcd cells. One could employ 25 ~ JlU~ , reagents (i.e., free labeled or unlabeled receptor) to maximize selection of high af~lnity ligands.
There are of course a variety of alternatives to flow cytometry for purposes of screening and selecting for library molecules of interest. In one F..ll.o.i;l~.. ,ll, an encoded synthetic library is sereened for ~ulLil~ -ubial activity to find ~....1l,.~,..,.1~ that 30 retard the growth or kill bacteria or any other Illi~rlUOl~Ulhllll that can be plated in two riimFn~ n~, such as virus-infected cells, many eulcaryotic cells including cancer cells, and some protozoa. Large libraries of related or unrelated chemical structures can be screened 2~ 75587 WO 9~/12608 PCTIUS9~/123.17 against cells in agar culture by controlled release of the peptide or compound from the bead on which it was ~yllLi~
The steps of the method follow: (1) plate the cells of interest on agar plates; (2) overlay the cells with another layer of agar in which the beads bearing the 5 ~y~ ~ peptide/drug are suspended at a dilution that provides for even dispersion so that individual beads can be picked, e.g., with a capillary tube, from the solid agar; (3) initiate release of the peptide/drug from the beads; (4) culture the plate to allow diffusion of the peptide/drug from the bead immr-bili7PA in agar into the ~UllUul~ lg agar and into the agar below containing the indicator cells; (5) read the extent to which the diffused test 10 r~ u~ from individual beads have affected the growth/.,lul~ul~olo~ y/~ uLy~ of the indicator cells; (6) choose zones where the indicator cells exhibit the desired response (e.g., death of a bacterial lawn) and using a capillary tube or similar, pick out the zone of agar that contains the original bead from which the test drug had diffused; (7) read the tag, e.g., by PCR amplification of the encoded material on the individual bead, to determine 15 the structure of the peptide/drug that elicited the desired response; and (8) optionally chemically synthesize the ~I,U,~IU~) ' drug/peptide and verify desired effect.There are a variety of ways to release the test compound from beads. For instance, one could partially cleave the peptides/drugs from beads using TFA and allowing cleaved peptide to dry down onto the bead surface in such a form that subsequent20 Ir~ ", in water (agar) will allow release of the peptide/drug and Inr~1i7~tinn of the released compound to the zone of agar around a particular bead. One could link the drug/peptide to the bead using chemistry that is sensitive to a particular change in bead environment that can be initiated upon plating onto the agar and indicator cells or after plating and agar 5111itijfir:~ti(m, e.g., a l,l..,t~ e linkage, a thiol sensitive linkage, a 25 periodate sensitive linkage, etc. These chemical agents could themselves be diffused in through another thin agar overlay, if necessary. Such release chemistry must be compatible with the integrity of the test substance, integrity of the encryption on the bead, and he Ith of the underlying indicator cells. The particular release chemistry used will . also of course depend on the type of chemistry used for synthesizing the library and the 30 nature of the indicator cells. The method is especially preferred for screening libraries of beta-lactam antibiotics for i~Pntifir~tinll of new antibiotics that might kill newly evolved strains of bacteria resistant to existing beta-lactams and for screening peptide libraries of analogues of known anti-bacterial peptides such as the magainins.

:
~ 1 755&7 Wo 95/12608 PCT/USg~/12317 v4 Other methods can also be used to screen bead-based molecular libraries.
Affinity adsorption techniques can be employed in l..Ulljl.ll~,LiUII with the libraries of the invention. For example, the mixture of beads can be exposed to a surface on which a receptor has been immobilized (see PCT patent publication No. 91/û7û~7, iliCUIL)vlcl~t~d 5 herein by reference). After washing the substrate to remove unbound beads, one can then elute beads bound to the surface using conditiûns that reduce the avidity of theul;ZSvll1~.~l~Lul interaction (low pH, acid treatment, or base treatment, for example) The process of afhnity adsorption can be repeated with the eluted beads, if desirable.
These methods, and related variants, such as the use of magnetic selecfion, describe~i 10 above, can be practiced in diverse ways; for instance the solid support can be a resin packed into a ~ jC column.
In another mefhod of the invention, libraries of "tethered" compounds are used as a source of structural diversity in a form suitable for affinity pllrifc:lfinn of families of related molecules, such as families of receptors of,ul1~ ulogic interest. In 15 general, this method relates to the use of a tagged and tethered molecular library to screen a second library of untagged molecules. The tagged, tethered library molecule serves as an affinity pllrih~finn reagent to screen complex mixtures of soluble proteins, ol;g,~ lP~,~I,vl,yd1~Lt~,antibodie5,etC. Subsequenttoaffinity,u ~ 'r~
molecules that bind to the . ..I..I.il. ,1..,;,,l library members are identified by elution and 20 .~,uu~u, ' separation and i,i.or,fih,~fi~m methods. The: ' I library is then divided into smaller fractions of ~ ~ liy ,J..LI ~ u"-~ to determine, through repeated cycles as necessary, reductively and precisely which compound(s) mediate the binding process.
In similar fashion, ~ chemical libraries can be used to identify 25 and clone novel receptors. Many receptors are members of families of proteins that share sequence homology (usually reflecting divergent evolution from an ancestral parent) but exhibit differences in their specif.~i1y/drr....~y for structurally related sets of ligands/cognate receptors. Each member of a receptor family (R~,) may represent a separate target for specific ,UI~ UlOy,;C action and hence for drug discovery and 30 dcvclu~,--.~.-~ by virtue of their different properties, i.e., locations in the body, ~recir~ifirs affinities for ligands, etc. If one identifies a receptor (R,) whose binding properties are of sufficient interest so that the i~nfifi~fitln of other receptors in the same family would be beneficial, then one can employ the following method to identify receptors related to R, in wo g~/12608 PCT/USg~1123 17 their binding site properties. One first identifies a ligand that binds to R, and then creates a tagged . . .".1,i1, I' ll iAI compound library of molecules closely related structurally to the ligand.
Next, one prepares polysome ~ Ud~irVlls from cells believed likely to 5 express additional members of the receptor family. Such polysomes comprise ribosomes attached to mRNA with pendant receptor in various stages of protein synthesis from nascent peptide to almost fully elaborated protein. The receptor protein nearing completion of synthesis will express the specific receptor property of binding to one or more members of the c, ~ 1 library. Using the ~U~ library tethered to solid support,0 affinity Fllrifi~Atir n of polysomes bearing receptors with affinity for any member of the iA1 library is performed. Such affinity ~u~ i ri~ may involve column . ' . methods, batchwise separation of imn~-hili7r-~ ~;u~ -.r.~ from the liquid phase, or aqueous two phase separation methods to achieve separation of the solid phase bearing attached receptor and relevant mRNA encoding the receptor from 15 non-adherent polysomes.
Next, one performs cDNA synthesis from the mRNAs that encode the cognate receptor population using standard technology (reverse LIAI'`' ~ ., etc.) and clones the cDNA population into a vector suitable for rapid sequence analysis. Dependent on prior knowledge of the receptor sequences that are li~ely and the degree of sequence 20 Cul,~.,vALiu-, that can be ~Antil-ir:~f~A, one may attempt to use PCR or another AnnrlifirAtirln to amplify the cDNAs enriched by this method. By sequence analysis of a suitable number of cDNA clones, one can identify cDNAs (whether full length or not) that show sufficient sequence homology with the sequence of the already known receptor Rl to represent putative additional members of the same receptor family (R~). One prepares ûptionally full 25 length cDNA clones of these novel cDNAs (or relevant portions thereof, such as the portion encoding the e~tr~r~ Ar domain of relevance to ligand binding) by standard cloning methods and expresses these cDNAs by standard methods (i.e., in eukaryotic expression systems as soluble or membrane bound proteins as Al,lv,u~u ). Using ~, st;andard formats for testing receptor ligand int~rA~tir~n, one tests for binding of populations 30 of mixed~u~ -u~ fromthe IUlll~ I;Al libraryorindividual~ ,v~ Inthisway, one can identify precisely which compound(s) from the library bind to the newly identifled receptor.

21 755~7 WO 95/12608 PCT/IIS9 11123~7 Individual beads can be physically separated, for example, by limlted dilution or by methods similar to those in which cells are incubated with a receptor coupled to small ~ L~ beads and then cells expressing a ligand for the receptor are extracted using a high power magnet (see Miltenyi et al., 1990, Cvtometrv 11: 231-238 ;II~.UI~JI ' ' herein by reference). As noted above, m~nPtil~lly selected cells can be further analyzed and sorted using FACS. ~ P~ may also serve to label a receptor, allowin~ one to identify and isolate beads by selecting beads that are l~lio~ Li~ ly labeled.
B. Screenirlg Soluble Molecules One can also employ tagged molecular libraries to useful effect in novel assays of the invention in which a ligand is solubilized in either tagged or untagged form prior to binding to a receptor of interest. For screening very large libraries of soluble (bead-free) tagged molecules, one preferably employs affinity ~ n~ y under conditions of weak affinity. For example, a 3û mg library of lûl8 molecules can be screened with a simple 10 mL affinity clll -ll a..~ .l y column containing a few hundred ~g of a receptor of interest. O ~ IP5 are preferred tags for such libraries, being readily PCR amplified and cloned into the commercially available TA cloning vector (Invitrogen, Inc.), a convenient form for storing tag inf~rm~rion prior to analysis by DNA
sequencing. In addition,, l ~ ' '- tags can be, 1, as described above, allowing one to collect pools of soluble tagged molecules, clone the .-~ 1 tags from the selected pools, and then sequence the tags to identify the desired comr~ln~
Soluble tagged molecules can also be screened using an immllhili7P~i receptor. After contacting the tagged molecules with the ' 1i7P~I receptor and 2'i washing away non-specifically bound molecules, bound, tagged molecules are released from the receptor by amy of a wide variety of methods. The tags are optionally amplified and then examined and decoded to identify the structure of the molecules that bind s specifically to the receptor. A tagged oligomer in solution can be assayed using a receptor ' '~ ' by attachment to a bead, for example, by a ~omrPti~inn assay with a 30 Il,--..r~ ly labeled ligand. One may recover the beads bearing imm~-bili7P~I receptors and sort the beads using FACS to identify positives (diminished fluorescence caused by the library molecule competing with the labeled ligand). The associated identifier tag is then be amplified and decoded.

~ WO 95/12608 2 1 7 5 5 ~ 7 PCTIUS9.11123~7 The soluble molceules of the library ean be ~yllLi~ ~ on beads and then cleaved prior to assay. In one c~lbvdilllc~L, the llliClU~ u~,;c beads of a molceular library are placed in very small individual culll~uLlll~ or wells that have bcen "nanofabricated"
in a silicon or other suitable surface. Beads are loadcd in the wells by dispersing them in 5 a volume of loading buffer suffieient to produee an average of one bead per well. In one ~llll,odill.~,L, the solution of bcads is plaeed in a reservoir above the wells, and the bcads are allowed to settle into the wells. Clcavage of the oligomers from the bcads may be ""~ A using chemical or thermal systems, but a l - 1 v~lc system is preferred.
The moleeules of interest ean be clcaved from the beads to produce either untagged 10 moleeules in solution (the tag remaining attaehed to the bead) or tagged moleeules in solution. In either event, the moleeules of interest are eleaved from the beads but remain eontained within the ~:ollll,~UL,,,~I~L along with the bcad and the identifier t~Lg(S).
In one _..lbo~i".~l.L, a surfaee or a portion of the surfaee of the well is eoated with a rceeptor. Binding buffer and a n.,.,,. ,~ y labeled known ligand for the 15 receptor is added to the well to provide a solutiûn phase . . on assay for ligands speeific for the receptor. The binding of the nuvlc~. . .lLly labeled ligand to the rcceptor can in one embodiment be estimatcd by eonfoeal imaging of the monolayer of immobilized reeeptor. Wells with deereased llu~lc ,~ ~.lcc on the reeeptor surfaee indieate that the released ligand eompetes with the labelcd ligand. The beads or the tags in wells showing 20 eompetition are examined to reveal the identity of the Culll~LiLivc ligand.
Reeovery of identifier-tagged beads from positive wells may optionally be effcctuated by a ll,i~,u,., ~ .. to pluek individual beads out of wells. Another mode involves the use of beads that have illCUllJI ' ' a fluoreseent moleeule, either during bcad ~l~lur~cLulc or through labeling. A laser of the a~lllul vv~1. ..6LII is used to bleach the resident beads in only the positive wells. All the bcads are then removed cn masse and sorted by FACS to identify the bleaehed positives. The assoeiated tags may then be amplified and dccodcd to identify the molceules that bind speeifieally to the reeeptor.
In another c.,Lodi,.,c,lL of the invention, one employs relatively large tagged ~- bcads, from whieh the moleeules of interest are eleaved in a series of reaetions. In this method, the beads are 50 to 500 ~um in diameter, with eapaeities cquiva~ent to 100 to 50û
pmol of peptide per bead; preferably, one uses 100 ~Lm beads with a eapaeity of about 200 pmol, if c u~Llu~Lill6 a peptide library. The typical size of such a library is from about 106 to 10~, preferably 107 different molecules. The library is dividcd into about 100 poo~s, 21 755~7 wo 95112608 r~ Tluss~ll23~7 each containing about 100,000 beads. A certain p~r~ ntrgf-, about 25 7'o, of tlle molecule of interest is cleaved from the pool, producing, in the case of a peptide library, for example, each peptide at 50 nM in a volume of 1 mL.
The cleaved pool is then tested in a ~ i..,. or functional assay. One 5 identifies the pools with the highest activity, and then retrieves the remainder of the original pool and aliquots the remainder into 100 pools of 1000 beads per pool. The process is repeated until one has a single bead, from which one reads the tag and identifies the compound of interest. This method avoids the resynthesis and frame limitations of the Houghten method and is adv~l~..~ in that the pools are random, rather than related, 10 ~u~ ,u ,~l~ The chances of a mixture being active because of the cumulative potency of many low affinity related molecules is reduced.
C. Screening Natural Product Libraries With the automated high flux assays that are now available, the present 15 limitations in natural product screening are first, the ability to obtain and handle (dispense, dissolve, label, etc.) the samples; and second, the substantial effort required to characterize the active ~ of positive samples. The present invention provides methods for generating and screening natural product libraries that can provide a huge number of samples in readily screened form and to identify active ~..,,,1,.,,...,1~ in the samples. The 20 basis of the method is the ...."h;"~l;.", Of hiflfh,-mir~l and chemical diversity with metabolic diversity from "natural products", i.e., from nature. The simplest example involves feeding collections of peptides to cultures of ~ u~r,o~ IlC Each microbial strain might create many modifled peptides (a metabolite library). Because each culture would (potentially) contain a very complex mixture of I~ Lbol;t~s~ an efficient method of ~5 screening is required.
Several approaches are available and might be orthogonally classified as factored or tagged, and soluble or tethered. For the sake of illl~ctr~tif)n, cons;der as the "feedstock" a library of soluble peptides. An aliquot of the library is incubated with each of the many strains typical of a IlliWUUl~ lll r~ td~iUII screening program, and the ~
30 media screened in typical fashion. Positive cultures are then incubated with subsets of the libraries and rescreened. This process of factoring continues until the input peptides generating the most active mrt:~hfllitf~c are identi~ied. The . ~ ", of the active metabolites then proceeds aided by the knowledge of the likely precursor molecules.

~ wo 95112608 2 1 7 5 5 8 7 p~ S9~1123~7 Thus, the first screening identifies the active organism(s), subsequent steps identify the active precursors, and finally, the active ~ dboli~ are identified by standard analytical means.
In all its formats, however, factoring is a tedious process. Libraries 5 produced by split synthesis and cleaved free of the resin produce soluble uu~ Jùul~ds amenable to cellular uptake and Illc~dbolialll by intact organisms. However, theff~nfPntrAfinnQ of the individual fnmrounfic is quite low (inversely related to the diversity of the collection), leading to inefficient enzymatic turnover and very low cnnfrntr~innc of the resulting ~ The ~ of the c.~ may be increased by 10 producing subsets of the libraries and fermenting each subset separately with each microbial isolate. Sub-libraries are ~ull~Lluu~cd by fixing one or more of the positions and " -ficl".;,;.,e the remaining positions. For example, there are 500 pentapeptide sublibraries containing all pf-rml,t~tinnc of 2 fixed positions utilizing 50 building blocks. Each of these ...1,1;1" . ;, ~ contains 125,fLiOO ~ ùll 1c The use of tagged libraries offers a major 15 advantage in ease and sensitivity, but requires rnffiififAtinnc in the method of exposing the compound collections to the metabolic activities. The .~"..1. . ~-II;AI feedstock need not be only peptides but could consist of any type of c~ ;AI chemical collections.
Oligomer and other molecular libraries can be cullaLIu~Lc~i in a ~ulllbilldiulidl process and each step encoded with identifying tags. This may be dfne via a direct 20 linkage and parallel synthesis of the oligomer to the tag. If f~ ifif-C are used as the tags, then the complexes will be relatively large but small enough to insert actively into the cells via liposome fusion, elc. L u~uu,dLiu.., solvent ~ I,;1;,AI;.,.., etc. Once inside, the complexes would be subject to the metabolic machinery of the cells. One would avoid the vulnerability of the olign~-lrlf-~ifif- tags to ri~lAllAI;- I~ by the use of modified 25 nllrl~rJtifl~s and nucleotide linkages. Upon recovery of the active " 1-l~ from the culture of from Iysed cells, the samples are screened and the tags decoded to reveal the precursor compound. Scaled-up fi-rmPr~ inn of the active organism with the active precursors should produce sufficient quantities of the active m.ot~hr,litrc to ~~- Libraries of . u",l,uu,~ made by an encoded ~O~ IAI~ process on beads can be 30 exposed to Iysates of bacteria, fungi, plant cells, etc. With this format, the need to insert the tagged complexes into intact cells is avoided, and only a relatively few of the many molecules on the bead need be processed to be detected (e.g., in a nl,ulc~.c.l~c-activated binding assay).

WO 9~112608 2 ~ 7 5 ~ ~ 7 PCT/US9.11123-17 Another useful method of the invention involves the utilization of the products of one mlerobial culture as feed for another culture. To illustrate, consider a collection of 100 different microbial isolates from large scale cultures (~ I liter). The ~U~ .L~u,L of each culture is recovered by filtration and divided into one hundred 10 mL
aliquots. Eaeh aliquot is inoculated with one of the 100 strairis and incubated. 10,000 samples (1 :-I,nl;lr~ of "~rlAI..,Iilr~) are thereby generated from the 100 microbial isolates.
This method of .~ ,L~Ib~ can be extended to sequential ~ LabOli,lll by greatly different species: subjecting the product of microbial fPrmPnt~tinn to ineubation with exotic plant Iysates or incubating extracted fractions of plant tissues with fungal 10 cultures, for example. These methods can be used in ~.,,,,1,;1,-l;..; any product of a chemical diversity generating method can be subjected to these sequential l~l~ Llboli~."
product exposure steps.
In another aspect of the invention, natural product diversity is screened by creatirlg a mixture of c, ' 'Iy-tagged liposomes, each liposome preferably 15 rl~ g only one member or a simple mixture of a natural product compound library. The invention allows for the ~ P~ assay of lOOO's-lO,OOO's of chemical UO~ JUUlldS or natural product extracts and assay of lOO's of ~ ly separated fractions derived from natural product extracts that are signal-positive. In this rnnnPrtinn ~cimlllt~nPo~ means assayed together in the same tube with the cells of the readout 20 system.
The mixture of, I 'Iy tagged liposomes is prepared as follows.
For each individual natural product extract or cbemical from an inventory, one prepares separate liposomes r~ lg the test substance in aqueous phase. A unique liposome tag is il~co,l~o,_Lcd into the liposome IJlc~u~Liull at the time of Pnr~lrslllAtinn The 25 liposomes can be Iyophiliæd for long-term storage at lu.. t~ clALulC~ a significant advantage to the collection and storage of natural product samples near the site of colleetion, as well as for the long term storage of the natural product extract in a form suitable for subse~uent ~ulll~ Lulidl ~ .l,r,;",r..lAI;nn The lipids in the liposome preparations are preferably identical for all samples and chosen in terms of types and 30 rnmrn~itinn to produce unilamellar liposomes of the desired siæ and integrity. Agents such as trehalose can be included at the time of liposome folmation to allow Iynrhili7Atinn and subsequent rcronctitlltiorl of intact liposomes by addition of water. At the time of generatiOn/lr~ of tagged liposomes Pnr~r~lllAtin~ the extract/chemical, one can 2~ 75587 WO 95/12608 PCT/US9~/122~ 17 also use a high pressure technique that allows for the r^nrA-rs~ ^n of greater volume of aqueous phase than the calculated volume enclosed by the liposome. A 3 - 5 fold irlcrease in volume-equivalent can be rn^AArclllAte~i by this pressure method, allowing greater volume of test material to be tested, hence greater signal in the cell-based readout.
Existing liposome technology allows for creation of liposomes that incorporate a high percentage (>80%) of the aqueous phase (relevant to the efficiency of use of each test substance). U-lu-~oll,u-dlcd aqueous phase can be removed by diverse "wash" methods. In addition, one can create liposomes that do not leak or exchange eni^Arc~ aqueous phase (relevant to the specificity of tagging and absence of mixing enclosed aqueous phases), as well as liposomes that do not exchange ~ inserted into their lipid monolayer (glycolipid/protein antigens inserted as tags cannot be exchanged).
A wide variety of tags can be employed with the method. For example, the tags can be: (a) different lluulu~I-ol~, with excitation and emission properties that allow the nuulu~ ulc~ of each to be measured in the presence of each of the others, or",~ thereof -- the nuulu,.l-ul~ can be selected to partition in the ~ J1 aqueous phase or in the membrane phase of the IC~J'I`l;ll'~' i liposomes, facing outwards;
(b) different metal cations of rare earth elements that can be distinguished individually by atomic absorption ~e~lUIll~LIy -- the rare metal atoms would be designed to partition as salts in the ~ ^i aqueous phase of the lc~ Iiposomes; ( c) different antigens, that can be di~Lill~ui~ i by their specific reactions with d~ lUI rAi n îî I~^,nAI
antibodies and primary/secondary florescent detecting antibodies~nu<,~ ul- ^, as necessary -- the antigens, bome on proteins, ~Iy~uL~Iut~ ;l., and/or glycolipids, can be selected to partition in the membrane phase of the ~ ' liposomes, facing outwards; and (d) ~o-l-l,;,-a~ s of antigens, IIUUIU~ OICS~ and/or metal ions can greatly increase the number of possible signatures for CimlllrAA~uc screening, and an additional level of tagging of different liposomes (increased numbers) can result from use of different levels of lI.,ulu~Jl.ulcs/metal ions/antigens, such that the different "quanta" of each comronent in the signature mixture could be identified.
3û One can also employ a general fluorescent tag that shared by all liposomes that enables rapid selection of cel~s fused with a liposome from those that did not fuse with a lirosome. This tag is distinct from any tags used in ~ labelling of the individual liposome ~ ,audLiul,~ and is mixed in with the liposome-generating lipids, the WO 95112608 2 ~ 7 5 5 8 7 PCTlU59iill23 i7 signature tags, and the aqueous sample of drug/natural product at the time of liposome generation. One can also employ a fluorescent tag that is self-quenched at high density (i.e., in the liposome membrane) but that will exhibit lluu~ r 1l~ r in the outer cell membrane of a cell after a liposome fusion event and lateral diffusion of the fLuorophore in 5the cell membrane. Depending on the mode of liposome fusion with cells, one can also incorporate a fusogenic protein of viral origin, or a glycolipid, for example, that will F
mediate ti~ht adhesion of liposome to cell (dependent on a lectin like adhesion process mcdiated by a suitable rceeptor ;- .,,1,l.,...1 as necessary into the cell line used for read out). Such an element would not affect liposome-liposome irteraction (an event to be 10 avoidcd) but can enhance the efficiency of liposome-cell fusion.
The method can employ a cell read-out system that utilizes a cell line that contains a reporter gene (e.g., luciferase, beta-g~ t~ s~) dU..~I~L1~III of a promoter that is activated in response to addition of an exogenous ho}mone or ligand, such as a steroid, cytokine, ~ ;." antibody, antigen, etc. to the cells. Binding of the 15 activating ligand to either a cell surface reccptor or an intr~rt ll~ r receptor activates a signal cascade that leads ultimately to activation of the responsive promoter and Ll~ul~ iL)L;ull of the signal gene. Exprcssion of the signal protein leads to generation of a signal from the individual activated cell that can be deteeted LI~ LiL~ Li~Cly. In a search for Ctlrnro~ln~iC that act on any part of the intr~tll~ r signal ~ ;.". cascade as 20 r~nr~goniC~ the entire population of cells ean be pretreated by addition of the exogenous signal agonist (cytokine, hormone, ete.), and one measures a deerease in signal output on an individual cell basis after the liposome fusion event. In a seareh for ct~mrt~llntl~ that act on any part of the intraeellular signal l,~.lc.~i.,. ~;I~n easeade as agonists, no exogenous signal nced be addcd to the cells, and one can measure the -l~u~-,.---- ~ of a signal on an 25 individual cell basis after the liposome fusion event.
The mixture of tagged liposomes is mixed with a very large number excess of read-out cells. Cell number excess is eritic~al such that after liposome-cell fusion only the following products will result: (i) cells that did not fuse with a liposome; and (ii) cells that fused with one liposome (acceptor cells). Efficient mixing is essential at this step and 30 can be performcd using a ~..1.l;"l..7u~ly stirred or linear-flow cell suspension to which the liposome mixture is added at a slow rate. Fusion is initiated by standard methods such as addition ûf PEG or applieation of a high voltage. Fusion may be enhaneed if necessary by inclusion of a fusogen or a ligand-receptor recognition pair into the eell-liposome WO 95/12608 5 5 8 7 PCT/tJS9 1/123J7 ",. .,.~ The ~usion step ef~ectively adds the aqueous phase ~ulllL/alL~ of a single liposome to an acceptor cell. Hence, the aqueous natural product extract, test compound from a chemical inventory, or fraction from .1.~ ".~ separation of a natural product extract is now able to act at any point in the intr~t~Pillll~r signal tr~nc~ tif~n 5 pathway. The fusion step also adds the specific tags that provide the signature of the particular test compound sample to the individual acceptor cell. If those tags were in the lipid membrane of the liposome, then the tags are distributed in the outer cell membrane of the acceptor cell. Antigens at this location are accessible to panels of specific mcmf~ n~
antibodies. Rare earth metal ions that were in the aqueous phase of the particular 10 liposome are in the acceptor cell cytoplasm. The fusion step also adds the shared liposome tag that identifies cells that acted as acceptors from those, the excess, that did not undergo a liposome fusion event. The tag can be a nuulu~llulc; that moves from the liposome membrane to the acceptor cell membrane.
The mixture of cells, cells fused to individual liposomes, and any unfused 15 liposomes is next incubated with the exogenous ligand (e.g., in the case of testing for an antagonist) or incubated without any addition (e.g., in the case of testing for an agonist).
The time of this incubation is dPtPrmi ~A using control c,~ u ,~ at defined and incubation times.
Preferably, one uses FACS to select ~ u~; u~ (cells) of interest. For 20 instance, one can first use forward or side light scatter to sort cells (whether acceptors or not) from any unfused liposomes. Large cells can be readily separated from smallliposomes. Next, one can sort cells that were liposome acceptors from those, the excess, that were not liposome acceptors. Cells that were acceptors bear the shared liposome-derived fluorescent label, whereas the non-acceptor cells are non-fluorescent with 25 this label. This step is of course optional but, if performed as a presort, allows separation of the (typically) majority of cells that are irrelevant to subsequent analysis from the minority that were acceptors. For i~iPntifi~ti~m of an antagonist, one can sort on the basis of light emission from the reporter protein (e.g., beta-g~l~rt~ciA~cP or luciferase), - separating the majority of lluul.,.,~ ~.lc~-positive cells (rendered such by addition of the 30 exogenous ligand earlier), from the minority of nuUI~ i~.., c-negative cells or low lluUIc~ cells. The latter two cell categories result from presumed antagonist effects of cu~ u~,,-A~ that were ~ 1 nr~l in the particular liposomes that fused with these individual cells. For i~iPntifi~tit-n of an agonist, one can sort on the basis of light wo g~/12608 2 1 7 5 5 8 7 PCT~s9~
emission from the reporter protein, separating the majority of lluu~ e-negative cells from the minority of lluul~ cll~r-positive cells. The latter cells have resulted from a presumed agonist effect of liposome-derived compounds.
In some ~ one can sort all cells of interest according to tlle 5criteria above as a population and collect occasional cells as cloned individuals using standard FACS methods. These individual cells can be analyzed as single cells for the r particular tags that they bear, allowing precise i~ l of the particular liposome that mediated the desired effect. In other .~ , one can analyze the tag ~iicfrihufif~n in the entire sorted event-positive population and dependent on the design of the experiment 10and particular tags that had been ill~Ul~JUl~i in samples from different times/locationslinventories, be able in a first pass to determine the diversity of tag types in the total event-positive population.
Collected single cells or pop~ til nc of cells can be analyzed by methods d~lU~JlidLt: to the particular tag ~ c used. Fl~ tags can be analyzed by 15FACS and/or traditional a~e LIu~,l,u~u.l.~,Lly. Antigen tags can be analyzed by addition of d~ JlU~Jl' ' Iy labeled mt)nll~ n:~l antibodies and ELISA, FACS, l.l-lio;~u~u~ic, or !1lll.l..` ~. f"' C' assisted assays. Metal ion tags can be analyzed last by atomic absorption alJ~Llulllc:~ly. After tag decoding, the tests can be repeated either with mixtures of only those liposomes that yielded a positive event on first pass or with pure liposomes of each 20 member of interest added to separate cell samples.
These and other methods of the invention can be automated to facilitate practice of the invention, as discussed in the following section.
VII. IllaLl Ulll~"lLdli The coupling steps for some of the monomer sets (amino acids, for example) can in some f lllbO.lilll.llLa require a relatively lengthy incubation time, and for this and other reasons a system for ~,clrulllling many monomer additions in parallel is desirable.
The present invention relates to automated ill;,Llulll~..lhLiull for use in generating and 30 screening encoded synthetic molecular libraries. One preferred instrument, able to perform 50 to 100 or more parallel reactions cim~ rPmlcly, is described in U.S. patent application Serial No. 08/149,675, filed November 2, 1993, illcull-u~d~d herein by reference. Such an instrument is capable of fiiclrjhlllin~ the reaction mixture or slurry of WO 95/12608 ;~ ¦ 7 5 5 8 7 PCT/US9-11123~7 synthesis solid supports, under ,ulu~ "~ f control, to the various channels for pooling, mixing, and l~diaLl;buLiull~
In general, however, the il.,Llu~ lL~lLiul~ for generating synthetic libraries of tagged molecules rcquires plumbing typical of peptide ayllLh~ a, together with a large S number of reservoirs for the diversity of monomers and the number of tags employed and the number of si~ coupling reactions desired. The tag dispensing capability translates simple ill~LIu-,Liulls into the proper mixture of tags and dispenses that mixture.
Monomer building blocks are dispensed, as desired, as specif~ed mixtures. Reaction agitation, L~ dLulc:, and time controls are provided. An dl~,UlUI 1~ designed lû instrument also serves as a multi-channel peptide a~lLi.~ ,i~. capable of producing 1 to 50 mgs (crude) of up to 100 specific peptides for assay purposes. Sce also PCT patent publication 91/17823, illCul~ ' ~ herein by reference.
Typical ill~LIulll~,lLdLiull comprises (1) means for storing, mixing, and delivering synthesis reagents, such as peptide and ..1;~ synthesis reagents; (2) a sealcd chamber into which the various reagents are delivered and inside of which the various reactions can proceed under an inert ~I~lllu~ , (3) a matrix of sealed reaction vessels; (4) means for directing the flow of reagents to the d~JIJlU,UlidL~ reaction vessels: (5) means for combining and ,u~uLiLiullillg small (û. 1-100 ~Im) beads; and (o) means for washing the beads in each reaction vessel at the conclusion of each chemical reaction. The matrix of reaction vessels can have any one of several designs. For example, the vessels can be arranged in a circle so that the vessels can be made to rotate about a central axis (i.e., a centrifuge). Alt~ Li~ ly the vessels can be arranged in a 12x8 matrix (96-well microtiter plate fommat). Any iu ~ amenable to accessibility by robotic delivery, aspiration, and transfer functions is useful for some arr1i~ ~til~n~
The system used for combining and ,~;~ .u~ particles can have one of several designs. For instance, the beads can be suspended in a solvent of d,UI~lU~lidL~
surface tension and density such that a robotic pipetting instrument can be used to transfer the beads to a combining vessel After mixing, the beads can be l~diaLIibut~ to the -- rcaction vessels by the same robotic pipettor. Altematively, the beads can be combined by using a special valved reaction chamber. The valve is opened to allow solvent flow to transfer the beads to a combining vessel. After mixing, the beads are I~LiLiull~ by reversing the flow to each reaction vessel.

In another embodiment, the beads are combined using closely spaced reaction vessels with open top ends. Flooding the vessels allows the beads to mix. If the beads are magnetic, then the beads are re-partitioned by pulling the beads back down to the bottom of the vessels by application of a magnetic field. Non-magnetic beads are re-partitioned by vacuum suction through the bottom of the reaction vessels. In yet another embodiment, the beads are partitioned by distributing them on a flat surface and then restricting them to certain sectors by covering them with a "cookie-cutter" shaped device, described more fully below.
The system for washing the beads can also have one of several designs.
The beads can be washed by a combination of liquid delivery and aspiration tubing. Each reaction vessel has its own set of tubing, or a single set can be used for all reaction vessels. In the latter case, the liquid delivery and aspiration lines can be mounted on a robotic arm to address each vessel individually. The beads in each vessel can be made to form a single pellet by either centrifugation or the use of magnetic beads and application of a magnetic field. One can also employ a reaction vessel with a bottom wall composed of a chemically inert membrane so that reagents can be removed from the vessels by application of a vacuum. Reagents can be also be removed from each vessel by using vessels that can accommodate continuous flow through of reagents and washing solutions, i.e., a vessel with luer fitting and membranes on each end.
Any automated combinatorial instrument that relies on an individual reaction chambers, each connected to reagent delivery systems and to a "mother pot" to which the beads are pumped for pooling and from which the beads are reallocated among the reaction chambers for successive rounds of monomer addition faces a very important practical limitation. There is a wealth of monomer or other building block units, and the difficulty of partitioning beads and reagents among the potentially large number of reactions may limit such instruments to fewer than 100 separate parallel reactions.
The present invention provides an instrument that avoids the need to pump beads between chambers to mix and reallocate, simplifies reagent delivery, and allows the simple and accurate partitioning of very small numbers of tiny beads. The basic design consists of a plate with an array of reaction "sites" located on the surface; the surface may be planar or may consist of an array of shallow wells that form reaction sites. In one embodiment, there are 256 sites in a 16 x 16 array. Each reaction site is a spot, or well, on the surface to which a group of synthesis beads is attracted. The attractive force may be ~ WO 95/1260~ 2 ~ 7 5 5 8 7 PCT/US9~/123~7 m~nrlicm, vacuum filtration, gravity with passive mPrh~ni~l sorting, or various other simple means. The beads are initially applied as a dilute slurry in a shallow reservoir evenly covering the array of reaction sites. Upon application of the attractive force, beads are ,.... ~"~ A at each site.
After positioning all the beads on the reaction sites, the sites are then separated by mPrh~nir~l partitions to create (temporarily) the individual reaction chambers as shown in Figure 29. A variation provides partitions p~ lLly affixed to the surface to form shallow wells. The reaction ~. \1.."....1~ are delivered to each chamber, the beads released into Cllcr~Pncirm, and the reaction initiated. When desired, the beads can be reattached to the surface and the reagents removed. After all steps for a coupling cycle are completed, the chamber partitions are removed, and the beads are released into the common reservoir above the array of sites.
Mixing of the beads is caused by induced convection of the reservoir fluid, and the beads are then reattracted to the surface sites for the next round of coupling.
Subsecluent steps, including the wash steps, are ~ t~ i in a similar fashion.
Addition and removal of reagents is done with a c~.",l, ~ " of plumbing and automated pipetting. Addition of reaction specific reagents (mrml-mPr~, for example) may be done with robotic ""~ Addition of common reagents and the removal of all reagents can be done with a fixed plumbing system not recluiring valving at each reaction chamber.
Some common steps such as washes can be done on the beads gl ma~, before installing or after removing the chamber partitions.
The use of large numbers of monomers or other building bloclcs places an additional burden on the encoding process. In one encoding scheme for nli~ lPolirlp tags, a basis set of 1000 monomers might require a 5 base secluence to tag each reaction step; a set of more than 1024 monomers could require 6 bases to encode. To reduce the plumbing complexity of the synthesis instrument (i.e., to reduce the number of specific reaction additions), a special encoding strategy is provided by the present invention. To illustrate the method, consider an array of 16 x 16 reaction sites, an ,.,,~ ,c,. ..1~ .1l that `- allows 256 different reactions to be carried out cim~ r,P~ucly To encode each reaction individually with multiple base coupling is a difficult ul~d~k,l~ g~
The array consists of 16 rows and 16 columns, each site in the array having a unique ~r,~",.l.l,;r:~l address. Each row of sites can be tagged as a group, and all 16 rows can be uniquely encoded with 2 base codons ("subcodons"). A striped template or wo g~JI2608 2 1 7 5 5 8 7 PCTIUS9~/123~7 ~1 channel block can serve to form the 16 reaction chambers for these 2-base additions (note that the bases are coupled as monomenc ~ if ~C not as dimers). See PCT
patent publication No. WO 93/0966g, iul~u~ cd herein by reference. This form of addressing of the reaction sites is analogous to others; for example, an optical method can 5 be used to label the beads, as in the striped masking process described in U.S. Patent No.
5,143,854, il-~ul~JuldL~d herein by reference. If a template or channel block is employed, then the template is lowered onto the synthesis surface just as is the grid template that isolates the individual reactions during synthesis of the library molecule.
The beads are not released during the fagging reaction, however, as their 10 spatial ~,I~ALio,l must be maintained through the next step. When the rows have been tagged with subcodons, the template is lifted, rotated 90, and lowered to form stripes covering the columns. The 16 columns are then labeled with 2-base subcodons, resulting in the unique tagging of each of the 256 reaction addresses with a 4-base "~u~ l"odu,l". By identifying the reaction addresses, the au~ u~:lull~ also specify the monomer that waS
15 added in each reaction.
VllI.Apparatus for Parallel Coupling Synthesis Reactions In general, the device of the present invention provides for the synthesis of 20 diverse materials on a solid substrate. By way of example, the present invention utilizes beads such as those described herein. Examples of a fhe synthesis of diverse peptides are discussed below to provide a framework for the discussion of the ~yl.tll~i~l.
The invention will utilize a plurality of substrates, referred to as "S," on which synthesis reactions take place. The substrates are optionally provided with a linker 25 molecule "L" on which coupling reactions take place. The substrates are divided and reacted with diverse monomers, such as "A" and "B" to form collections of, for example, the following substrates:
S-A and S-B
Thereafter, the substrates are l`~U'I'I';l~''''l, mixed, and divided again. After such mixing 30 and dividing steps, two or more collections of substrates are formed, each containing both S-A and S-B.

~ WO95/12608 2~ 75~ PCT/US9.1/123.17 Additional coupling reactions then take place. For example, the pooled products above may be reacted with monomers C and D to form the following collections of products:
1. S-A-C S-A-D
2. S-B-C S-B-D
t From even the above simple example it becomes apparent that such synthesis techniques rapidly create large collections of diverse products. By carefully planning the synthesis of such diverse collections of molecules and/or by providing for the parallel synthesis of tags on such substrates, the substrates will fnd use in a variety of ::rplin ~tilm~ as described above. In a particular ~ - the present invention provides devices and methods that may eff1ciently generate substrates for these and other uses.
A. General Fig. 1 illustrates a device used to synthesize diverse collections of molecules. The device includes a parent mixing vessel 200 coupled to a plurality of reaction vessels 201-209 by a top common manifold 212 and tubes 215, and 221-229. Top common manifold 212 couples to tubes 221-æ9 and 215. Reaction vessels 201-209 also selectively couple to monomer addition reagent supply reservoirs 231-239 via valves 111-119 and tubes 241-299. A l~ delivery system (PDS) 265 is coupled to both parent vessel 200 and reaction vessels 201-209 via tubes 260 and 256 respectively.
A synthesis reaction begins when a bead suspension is transferred from parent vessel 200 to reaction tubes 201-209. A valve 129 opens (all valves are closed as default), and the bead suspension enters top common manifold 212 from parent vessel 200 through tube 215. The bead suspension is thereafter distributed among reaction vessels 201-209 through tubes æl-229. Selected reagents from monomer reservoirs 231-239 then enter respective reaction vessels 201-209 through respective tubes 241-249. Coupling reactions then take place inside reaction vessels 201-209 on beads contained therein.
Fig. 1 shows ylw~ i~l delivery system 265 coupled to parent vessel 200 - via a tube 260. P~W~Uli~l delivery system 265 delivers pl~;a~ d reagents to parent vessel 200 from delivery system 265 via tube 260 when valve 10 and vent valve 90 open.
Plw,u~ d delivery system 265 is also coupled to reaction vessels 201-209 through a tube 256, an isolation valve 100, lower manifold valves 101-109, lower tubes 271-279, injection valves 111-119, and tubes 241-249. To deliver a reagent from PDS

wo 95/12608 2 ~ 7 5 ~ ~ 7 PCT/US9~/123~7 265 to selected reaction vessels 201-209, the pressurized reagent enters tube 256 and a lower manifold 214 through open valve 100. Thereafter, the ~ UI;L~ reagent is forced up selected tubes 271-279 through selected open valves 101-109~ The ~JII...~UIi~l reagent is then forced into selected reaction vessels 201-209 through selected tubes 241-249.
To deliver a reagent from, for example, a given monomer reservoir '231 to a respective reaction vessel 201, a quantity of ~ D~u~ d activating solution from PDS 265 is forced into tube 256, into lower manifold 214, and up tube 271. At an d,~)~JlU~
moment, a quantity of monomer reagent from monomer reservoir 231 is injected into the stream of activating solution travelling up tube 271. Following the reagent injection, the stream of solution including the monomer reagent injected from reagent reservoir 231 enters reaction vessel 201 through a tube 241 to participate in the coupling reactions.
To optionally tag the beads inside selected reaction vessels 201-209 w;th a monomer from monomer reservoirs 406-412, a ~ UIi~.i tag monomer reagent from monomer reservoirs 406-412 enters a common manifold 255 of PDS 265 through an open valve 4-7. Thereafter, the pressurized tag monomer and an dl~lJlUIJlidL~ activation reagent enter lower manifold 214 through open valve 100 and tube 256. The pl~auliL~ monomer tagging reagent and its d~lJlUIJlidlC activation reagent travel up selected tubes 271-279 and 241-249 through selected open valves 101-109 into selected reaction vessels 20~-209 where the synthesis of tags on beads takes place.
After desired monomer and/or tag addition reactions, the bead suspension in reaction vessels 201-209 is transferred back to parent vessel 200 for pooling and mixing.
To move the bead suspension from reaction vessels 201-209 to parent vessel 200, the bead suspension is ~ ,auli~ d with argon from tube 250 via open valve 122 and 101-109.
Valves 100 and 110 are closed, thereby pushing the ~I-,a~Uli~i bead suspension into tubes 221-229, top common manifold 212, tube 215 through open valve 129, and finally parent vessel 200. In parent vessel 200, the bead suspension is mixed in ~ JdUd~iUII for re-allocation among reaction vessels 201-209 to further synthesize the desired set of molecules.
In an alternative ~ ,of~ a plurality of three-way valves can be provided between each of the reaction vessels 201-209 and tbe parent vessel 200. Such valves will preferably be held in the top common mamifold 212. In this way, certain vessels can be isolated from the parent vessel 200. This may be particularly advantageous when l~di~LIibu~ g the bead suspension for further synthesis. For example, if the beads WO g5/12608 2 1 7 5 5 8 7 PCT/US9~/123~7 were initially allocated to all the reaction vessels 201-209 for synthesis and then returned to the parent vessel 200, during re-allocation only certain of the three-way valves could be opened so that, for instance, only reaction vessels 201, 205 and 209 received the bead suspension for further synthesis.
Fig. 1 also shows n~ ",f ~ agitators 280 and 285 coupled to a top reaction vessel bracket 290 and a bottom reaction vessel bracket 295. Top reaction vessel bracket 290 is held stationary while bottom reaction vessel bracket 295 is permitted to follow the motion of n---,f~ agitators 280 and 285. Each n--,...-.... ,.I~ic agitator cooperates with a vortexing motor 300 to exert an agitation force on bottom vessel bracket 295 and the bottom end of reaction vessels 201-209. Since the tubes between the brackets are flexible, this agitation force causes the contents of each individual reaction vessel 201-209 to vortex inside the reaction vessel thereby enhancing synthesis reactions.
Top common manifold 212 connects to tube 215 at one end to provide a conduit for L.dll~rt,~ g material between parent vessel 200 and top common manifold 212.
At the other end, top common manifold 212 connects to a tube 126. Tube 216 provides ~lc~ cd argon to top common manifold 212 through a valve 121. Tube 216 also allows top common manifold 212 to vent its contents through a valve 120.
Two capacitive sensors 90S and 99S are located near the exterior surface of parent vessel 200 to detect the level of liquid in parent vessel 200. If a fluid exists within the detection envelope of a capacitive sensor, that capacitive sensor is turned on.
Conversely, the capacitive sensor is off if no fluid exists within the detection envelope.
Sensors lOlS-119S are optical sensors for detecting the presence of a fluid within a cllhct~nti~lly translucent tube. These optical sensors are on when a column of fluid is present in the tube. The optical sensors are off when no fluid is detected.
Likewise, an acoustic sensor 120S detects the presence of a fluid in its detection envelope. Fluid, including bead ~crPncirm flowing through a tube which has been placed in the acoustic sensor's detection envelope turns acoustic sensor 120S on.
Conversely, acoustic sensor 120S is off when no fluid is present in the tube which has ~- been placed in the detection envelope of the sensors. Acoustic sensor is used for sensor 120S because optical sensors cannot reliably f~ictin~,.ich, under certain conditions, between an empty translucent teflon tube and a translucent teflon tube containing a bead SllcrPncif~n Further, although an acoustic sensor is chosen for sensor 120S, any sensor which can distinguish the difference between an empty tube and a tube filled with either a fluid or a wo 95/12608 ~ 1 7 ~ 5 8 7 PCTlUS9~/lZ3 bead suspension may be used. Because acoustic sensors are fairly costly relative to other types of sensor such as optical sensors, there is only one acoustic sensor 120S per synthesiær.
The reaction vessel bank is designed such that there is only one or fewer 5 valve between the parent vessel and the }eaction vessels. In fact, valve 129 is optional.
This design is advd,l~5cvu~ because it reduces the possibility of the mechanical opening and closing action of valves damaging the fragile beads and the synthesiæd polymers.
A~so, if the size of the beads are large enough, they may become lodged in the valve and clog the system. FUI~1-. .-11~111, some polymers are ~III~ld~UI~ sensitive and may be 10 adversely affected by the heat generated by the valves during operation. Accordingly, it is desirable to reduce the number of valves through which the bead suspension must traverse.
If valve 129 is not included, ~ techniques can be used to prevent fluids from flowing between the parent vessel and the reaction vessel banks.
As discussed earlier, the valves used in this r,.~l-9(1;.~ are closed in their 15 default state. Absent a specific command to open, the valves always remain in this default closed state.
B. MPrh~nir~l t'nnnr~mPnt~
MPrh~rir~lly speaking, the automated synthesizer may be roughly divided 20 into three subsystems: the reaction vessel bank, the parent vessel, and the pressuriæd delivery system. As mentioned above, coupling synthesis takes place at the reaction vessel bank inside the reaction vessels. The parent vessel holds, pools and mixes the beads from all reaction vessels. The delivery system ensures that the proper solvent and/or reagent solution in an d~ Ul reagentlsolvent ~ . is delivered to either the parent 25 vessel or the reaction vessel bank at an d~ Jl;d~t~ step in the synthesis process.
Furthermore, the entire system is sealed during operation. plr~ " where necessary, is done with an inert gas such as argon. Argon is the preferred ~ UIi .;llg agent because of its availa~ility and low chemical reactivity.
For ease oF discussion, the automated synthesiær will now be described 30 with reference to a specific example. The specific example used throughout this disclosure involves the synthesis on beads of a set of polypeptides. The beads are tagged for i~l~ .lli~i. .l;.~,~ following each amino acid coupling reaction with four nucleotide monomers:
A, T, C, and G.

WO 9S/12608 PCTIIJS9 ~/123~7 It must be recognized, however, that the automated synthesizer is neither limited to the synthesis of the particular polymer described in the above specific example nor to tagged polymer synthesis. Although reference will be made throughout thisdisclosure to the synthesis of polypeptides and the tagging of beads with the above S nllnl~-o~ c utilizing a reaction vessel bank having nine reaction vessels, there is no P inherent upper or lower limit in the number of reaction vessels which may be included in each reaction vessel bank In fact, modular ~ aLlu~_liull of the device permits easy addition of additional reaction vessel banks. Further, many other molecules and tags may be ayllLl~ on the beads, or the tags may be eliminated entirely.
1. The P1c,au1i~ Delivery System The detailed description of a ~ au~ ;l delivery system 265, which has been specifically tailored to synthesize the polypeptides according to the specific example, has been divided into three parts: reservoirs for use syllLl1.,,iL;11~ polypeptides, reservoirs for use in tagging beads, and the delivery vaives.
a. Reservoirs for use in syllLl-~ g polypeptides In addition to the nine amino acid monomers used to synthesize the peptides of the specific example, several other additional "common" reagents will be employed in the synthesis. In a typical peptide synthesis, for example, the following reagents may be employed:
TABL~ 2 D~1u~t~Liu,l lû% Piperidine in DMF
Activation O.~M HBTU and 0.6M DIEA
in DMF/DCM mixture having a 3:1 ratio Capping acetic anhydride in THF
~- n-methyl imidazole in THF
Washing DMF
THF

2 1 7 ~ 5 8 7 wo 9s/1260~ Pcrluss~ 7 ,~

b. Reservoirs for use in tagging beads In the specific example, the beads are optionally tagged. In a peptide synthesis reaction, the beads are in one . ' ' tagged with a nucleic acid comprising n~ oti~ from tlle group A, T, C, and G. In addition to the four nucleotide reagents, 5 the following solvents and reagents are used during the synthesis of tags.
TABLE~ 3 Funcbon ~ ~ Chemical n~ ut~Liu-- trichloroacetic acid in DCM
Oxidation I2, collidine, HlO, and MeCN
Activation 0.5M tetrazole in MeCN
Capping acetic anhydride in THF
N-methyl imidazole in THF
Washing MeCN
These nucleotide reagents are contained in reservoirs having suffic;ent volume and quantity to ~rcn~rlich the synthesis of tags utilizing the automated synthesizer.
Flg. 2 shows a lc~.. ,.~.l~live reseNoir 400 for containing, for example, the MeCN solution in Table 3. There are two tubes associated with each reservoir listed in Tables 2 and 3. As shown in Fig. 2, a tube 450 contains ~ ul;~d argon for ~Ui~:~U1;Lil1g the reservoir to force the contents of the reservoir up a second tube 452. In some ~ d; ~ , the reagent reservoirs are always pressurized. In other embodiments, the argon tube is controlled by a local on/off valve to pressurize a reagent reservoir only when the contents of that reservûir are needed.
c. Delivery Valves Fig. 3 shows a IC~ ' "YC 3-port solenoid valve in greater detail. The -~
valve may be, for example, a Model 2-110-900 by General Valve Colp. of Fairfield, New Jersey. Further, the 3-port valve of Fig. 3 represents, for example, valve 4 which delivers a reagent from reservoir 412. Three-port valves are used in the ~ u~ ,d deliverysystem 265 of Fig. 1. The 3-port solenûid valve employed in the present embodiment 2 1 755~7 WO 95/126~)8 PCT/US9~/123~7 includes a first port 454 and a second port 456. The 3-port solenoid valve also has a channel 458 through its body that . u~ ; .UrC with first port 454 and second port 456 and always permits a fluid to flow freely between the first and second port. To fo}m a common manifold 462, second port 456 is coupled with, for example, first port 454 of 5 another 3-port valve. The other 3-pc~rt valve may be, for example, valve 5 of Fig. 1. A
solenoid inside the valve, responsive to a control signal through wires 190, selectively permits a third port 460 to c..., . l l~ - with channel 458. Third port 460 of valve 4 is coupled to reservoir 412 of Fig. 1.
To control the injection of a reagent from reservoir 412 into manifold 462, a line 464 carrying the~ u~ reagent is connected to third port 460 of valve 4. At an d~ ulJliaL~ moment, the solenoid opens and permits third port 460 to ~nnnmllni~^ with channel 458, thereby causing the ~ UI;LCd reagent from third port 460 to be injected into channel 458 of valve 4 and into common manifold 462.
Fig. 4 shows a ~ lLaLiv~ on/off 2-port solenoid valve 10. This valve may be, for example, a Model 2-17-900 by General Valve Corp. of Fairfield, New ~ersey, for selectively permitting a fluid or a gas to flow in a channel between its two ports. As shown in Fig. 4, valve 10 includes two ports 468 and 470. Valve 10 also has a channel through its body that cnmn~ ni~ between a first port 468 and a second port 470 to permit a fluid or a gas to flow between the two ports. A solenoid inside valve 10, responsive to a control signal through wires 472, selectively permits first port 468 to ~u, . ,;l ~1~ with second port 470. When one port of valve 10 is connected to a tube carrying a ~ UliLVd gas or fluid, valve 10 can be used to permit or inhibit flow from that port to the other port of valve 10.
Fig. 5 shows in grc~ater detail a ~JIC~:~UIi~ delivery system 265 according to one aspect of the present invention. Fig. 5 shows 24 valves 0-23 through which a common manifold is fûrmed. The 2-port and 3-port valves are daisy-chained by coupling their first and second ports together so as to form a common manifold through which reagent flows. Three-port valves 1-7, 9-12, and 14-22 may be, for example, substantially ~^ similar to valve 4 of Fig. 3. Two-port valves 0, 8, 13, 23 may be, for example, 3û s~lhct:lnli~lly similar to valve 10 of Fig. 4. The common manifold includes the through channels of the 3-port valves and of the on/off valves, as well as the coupling tubes between adjacent valves. As previously mentioned, the third port of a 3-port valve is controlled by a solenoid in the valve. The third port of each 3-port valve is coupled to a wo 95/12608 5 8 7 PC r/uss~ll23~7 tube from a reagent or solvent reservoir to transfer a reagent or solvent to and from PDS
265. Alternatively, the third port of a 3-port valve may serve as an exit port for delivering reagents to, for example, valve 100 of a reaction vessel bank. Two-port valves are used primarily as isolation valves or argon supply valves.
As shown in Fig. 5, the 24 valves are phystcally arranged in three separate banks to save space. The delivery system of Fig. S also includes a tube 480 for ~r connecting the left bank of valves with the center bank. A tube 482 cormects the right bank with the center bank. Table 4 lists the valves used in the delivery system, specifying the types of valves used and the reagent reservoir controlled by each valve in a typical 2t 75587 WO 95112608 PCT/US9 1/123~17 Reservoir Va~ve ~ Reservolr - 5 0 On/Off -) Argon FWO 60 400 MeCN
r 2 FWO 60 402 1% trichloroacetic 3 FWO 60 404 Tetrazole 8 On/Off -- --
9 FWO 30 414 Waste 1510 FWO 30 416 Bottom of Parent Vessel 11 FWO 30 100 RV Banks 12 FWO 30 420 Waste 13 On/Off -- --14 FWO 60 422 Top Parent 2015 FWO 60 424 ~ collidine, H~O, 16 FWO 60 426 Acetic anhydride in THF
17 FWO 60 428 in THF
18 FWO 60 430 Piperidine 2520 FWO 60 434 DIE~A
21 FWO 60 436 MeCN
22 FWO 60 43~ DMF
23 On/Off -- Argon -, For example, valve 22 is shown to be a FWO60 valve or a fast wash out (FWO) 3-port valve having a 60/1000-inch through channel. FulLllc;llllult, valve 22 controls a reagent from 1"~ reservûir 438 which, as indicated by Table 4, contains DMF. As a further example, valve 23 is an on/off valve controlling the flow of ~f 75587 wo 95/12608 PCT~159VI23~7 Uli~ argon from an argon supply source (not shown~ to the common manifold of PDS 265.
Fig. S shows a tube 484 connected to valve 0 for ~ Uli~illg the common manifold of PDS 265 from one end. Anothe} tuoe 486 is connected to valve 23 and 5 pressurizes the common manifold of PDS 265 with argon from the other end.
As an ili1lc~r~ion, the operation of ~ Uli~.~ delivery system 265 during a peptide synthesis deprotection cycle is described below. For d~.ut~Liul, of polypeptides, a solution of 10% piperidine in D~F is delivered to the reaction vessels in the reaction vessel (RV) bank. Table 4 indicates that valve 18 permits the flow of piperidine from reservoir 430. Cu~s~L~,lLly1 valve 18 needs to open to permit piperidine from ~Ir~aaul;~l reservoir 430 to flow into the common manifold of PDS 265. To force the solution to enter RV bank valve 11, isolation valve 8 is closed and isolation valve 13 opens to force the ~ uli~cd piperidine to enter open RV bank valve 11.
As shown in Fig. 5 and Table 4, RV bank valve 11 and parent vessel valve 15 10 are centraily located in the chain of valves. This ~ f ~1 ad~UlL~eU~I~Iy minimizes the length of the manifold section between these valves and a given reagent valve. Cullac LU~..Lly, a smaller volume of reagent is recLuired to fill up this manifold section. Isolation valves 8 and 13 can be closed to prevent the reagent from one end of the manifold from uvc~ oULil,g RV bank valve 11 or parent vessel valve 10 and from 20 Il,,,,rr~ ly entering another portion of the common manifold.
Table 4 also shows valves 4-7 and 9-12 to be 3-port valves having a through channel dimension of 3011000 inch. In contra3t, the remaining valves in the manifold have a through channel dimension of 60/1000 inch. The reduced channel cross section further reduces the volume in the respective portion of the manifold. Cu-ls~ucllLly, less reagent 25 is needed to fill up the manifold.
For example, nucleotides A, T, C, and G are relatively costly. It is therefore desirable to keep the volume of reagent used to the necessary minimum.Nucleotide valves 4-7 are located proximate to RV bank exit valve 11 to keep the distance between a nucleotide valve and RV bank exit valve 11 short and the required volume of 30 reagent low. The cross section of the manifold along the path from any nucleotide valve to RV bank exit vaive 11 is aiso kept small to further reduce the volume of nucleoîide reagent present in the manifold. In fact, tube 480 of Fig. S as well as the portion of the WO 95112608 PCT/US9-J/123~7 manifold between the nucleotide vaives and isolation valve 8 have a reduced cross section of 30/1000 inch.
C. Reaction Vessel Banks Fig. 6 shows a simplified reaction vessel bank 500 according to one aspect of the present invention. For ease of iilllctr~til-n, tubes through which solution flows have been partiaily deleted. Reaction vessel bank 500 includes a top bracket SOZ, two side brackets 504 and 506, and two bases 508 and 510. A top reaction vessel bracket 290 attaches to side brackets 504 and 506. A vortexing motor 300 attaches to top reaction vessel bracket 290 for supplying an agitation force to a pluraiity of reaction vessels 201-209 via a drive belt 521 . The bottom of reaction vessels 201-209 are attached to a bottom reaction vessel bracket 295. Brackets 502, 504, 506, 290, and bases 508 and 510 may be constructed from any suitable material. For ease of machining, strength, and light weight, aluminum is used to construct the above-mentioned brackets in the present ~mhQ~imPnt lS Bottom reaction vessel bracket 295 iS attached to top reaction vessel bracket 290 by two n~ shafts 280 inside shaft housings 520. N~ l iC shahs 280 are rotatably mounted through aperhtres (not shown) in top reaction vessel bracket 291).
. ;. shafts 280 are u~.~ ly coupled to a vortexing motor 300 through belt 521. As will be discussed later, -- - shafts 280 translate the rotational force supplied by vortexing motor 300 to an agitation force for urging bottom reaction vessel bracket 295 to move in a circuiar pattern. This circular motion exerts a vortexing effect upon the contents of reaction vessels 201-209. Because every reaction vessel 201-209 is attached at its respective lower end to bottom reaction vessel bracket 295, ail reaction vessels are agitated uniformly and ! ' '' Fig. 6 aiso shows a bottom bracket 522. Bottom bracket 522 is attached to side brackets 504 and 506 and may also be Cu~ ul,t~ from any suitable material, including aiuminum. A pluraiity of amino acid reservoirs 231-239 are mounted beneath bottom bracket 5æ The amino acid reagents in amino acid reservoirs 231-239 are used ~~ as building blocks for ~ Lil~ul~, the set of puly~l~Lidc~s of the specific example. The present . ~ ' using nine different amino acid monomers per bank for g the set of A~oly}~.d.,s.
Fig. 6 also shows an isolation valve bracket 526 attached to side brackets 504 and 506. Isolation valve bracket 526 includes a channel 530 for mounting a plurality wo 9~12608 ~ ~ 7 ~ 5 ~ ~ PCT/U59~11 of lower manifold valves 101-109. As shown in Fig. 6, each lower manifold valve 101-109 is secured within channel 530 in the present ~ ùd~ .lL. However, lower manifold valves 101-109 may be secured to isolation bracket 526 using commercially available mounting hardware or othe} mounting methods. Lower manifold valves 101-109 are 3-5 port solenoid valves and are the same as the 3-port valve discussed earlier in connection with Fig. 3. As used in reaction vessel bank 500, the through channels of lower manifold valves 101-109 are coupled together to form a common lower manifold 214 through which solution from the pressurized delivery system 265 flows.
Three 2-port valves 100, 110, and 122 are also shown in Fig. 6. Nine valves 101-109 control the flow of solution from lower manifold 214 to the nine reaction vessels 201-209. Isolation valve 110 at a first end of the common lower manifold 214 opens to a waste line (not shown in Fig. 6). Isolation valve 100 at a second end of common lower manifold 214 selectively inhibits or permits the flow of solution from PDS
265 to the rest of the common lower manifold 214. An optional isolation valve 122 supplies local argon pressure to assist in the delivery of solution to and from various portions of reaction vessel bank 500.
In another el--bo~ -l-.-L, the eleven isolation valves 100-110 and 122 are provided for in an 1 l-valve block such as model P/N601374, by ABI of Foster City, California. The block comes ,~ s~ "~1~1 1 and thus simplifies ~UII~Llu.Liol~. The eleven valves of the 11-valve block function substantially as discussed above.
An injection valve bracket 532 made of a suitable material such as aluminum is attached to side brackets 504 and 506. A plurality of injection valves 111-119 are mounted through apertures in injection valve bracket 532. Fig. 6 shows a total of 9 injection valves 111-119 to control the injection of amino acids from nine amino acid reservoirs 231-239 Injection valves 111-119 are 3-port solenoid valves and are the same as the 3-port valve discussed earlier in connection with Fig. 3. The first port of each injection valve couples to a reaction vessel 201-209 while the second port of each injection valve is coupled to the third port of a lower manifold valve 101-109. The coupling is a..u,..l,li,licd with ~ ,UI 'y sized tubes, such as the 1/16-inch teflon tubes employed 30 in the present ~ I,udi-,-..-L. As is apparent from the foregoing, the through channel of each injection valve 111-119 permits a solution to flow freely between a reaction vessel 201-209 and the third port of a lower manifold valve 101-109. The third port of each injection valve 111-119 is connected to an amino acid reservoir 231-239 to selectively ~ WO 95/12608 2 ~ 7 5 5 8 7 PCT/US9.J1123J7 inhibit or permit an amino acid to be injected into a stream of solution flowing between a lower manifold valve 101-109 and a reaction vessel 201-209.
Fig. 6 also shows a top common manifold 212. Top common manifold 212 includes nine manifold ports 542 for connecting top common manifold 212 to the nine reaction vessels 201-209. In the present ~ ~l;",. , 1/8-inch flexible teflon tubes are r used to couple manifold ports 542 to the top end of reaction vessels 201-209 Top common manifold 212 also includes a first end port 544 for connecting with a parent vessel (not shown in Fig. 6) where the beads from individual reaction vessels 201-209 are pooled and mixed together. A second end port 546 connects top common manifold 212 with a 3-port pressure/vent valve (not shown in Fig. 6). The pressure/vent valve and second end port 546 provide another route through which lJlC~ UliLI~ argon, solutions, reagents, etc., may be supplied to top common manifold 212. Altematively, the pressure/vent valve and second end port 546 provide an additional route through which aul;L~ argon, solutions, etc., may be vented from top common manifold 212 to thedylJIO~JIiALc reservoir.
An altemative Al IA I~ for the reservoirs 231-239 is shown in Fig. 6A.
Instead of employing a single group of reservoirs, e.g., reservoirs 231-239, a plurality of groups of reservoirs can be provided, e.g., 231a-239a, 231b-239b, etc. The reservoirs are held within a rotatable carousel 1000. The reservoirs are open at a top surface 1002 of the carousel 1000 so that the reagents held in the reservoirs can be accessed from the top surface 1002. The carousel 1000 is held within a pressure vessel (not shown) so that each of the reservoirs are subjected to the same pressure within the pressure vessel. To transfer the reagents in the reservoirs to the reaction vessels 201-209, a plurality of tubes in ll with the tubes 241-249 are disposed within the pressure vessel. The tubes within the pressure vessel are placed into the reservoirs of a selected group of reservoirs, e.g., reservoirs 231a-239a. The tubes can be placed into the reservoirs by translating the tubes toward the reservoirs or by translatung the carousel 1000 toward the tubes. The carousel 1000 is rotated to align the tubes with the selected group of reservoirs. The pressure within the pressure vessel is such that a pressure gradient exists between the reservoirs and the tubes 241-249. When the tubes are placed into the reservoirs, and when selected valves 111-119 are opened, the pressure gradient drives the reagents in the reservoirs into the tubes 241-249 for delivery to the reaction vessels 201-209 as previously described. The carousel 1000 thus provides flexibility to the ~y,.Ll~ L~. by allowing the WOg5/12608 2 ~ 7 5 ~ 8 7 PCT~S9UI23~7 ~

reagents to be selectively chosen from a variety of different reagents, e.g., allowing a different set of building blocks to be used at each synthesis step.
Fig. 7 shows in greater detail the i-~k~ ,r~lion~ among an amino acid reservoir 231-239, an in~ection valve 111-119, a lower manifold valve 101-109, and a reaction vessel 201-209. A lower manifold valve, for example, valve 101, which is a three-port valve, is connected to common lower manifold 214 so as to permit a solution to r flow freely between the Flrst port and the second port of lower manifold valve 101. The third port of lower manifold valve 101 is connected via tube 271 to either the first or second port of the 3-port injection valve 111. The other port of either the first or second port is coMected to one end of reaction vessel 201 via tube 241. The other end of reaction vessel 201 is connected to a manifold port 542 of top common manifold 12 (not shown in Fig. 7) via a tube 2Z1. Tubes 271, 241, and æl are made from a chemically resistant material such as teflon. In fact, the present ~ u~ employs translucentPTFE and FEP teflon tubes of various cross-sectional dimensions throughout because of the low reactivity and optical .1,."-~ of the translucent teflon material.
Amino acid reservoir 231 is LJIC~ UI;~ with an inert gas such as a}gon via tube 562. The UlC:~Uli~d amino acid solution in amino acid reservoir 231 enters the third port of 3-port injection valve 111 through tube 560. Upon receipt of an d~ylu,ulialc command, injection valve 111 opens to permit the l~ amino acid solution to enterthe through channel of injection valve 111.
l~ig. 7 also shows two optical sensors lllS and 101S. Optical sensors lllS
and 101S detect the presence or absence of a liquid within substantially translucent teflon tubes 271 and 241. As shown in Fig. 7, optical sensor lllS is positioned below injection valve 111 and optical sensor 101S is positioned below reaction vessel 201. Data from optical sensors lllS and 101S are sent to a control computer (not shown in Fig. 7) for use in controlling various phases of the synthesis reaction.
Fig. 8 shows in greater detdil the ~ C,--, IIlif agitator 280 of Fig. 1.
N""- o ,~ l "~ agitator 280 includes two cylindrical shafts 564 and 568 coupled to a cylindrical knuckle 566. Shaft 564 aligns lt)n~itll~in~lly with the radial axis of cylindrical ~
knuckle 566 and is coupled at one of the two planar surfaces of cylindrical knuckle 566.
Shaft 568 is coupled to the other planar surface of cylindrical knuckle 566 and is offset from the radial axis of cylindrical knuckle 566. In one emT-o~iimrnt, shafts 564 and 568, and cylindrical knuckle 566 are machined from a single piece of metal stock.

WO 95/12608 t 7 5 5 ~ 7 PCTJUS9.1/123~7 When cylindrical shart 564 is torqued to rotate within a fixed rotary support such as a roller bearing, cylindrical shaft 568, which is offset f}om the axis of rotation of cylindrical shaft 564, moves in a circular path around the axis of rotation of cylindrical shaft 564. More than one n~ u~ agitator 280 may be operatively coupled, for S example, by a belt-and-pulley AIIAI~C" 1"-1ll to allow a plurality of ll~ ic T agitators 280 to move in unison. In the present Pmho~imPn~, shafts 568 of two n..,., .~ agitators 280 are connected to a single bracket to move the bracket in a circular path when shafts 564 are rûtated. r..~ u-c, shafts 568 and vortexing motor 300 are des~igned to move the bottom of each reaction vessel in a circu~ar path at 0 ~),UIU~.illlakly 1500 lCVUIl,l~iUll~ per minute To prevent damage to beads, the circular path of the present ~ bodil~ is preferably limited to a radius of ~lU~ .y 3.5 mm.
Fig. 9 shows in greater detail the upper portion of the reaction vessel bank 500 including reaction vessels 201-209 and vortexing motor 300 of Fig. 6. As discussed in connection with Fig. 6, reaction vessel bank 500 includes a plurality of reaction vessels 201-209 connected to top bracket 290. Top bracket 290 has a plurality of apertures 630 at which reaction vessels 201-209 connect. A teflon tube from above the aperture (not shown) connects to the upper end of each reaction vessel 201-209 at aperture 630 in a manner that permits a fluid to flow freely between the teflon tube and reaction tube 201-209.
The lower ends of reaction vessels 201-209 are connected to lower reaction vessel bracket 295. Figs. lOA and lOB show in greater detail a bottom view of the lower reaction vessel bracket 295 of Fig. 6. Fig. lOA is a close-up bottom view of a portion of lower reaction vessel bracket 295.
Fig. lOB shows a plurality of channels 65û in lower reaction vessel bracket 295. A flexible and ~llhst~n~iAlly translucent teflon tube (omitted from Fig. lOB for ease of illllct~tir-n) extends from the ~ower end of each reaction vessel 201-209 (also omitted from Fig. lOB for ease of illustration) and fits in a channel 650. A groove 652 for mounting an optical sensor is associated with each channel 650. Groove 652 is clearly illustrated in Fig. lOA.
Fig. lOB shows a plurality of mounting holes 654 for securely fastening optical sensors to lower reaction vessel bracket 295. Also shown in Fig. lOB is a plurality of optional holes 656 for reducing weight. As discussed earlier, lower reaction vessel bracket 295 follows the motion of the nc,.,,-, r.llli< agitators in a circular path to vortex ~ 1 75587 7 wo 95/12608 PCT/U59~/123 the contents of the reaction vessels. Optional holes 656 may be machined through lower reaction vessel bMcket 295 to reduce the mass of the bracket, thereby reducing the amount of power needed to move the bracket.
A through hole 658 near each end of lower reaction vessel bracket 295 connects a ~ agitator 280 to lower reaction vessel bracket 295. The lower ends of reaction vessels 201-209, which are extended by flexible teflon tubes 241-249 to ht through channels 650 in lower reaction vessel bracket 295, follow the circular movement of lower reaction vessel bracket 295. As lower reaction vessel bracket 295 moves in a circular path, the contents of all reaction vessels 201-209 in a reaction vessel bank are vortexed in a parallel manner.
Fig. 9 also shows optional 1~-. .. ~ . ..I, ;r agitator housings 520 for fittingover ~ - ir agitators 280. Optional n. .-~ agitator housings 520 enclose the - shafts within a hollow cylindrical housing to prevent possible injury to human users and damage to equipment when the - shafts are in motion.
The present ~--,1.~1;.-. ,1 uses a stepper motor (Model PX245-OlAA by Oriental Motor U.S.A. Corp. of Torrance, California) along with a stepping motorcontroller (Model RD122 by Semix Corp., of Fremont, California) for supplying the rotational force to the G 7 ~ ~ lt.;~ agitators. As shown in Fig. 9, three pulleys 6707 672, and 674 cooperate with vortexing motor 300 and two drive belts 521 and 676 to 20 rotate the two 1~- r- ~;- agitators 280 in unison inside optional n-.~ , agitator housings 520. Although the present ~ ,1,~1;- .: utiliæs a stepper motor and a stepping motor controller, the rotational force may be supplied by any other suitable type of motors, including other electrical or pneumatic motors. rultl~ u-c, the forc~ supplied by vortexing motor 300 may be i ' to n. . ~ agitators 280 by any suitable I l ,."- ;~ n means including chains and sprockets, pulleys and belts, gears, etc.
Fig. llA shows a lC~ , optical sensor 680 for use in detecting the presence or absence of a fluid within a t~_L 'Iy translucent teflon tube. Optical sensor 680 is the same as optical sensors 101S-1 l9S of the present ~mho~iim~-n~ Optical sensor 680 (Model EE-SX671 by Omron, Inc. of Srh~ mh~r~, Illinois) includes two forked ends 3û 682 and 684 for housing a light transmitter and a collector, I. ~IJaL;~y. Optical sensor 680 also has a body 686 for housing the ~ U~ t~ electronic circuitry to transmit sensor data to a control computer and for attacbing optical sensor 680 to a bracket.

WO 95/12608 2 ~ 7 5 5 8 7 PCTIUS9~/123~7 Fig. 1 lB shows in greater detail forked ends 682 and 684 of optical sensor 680. Located at the interior surface of forked end 682 is a cl~hst ~n~ y rectangular transmitter 685 for ~ light to a ~llhct~rti~lly rectangular collector (not shown in Fig. 11B) in the direction of arrows 688. The collector is located at the interior surface of 5 forked end 684 and is likewise of a cllh-~n~i~lly ~ ul~u shape. To detect the presence of a fluid within a substantially translucent teflon tube, the teflon tube is fitted through the gap between the two forked ends 682 and 684. When a fluid is present within the s~hct~n~i~lly translucent teflon tube, the collector is triggered signifying detection of a fluid within the teflon tube.
In practice, it was discovered that the ~lb~t~nfi~lly translucent teflon material may, when empty, cause optical sensor 680 to fail to trigger. To ~Iv~Lag~()u~ly use common optical sensors to sense the presence of a liquid inside a $l~h$t~n~ y translucent tube, a novel optical alignment block is used. Fig. 1 lC shows in greater detail an optical alignment block 690 Optical alignment block 690 is made of an opaque material which s~lhc~nti~lly blocks any light emitted by transmitter 685. Optical alignment block 690 includes two retaining walls 692 and 694 at a first surface 696 for frictionally engaging block 690 with one of the forked ends of optical sensor 680, and to securely hold optical alignment block 690 between the forked ends. In one cllll,~di~ .li, retaining walls 692 and 694 are designed to engage the collector forked end 684 of Fig. 1 lB.
Optical alignment block 690 also includes a channel 698 built into a second block surface 700. Second block surface 700 is the surface opposite the above-mentioned first surface 696. The axis of channel 698 is orthogonal to retaining wall 692 and 694.
Channel 698 is sized to grip the teflon tube snugly. As a result, the teflon tube is secured within channel 6g8 and is aligned at a right angle witb respect t~ the above-mentioned transmitter strip 685 when optical alignment block 700 is fitted into the gap between forked ends 682 and 684.
Fig. I ID shows an aperture 702 located along the center line of channel 698. Aperture 702 permits a small amount of light to travel through optical alignment -- block 690 along its bore between first surface 696 and second surface 700. When a cllhct:ln~ lly translucent teflon tube such as tubes 241-249 or 271-279 is fitted snugly within channel 698, the axis of aperture 702 runs through the center of the teflon tube.
The shape and size of aperture 702 is a function of the optical properties of the tubes.

WO 95/12608 2 ~ 7 5 5 8 7 PCT/US9~1123~7 When optical alignment block 690 is fitted between forked ends 682 and 684 in the manner shown in Fig. llA, light from transmitter 685 in forked end 682 travels through a cllhs~n~ y translucent tube 704. ~ost of the light is blocked by optical alignment block 690 after passing through tube 704. Some of the light passing through tube 704 reaches aperture 702 (hidden from view in Fig. llA) and travels along the bore of aperture 702 to reach the collector within forked end 684.
Since the axis of aperture 702 runs through the center of substanhally translucent tube 704, light passing through the center of the tube reaches a portion of the collector in forked end 684. Since light going through empty tube 704 is diffracted, an in~-~ffirirnt amount of light reaches the collector to trigger the sensor. When a fluid is present within translucent teflon tube 704, light passing through the filled tube is focused by the fluid within. The focused light enters aperture 702 from the direction of forked end 682 to trigger the collector in forked end 684. When a fluid is absent, the focusing effect is less pronounced. C~ , less light enters aperture 702. In fact, when there is no fluid in teflon tube 704, there is in~l~ffirirnt light passing through aperture 702 to trigger the collector in forked end 684.
As discussed earlier, optical alignment block 690 iS sized to snugly grip teflon tube 704. When optical alignment block 690 is fitted between forked ends 682 and 684, the teflon tube is securely gripped, as shown in Fig. llA, by optical sensor 680 and block 690. By securing optical sensor 680 to a bracket, teflon tube 704 is thereby secured to the bracket. In this manner, the teflon tubes 241-249 extending from the bottom of reaction vessels 201-209 of this r--' ' ' are secured to the bottom reaction vessel bracket 295.
As shown in Fig. 12, a reaction vessel such as reaction vessel 201 of the present ~",1.,"1",.~"l consists of a segment of FEP teflon tube 710. Tube 710 has an outside diameter of 1/4 inch and an inside diameter of 0.19 inch. As described in greater detail hereinafter, the diameter of tube 710 can alL~ ivr,l~l be made much larger for ~IJplb ~l~iUl~s where two or more reagents are ' 'y mixed in the reaction vessel201. Tube 710 is sealingly coupled with a flexible teflon tube 271. Flexible teflon tube "
271 is secured to lower reaction vessel bracket 295 of the reaction vessel bank. As the lower reaction vessel bracket 295 moves in a circular motion, the bottom of theflexible teflon tube 271 fo~lows the circular motion described by the bottom reaction vessel bracket 295 to vortex the contents within tube 710.

~ WO 95/12608 2 1 7 5 5 ~ 7 PCT/I~S9-J/123J7 In this f .1lbo~ -1L, tube 271 has an outside diameter of 1/8 inch and an inside diameter of 1/16 inch. Fig. 12 shows a tube connector comprising a first coupler 714, a second i11t~.~,O1111~U1 716, and a third coupler 718 for sealingly connecting tubes of different cross-sectional ~limPncinnc together. The aforemPn~ionpJ1 tube connector is 5 available from Norton, Inc. of Akron, Ohio. There is a frit or filter 1102 (hidden from view in Fig. 12) located at the bottom end of tube 710 for preventing substrates within tube 710 from entering flexible tube 712. The frit may be, for example, 2 micron titanium frit.
At the other end of tube 710, a fourth coupler 720, a fifth i~ ollll~Lul 721, and a sixth coupler 722 sealingly connect tube 710 to a tube 221. ~he couplers 720 and 722 as well as il~t_l-,UII..~Lul 721 are necessary because tube 221 of the present has different cross-sectional ~limPnci~nc from tube 710. Tube 221 connects to a manifold port 542 of top manifold 212 (not shown in Fig. 6).
A flexible O-ring 724 is fitted within a hole 726 in bracket 290 (shown in Fig. 12 in a cutaway view). O-ring 724 flexibly grips coupler 722, thereby flexib]y securing reaction vessel 201 to bracket 290. When the bottom end of reaction vessel 201 is agitated, O-ring 724 serves as a pivot point and holds the top end of reaction vessel 201 relatively immobile to enhance the vortex effects.
As shown in Figs. 12A and 12B, the reaction vessel 201 in one particular 20 f .IlI~o~i;ll.. 1 can optionally be provided with a t~,lllAu~.aLul~ control jacket 1100 for controlling the ;.Ill~ LLul~ of the reaction vessels 201-209. The L~ Lul~ control jacket 1100 in this P.,,~ ,l includes a fitting 1104 for connecting the reaction vessel 201 to the lines 221 and 241 (not shown). Inlet/outletports 1106, 1108 are provided for supplying a thermally conductive fluid to the reaction vessel 201. The thermallyconductive fluid can be used to either heat or cool the reaction vessel 201. In this ~lllbodilll~llL~ the reaction vessel 201 is formed from a teflon tube lll0, preferably having an outer diameter of 1/4 inch and a wall thickness of 1/32 inch. Spaced-apart from the tube lll0 is an outer tube 1112, preferably ,ul-~Llu~d of teflon and having an outer '~ diameter of 3/4 inch and a wall thickness of 1/32 inch. The outer tube 1 1 12 is positioned over the fitting 1104 to form an annular space 1114 for receiving the thermally conductive fluid. O-rings 1116, 1118 are placed between the outer tube 1112 and the fitting 1104 to form a fluid tight se~l. In this way, the thermally conductive fluid can be introduced into the annular space 1114 through either of the ports 1106, 1108 for heating or cooling the WO 9S/1260X 2 t 7 5 5 8 7 PCT~S9~/123~7 ~

reaction vessel 201. The ports 1106, 1108 also allow the thermally conductive fluid to be ;""~ ycirculatedthroughtheannularspace 1114.
An altemative ~".I~Ii",. .1l of a reaction vessel 1120 haYing an integrally formed ~.~ ul~ control jacket 1122 is shown in Figs. 12C and 12D. The reaction vessel 1120 functions cl~hcf~nti~lly identical to the vessel 201 except that the reaction vessel 1120 is preferably constructed of glass. The t~lll,U~,Ld~Ult: control jacket 1122 is also L
preferably COual~u-~ of glass Such a [-~mfi~ll~til~n allows the reaction vessel 1120 and the t~ d~ul~ control jacket 1122 to be formed as an integral unit. The reaction vessel 1120 includes a frit 1124, and ~ l;""~ 1126 and 1128 for connection to lines 221 and 241 (not shown). Inletloutlet ports 1130, 1132 are provided for circulating thermally conductive fluid through an annular space 1134 between the jacket 1122 and the reaction vessel 1120. Hose barbs 1136, 1138 are ~,UII~ ' 'y provided for connection of the inletloutlet ports 1130, 1132 to a suitable fluid source. In this way, thermally conductive fluid can be circulated through the annular space 1134 to heat or cool the reaction vessel 1 120.
D. Parent Vessel Fig. 13 shows in greater detail the pænt vessel of the present ~ o~
Parent vessel 200 has, for example, a volume of d~-~lu~dl~ t ly 30 mL. A tube 260 is sealingly connected to the bottom end of parent vessel 200 for ~ r~ " i,~ a reagent or argon to and from delivery system PDS 265 (not shown in Fig. 13). A frit or filter 746 is fitted near the bottom of parent vessel 200 to prevent substrates from entering tube 260.
There is a removable cap 743 fitted on the top end of parent vessel 200 for adding and removing material. Tube 215 fitted through cap 743 transfers material between parent vessel 200 and top common manifold 212 in a reaction vessel bank (not shown in Fig. 13).
Tube 215 extends through cap 743. A pressuri~ed argon/vent line 275 also extendsthrough cap 743. An optional rinse line 281 connects to a solvent source for delivering aaul~ solvent to the interior walls of parent vessel 5 to rinse the interior walls.
Fig. 13 shows two capacitive sensors 90S and 99S (Model 18-08 by Electromatic Control Corp. of Hoffman Estates, Illinois) mounted near the exterior of parent vessel 200. Each capacitive sensors 90S or 95S detects the presence of a liquid in its vicinity and transmits sensor data to a control computer (not shown) via w;res 756 and 758 respectively. Capacitive sensor 99S is used for detecting the level of reagents added wo 9~/12608 ~ t 7558 7 PCT/US9~/123~7 to the parent. Capacitive sensor 90S is for detecting the level of bead suspension for LlibuLioll. Both sensor levels can be adjusted according to amount of beads and the number of reaction vessels used. The capacitive sensor data is utilized by the software to control various cycles of the synthesis process.

E. Control System 1. Control Computer The automated ~yl~ utilizes a control computer to acquire data from the sensors, and to control the valves and the vortexing motor during the various cycles of the synthesis process. When used in ~;Ul.jU~ iO.l with the automated synthesizer, any computer including those popularly known as III;~,IU~'''''Il''l~: ':., 1ll;ll;' '''''1''ll(-'~
wnrkctAtinnc, ~--A;.,r,A"~, and the like, may be used to process the sensor data and to issue commands to control the valves and the vortexing motor.
Fu~ -l-ul~, sensor data from the sensors in the ~yll~hc~ may be acquired by any number of commercially available data acquisition devices using common data acquisition methods. Likewise, the valves and the vortexing motor may be controlled, responsive to an d~ , ' computer command, by commercially available input/output controllers.
In one ,-I-o~ , an IBM-compatible llli.,lU-,U~ JUt~l (also known as a personal computer or PC) is used as the control computer (Model Gateway 2000 4DX2-50V, by Gateway 2000 Inc. of No. Sioux City, South Dakota). Within the PC, there are a plurality of expansion slots permitting the addition of various expansion boards. These boards tap into the bus resources of the PC and permit the PC to ...,~.",~ Al~ with the circuitry on the card to perform an electronic function, Certain expansion boards alsû
permit the PC to ~ with external devices and circuitry. For example, a board popularly known as a modem board plugs into an expansion slot on a PC and permits the PC to c~ ", ~ with another computer having a modem. The use of expansion boards with a personal computer is a matter of common ~ knowledge.
'; In one ~--lbodi~ , the automated synthesizer .u~ A~ with the PC
via a m-lltirh~nn,-l digital I/O board (Model PCDIO120-P by Industrial Computer Source of San Diego, Califomia). The crerifi~ tinn of the PCDIO120-P board is described in detail in Product Manual No. 00431-050-20A which is also available from Industrial Computer Source.

wo 95/12608 2 1 ~7 ~ ~ ~3 7 PCT/US9.U123-17 Each PCDIO120-P provides 120 channels of buffered inputs/outputs (I/O) in five 24-channel groups. Each 24-channel group is controlled by a ~lu~;ld~ lblc peripheral interface (PPI) 825~A chip. The channels are selectable in set of 8 For either input or output.
S Fig. 14 shows a simplified diagram of a portion of the control hardware. Acomputer 760, such as the PC, having a plurality of expansion slots, connects to a display monitor 762 and a keyboard 764. A PCDP120-P I/O board 766 is inserted into one of the expansion slots to permit tbe PC to cnmm~r:^~t~ with five controller circuits 768. Each controller circuit 768 rnmTn~ ir~ C with I/O board 766 via a conductor channel 770~ In the present . ."1,.~.1;".. "1, conductor channel 770 includes a S0-conductor ribbon having the capability to service 24 I/O channels.
2. Controller Circuits The output signals from I/O board 766, typically 15 mA of source current 1~ and 24 mA of sink current, are inadequate to operate solenoid valves. Consequently, controller circuits 768 convert the output signals coming from I/O board 766 into power signals having adequate power to actually operate the solenoid valves. Controller circuit 768 has the capability to receive 24 output signals from T/O board 766 and in turn outputs 24 power signals 771 to control various devices of the synthesizer. The 24 power lines 771 of each controller circuit 768 are shown in Fig. 14.
Each controller circuit 768 also provides a central physical location into which sensor data from up to 24 sensor lines, one for each sensor, may be gathered. Data from up to 24 different sensors may be received by a sensor port 772 on each controller circuit 768.
Thus, each controller circuit 768 can service up to 48 TIO channels, 24 inputs and 24 outputs, of I/O board 766. Fig. 15 shows a Ic~ ,e~ ivc diagram of a controller circuit 768 according to one aspect of the present invention. A 50-pin header 781 connects the controller circuit 768 to I/O board 766 (not shown in Fig. 15). Header 781 is an input header and is connected via a bus 780 to a sensors port 772. Sensors port 772 comprises headers or connectors for connecting controller circuit 768 with up to 24 input devices such as sensors. T,ach conductor on bus 780 carries a signal from one sensor to input header 781. Fig. 15 also shows an optional LED bus 784 for carrying LED

WO95/12608 2 ~ 75~ Q;7 PCT/US9~1123.17 indicator signals from sensors port 772 to an optional bank of light emitting diodes (LE~s) 186. Each conductor in optional LED bus 784 carries a signal to one LED in bank 786.
Fig. 15 also shows another 50-pin header 788 for connecting controller circuit 768 to I/O board 766 (not shown in Fig. 15). Header 788 is an output header for receiving output signals from I/O board 766. A bus 790 carries up to eight output signals from header 788 to an octal inverter 74LS240 chip 792. Octal inverter 74LS240 chips 792 are ln~lur~Lulcd by Texas Instruments, Inc. of Dallas, Texas. A bus 794 carries the inverted buffered output signals from chip 792 to an octal latch driver 796. Latch dnver chips 796 are Model MIC59P50, ., ~ " r~ I lc~ by Micrel, Inc. of San Jose, California.
Output signals from each latch driver chip 796 are connected to an output port 798 via a bus 800. An optional LED bus 802 carries LED indicator signals from chip 796 to an optional bank of light emitting diodes (LEDs~ 804. Each conductor in optional LED bus 802 carries a signal to one LED in bank 804.
3. The Valves The solenoid valves such as, for example, valves 4- 7, 10, 14, 90-91, 100-121, and 129, used in the present r,,.,l-o~ are normally closed unless cf~mm:m~1~ to open. C~ c~ Lly, the default state for all valves in the ~,IIL~ is off. Safety is ensured because no material is permitted to flow when the synthesizer is in its default state. When open, valves use power and heat up. Besides the obvious drain on the system power, hot valves may adversely affect the chemicals passing through their ports. Because it normally takes a greater amount of power to open a solenoid valve than to keep an already opened valve open, a strike relay such as, for example, a model DlD20 byCrydom, Inc. of Long Beach, California, is used to operate the valves. A strike relay such as the DlD20 supplies +12 volts to a valve for a specified period of time, typically 100 millicf~ronrlc to open the solenoid valve from the off state. The period of time during which the strike relay supplies + 12 volts can be specified through software control, and the strike is supplied via an I/O channel. Thereafter, the strike relay supplies a reduced voltage, typically half the rated voltage or ~yylu~d~ L~I~ 6 volts in the present embodiment, to keep the solenoid valve open. C.~ ,lly, less energy is required to operate the valves and less heat is produced.
The present invention provides for four separate power supplies. A first power supply outputs +5 volts to power the l~L chips such as those found on controller wo 95/12608 2 ~ 7 5 5 8 7 PCrlUSg~1123~7 ~

circuits 76~. A second power supply outputs +32 volts for use by the stepper motor. A
third power supply provides + 12 volts to activate the solenoid valves. An optional fourth power supply also provides +12 volts for use by the sensors. A separate fourth power supply for the valves ensures that any noise ~enerated by the valves as they open and close 5 does not interfere with sensor operation.
In its default state, all valves are closed. As an additional safety measure, the synthesizer further provides for a solid state watchdog relay to shut off all valves in the event the control computer malfunctions. A solid state watchdog relay such as a Model SM-WDT5 by Brentek Tntprn~ti~n~l (available from Industrial Computer Source of San
10 Diego, California) is interposed between the control computer and the power supply to the valves. A softwarc ~ ' pulse is transmitted from the control computer to the watchdog relay on one of the I/O channels. When the pulse is absent, e.g., upon CPU
failure, latch-up or power failure, the watchdog relay shuts down the power supply for the valves, thereby closing all valves.
F~ Control Software The control software will now be discussed in detail with reference to the flow charts of Figs. 16-24. These flOw charts illustrate the commands issued by tlle control computers or completing relevant phases of the synthesis process. To simplify the 20 discussion below, it is assumed that at all relevant times, the valves of the pressunzed delivery system receive the ~ 1 commands from the control computer to deliver the desired reagent to the reaction vessel bank valve Fig 16 is a flow chart illustrating the ~.,,,,I,;,..U;..Il of commands issued bythe control computer for draining reaction vessels 201-209 of their contents. Before draining, reaction vessels 201-209 contain a liquid or a bezd C~r~ n~ n An argon supply valve 121, connected to top common manifold 212, receives an open command and opens to pressurize top common manifold 212 with argon. At the same time, selected 3-port valves 101-109 open to permit a liquid from reaction vessels 201-209 to enter lower manifold 214. Only selected valves 201-209 open because not all reaction vessels 201-209 are used during some coupling reactions. If a reaction vessel sits empty throughout a synthesis session, there is no ne~d to drain its contents. Waste valve 110 in bottom manifold 214 opens to permit fluid exit. As a f~ u~ of the pressure different~al, argon pressure pushes fluid from reaction vessels 201-209, through lower manifold 214, ~ WO 95/12608 2 1 7 5 5 8 7 PCTIU59~1123~7 and out waste valve 110. When sensor llOS turns off, signifying that no liquid is left to drain, the valves stay open an additional 2-5 seconds to ensure all liquids are drained from the reaction vessel bank.
Fig. 17 depicts the combination of commands issued by the control computer to clear lower manifold 214. At the start step, there is material in lower manifold 214. Thereafter, isolation Yalve 100 opens to permit ~ UliL~i argon from PDS 265 to enter lower manifold 214. .S ly~ waste valve 110 opens to vent material from lower manifold 214. Material exits from lower manifold 214 until no material is left. The valves return to their default state when optical sensor 1 IOS detects no material in the waste tube.
Fig. 18 shows the set of commands issued by the control computer to mix the contents of parent vessel 200. The system introduces argon into parent vessel 200 from below to mix the contents. The argon bubbles agitate the contents of parent vessel 200 as they rise from the bottom of the parent vessel to the surface of the contents inside ~5 the parent vessel. Again, all valves which have not been expressly . ~ to stay open are in their default state. Valve 100 orens to introduce pl~"u~;~l argon from PDS
265 to the bottom of the parent vessel to agitate the contents within. Valve 90 also opens to vent argon from the parent vessel. Valves 100 and 90 return to their default state after ~ Iu~ ly 15 to 30 seconds.
Figs. l9A and l9B depict the sequence of commands issued by the control computer to allocate bead suspension from the parent vessel to the various reaction vessels.
The sequence of commands i",l,l. .~,. ..lc a volumetric technique for filling the various reaction vessels with the bead C..crl-n~irm Using this approach, the reactions vessels are filled with little ~ e on flow rate. Thus, as will be seen, the bead suspension is distributed evenly among the reaction vessels regardless of the distance between that reaction vessel and the manifold port through which the bead suspension enters. At the start of the allocation cycle, the reaction vessel bank contains only argon, and the parent vessel contains a bead suspension at step 852.
- At step 854, the reaction vessel bank is partially filled with DMF to displace the argon that exists in the reaction vessel bank prior to the reallocation phase. Isolation valve 100 opens to permit JJI. ~Uli'~ DMF to enter the lower manifold from the u~;~cd delivery system. Valves 101-109 open to permit DMF to rise toward the reaction vessels. Valve 120 opens to vent argon from the top common manifold. Valves 2 1 75~87 WO 95112608 PCT/US9 1/123~7 100, 101-109, and 120 return, preferably in series, to their default state afler a ulu~all~ll.cd time period, which may be about 3 seconds each~ Reaction vessels 201-209 are then mixed to dislodge bubbles. Valves 100-109 open again for about 3 seconds.
At the expiration of this ,ulc~lugldl~ lcd time period, the level of DMF in each tube 241-249 leading to the reaction vessels will be near the top common manifold 212.
The reaction vessel bank and parent vessel 200 are then filled with DMF at step 858. Valve 100 opens to permit pressurized DMF to enter the reaction vessel bank from PDS 265. Valves 101-109 open to continue filling the reaction vessel bank with DMF. Valve 129 opens to permit the DMF which overflows the reaction vessel bank to enter parent vessel 200. Valve 90 also opens to vent the displaced argon from parent vessel 200. The filling continues until the level of fluid in parent vessel 200 rises to the level of upper capacitive sensor 99S when sensor 99S detects DMF within its detection envelope. The reaction vessel bank is then completely filled. Parent vessel 200 fills up to a~J~nu~ -,.t~,ly the level of second capacitive sensor 99S. Valves 90, 100, 101-109 then retum to their closed state at step 860.
Next, the top common manifold is cleared of DMF at step 862. Valve 121 opens to pressurize the top common manifold with pressurized argon. Valve 129 opens to permit DMF to enter the parent vessel from the top common manifold. Valve 90 opens to vent the displaced argon from the parent vessel. DMF from the top common manifold is thereby transferred to the parent vessel. The parent vessel is designed to have a sufficient volume to accept the additional DMF without ù._lnu..il.~,. After a pl=lJIu~;lallllllcd time period of, for example, about five seconds, valves 90, 121, and 129 retum to their default state at step 864. The ~.c~,u~;.a...,,led time period is variable but must equal or exceed the time it takes to clear the top common manifold of DMF.
Had the reaction vessels not been prefilled with DMF prior to the udLl~liù~ of the bead Cll~rPnCil~n, i.e., had the reaction vessels been empty, an uneven ~lictrihll~ion of bead suspension would occur. If the reaction vessels were empty, the reaction vessel which is the closest to the manifold port through which the bead suspension enters from the parent vessel would fill up first. There may be no bead suspension left for ~' some reaction vessels if a few were allowed to fill up ~ cly.
The present invention employs a novel method for controlling the volume at which a reaction vessel accepts the bead CllcrPncil~n First, at step 866, a small column of argon is introduced to the top of each tube which connects the reaction vessels to the top ~, wo 95/12608 ~ 1 7 5 5 8 7 PCT/US9-11123~7 common manifold. To create this argon bubble, valve 121 opens to pemmit yl~ u~
argon to enter the top common manifold. Selected vaLves 101-109 open in series to permit some DMF to drain from the reaction vessels to the lower manifold. Valve 110 opens to vent the displaced DMF from the bottom manifold. After about 0.3 seconds, a small 5 column of argon appears at the top of the tube which connects the reaction vessel to the top common manifold Valves 101-110, and 121 then retum to their default state at step 868.
At step 869, the bead suspension in the parent vessel is mixed in preparation for ~;~l.;l.ul,.." among the reaction vessels. The commands associated with this step are 10 similar to those discussed in connection ~vith Fig. 18. Valves lO and 90 then return to their default state at step 870. This step ensures that a I~UIIIO~-IIVJU~ bead suspension is evenly distributed among the selected reaction vessels.
A portion of the bead suspension is then introduced to the top common manifold at step 871. This step is timed according to a IJlti~JlU~ldUIIIII~ time period so that 15 the bead suspension that enters the top common manifold displaces most of the argon existing within the top common manifold without flowing past the manifold port into which the last reaction vessel tube, e.g., the reaction tube associated with sensor lO9S, connects.
A ~ ,Idllllll~,d period of about 0!5 seconds has been found to be ~dLi:~rd~ LUly. To introduce this portion of the bead suspension to the top common manifold, valve 91 opens 20 to pressurize the parent vessel with argon. Valve 129 opens to permit the bead suspension to flow into the top common manifold. Valve 120 opens to vent the argon existing in the top common manifold. After the expiration of the previously discussed l,.~k".,~;.dl.ll,l~d time period, valves 91 and 120 retum to their default state at step 872. Most illl~,olLd,llly, valve 129 continues to stay open to prevent beads and polymers from being damaged due to the closing action of the valve. In the present . .. ,~-~1;". .. : 2-port valve 129 continues to receive the command signal from the control computer to stay open in the manner discussed earlier. However, valve 129 may be a latch valve which toggles between the open and shut states upon receipt of a command pulse from the control computer. If valve 129 is a latch valve and is already open, no action needs to be taken by the control 30 computer to keep latch valve 129 open.
Fig. l9B is a ~,."1,...,-l,"" of Fig. l9A. After some argon which existed in top common manifold 212 has been displaced, tbe rest of the bead suspension is transferred to top common manifold 212 at step 874. Valve 91 opens to pressun~e parent Wo 95/12608 Pc rlUSs~1123~7 vessel 200 with argon. Valve 129 which has been kept open permits the pressurized bead suspension to enter top common manifold 212. Selected valves 101-109 open to permit the DMF within reaction vessels 200 to exit into lower manifold 214. Valve 110 opens to drain DMF from lower manifold 214. Partly due to the resistance of the bead 5~pPn~inn DMF recedes down selected reaction tubes 201-209 relatively slowly. The DMF displaced from selected tubes 221-æ9 connecting selected reaction vessels 201-209 with top common manifold 212 is replaced with the bead sllcr--noinn The column of suspension-bubble-DMF advances slowly downward towards lower manifold 214.
The column of bubble introduced earlier also ad~ ~euu~ly serves as a volume marker, i.e., provides a way for the control computer to determine when each reaction vessel has received a sufficient amount of bead s~srPn~inn The column of bubble stays trapped between the column of DMF and the column of suspension because of the surface properties of the teflon and the high contact angle between the DMF and teflon.
As discussed earlier, the optical sensors used in the present ~ bo~ can detect the presence or absence of a liquid column inside a cllhct~n~i~lly translucent teflon tube. As DMF is replaced by the downwardly advancing mass of bead C~lcrPncinn, the bubbles move down into the reaction tubes and into the tubes which connect the reachon vessels to the lower manifold. At the moment the argon bubble is detected by an optical detector IOIS-109S on its downward movement, that detector is ly tumed off. The sensor data, as discussed earlier, is ~ to the control computer which promptly issues a command signal to shut off a respective valve 101-109. After all valves 101-109 have been turned off, the bead suspension transfer is restarted and continues at step 878 until acoustic sensor 120S detects no fluid in the tube connecting the parent vessel with the top common manifold. At step 882, all valve3 except valve 129 return to their default state. As discussed, valve 129 stays open to avoid damage to the beads and valve 129.
The synthesizer at this point has suspension in its reaction vessels, and possibly some bead suspension residue in the parent vessel. To make sure all the beads are transferred to the reaction vessels, a rinsing process comprising at least one rinse cycle is employed. ' The rinsing cycle is initiated by showering the interior walls of the parent vessel at step 890 with DMF sprays to loosen any bead suspension residue which may have cling to the wall. Valve 14 opens to permit sprays of DMF to wash down the walls.
Valve 90 opens to vent the replaced argon from the parent vessel. The interior wall ~ WO 95/12608 2 i 7 5 5 8 7 PCT/US9~/123`17 continues to receive sprays of DMF until the level of DMF in the parent vessel nses to the level of lower capacitive sensor 90S and turns it on. This sensor data is received by the control computer which promptly issues a command at step 892 to return all valves except valve 129 to their default state. The contents of the parent are then stirred by argon 5 bubbles in the manner previously discussed.
Altematively, the parent vessel may be rinscd by refilling it with DMF and then mixing it to loosen any bead suspension residue which may have clung to the interior walls or frit of the parent vessel. First, at step 884 the parent vessel is refilled with fresh DMF. The refilling is - ~ ' ~' by opening valve 10 to permit DMF to enter the 10 parent vessel from the ~ Ul;~d delivery system. Valve 90 also opens to permitdisplaced argon to exit the parent vessel. When the level of DMF in the parent vessel rises to the level of the top capacitive sensor 99S, top capacihve sensor 99S is turned on.
This sensor data is received by the control computer which promptly issues a command at step 886 to return all valves except valve 129 to their default state. The parent vessel is 15 then mixed at step 888 by i~duc~ argon bubbles to the parent vessel in the manner previously discussed.
The mixture of DMF and bead suspension is then transferred to the reaction vessels at step 894 by opening valve 91 to pressurize the parent vessel with argon and to transfer the mixture to the top common manifold through valve 129 which has remained opened through out the rinsing process. Selected valves 101-109 open to permit fluid to flow from the reaction vessels to the lower manifold. Valve 110 opens to drain DMF
from the bottom manifold. The frits at the bottom of the reaction vessels strain all beads inside the reaction vessels. Eventually, the parent vessel is drained. Sensor 120 turns off when no fluid is present in the tube connecting the parent vessel with the top common manifold. This sensor data is ' to the control computer to signify that no fluid is left in the parent vessel to transfer. The control computer continues to open valve 91 for another 5-10 seconds to pressurize the top common manifold and to move any remaining mixture into the reaction vessels. After 5-10 seconds, all valves except valve 129 are returned to the default state. One rinse cycle is completed.
As discussed earlier, a plurality of rinse cycles may be employed to ensure that ~ ' "y all bead suspension from the parent vessel is transferred to the reaction vessels. Two to three rinse cycles have been found to be satisfactory.

wo 95112608 PC rlUSs~1123~7 When all rinse cycles are completed, all valves including valve 129 are returned to the default state at step 896. Note that valve 129 remains open throughout the bead suspension reallocation process, including the rinsing process, to minimize any damage to beads and polymers. The reaction vessel bank is then drained of all fluids in S the manner earlier discussed at step 898.
From the steps in Figs. 19A-19B, it can be seen that the use of the argon bubble allows the bead suspension to be distributed evenly among the reaction vessels regardless of the flow rate of each ffow path between the parent vessel and reaction vessel.
As long as the argon bubble remains stable between the bead suspension and the DMF
reagent, a viable marker is provided, enabling the sensors to determine the status of the reaction vessels. The ability to maintain a stable argon bubble, as previously mentioned, is due to the favorable physical properties of DMF, i.e., high contact angle of DMF with teflon.
However, it may be desirable to use fluids other than DMF when delivering the beads to the reaction vessels. This may create problems, p~uL;.,ul~uly if the substitute fluid does not have physical properties which are conducive to creating a stable argon bubble. For instance, ~rPt~nitril~ (MeCN), which is used as a solvent for DNA synthesis, is unable to produce a stable argon bubble. Thus, a different approach for disLI;l,uL;llg the beads to the reaction vessels is required.
Figs. l9C-19D illustrate an altemative set of commands issued by the control computer for mixing the contents of the parent vessel when a stable argon bubble cannot be produced.
This technique is particularly useful when only a small number, e.g., up to four to five, of reaction vessels are employed.
Steps 854a-860a are similar to steps 854-860 in Fig. 19 except that only a smaller number of valves 101-109 are opened, i.e., only those ~u~ d;l,g to the selected reaction vessels. The selected reaction vessels are partially filled with a solvent, such as MeCN in order to displace the argon that exists in the reaction vessel bank pnor to the reallocation phase. After which, the selected reaction vessels and the parent vessel are filled with MeCN. The flow of MeCN is stopped when the amount of MeCN in parent vessel 200 rises to the level of second capacitive sensor 99S, indicating that filling is completed. Upon comrl~tinn~ the selected valves then return to their closed state.

~ WO 95/12608 2 1 7 5 5 8 7 PCT/US9.11123.17 Next, at step 872a, the bead suspension located in the parent vessel is mixed in preparation for di~LLi~uLiul~ to the selected reaction vessels. At step 874a, the bead suspension is then introduced to the top common manifold and distributed to the selected reaction vessels by opening valves 91, 129, and selected ones of 101-109. These valves 5 remain open until the sensor 120S detects the absence of fluid in the tube connecting the parent vessel with the top common manifold. Since no argon bubble is produced, sensors lOlS-109S are not employed. Because only a small number of reaction vessels receive the beads, the time required for the beads to reach each of the reaction vessels is ~,U~JIU~illldt~ ly equal, thereby ensuring a generally equal distribution for each of the 10 reaction vessels.
At step 890a, a rinsing process, such at those already discussed in Fig. l9A-l9B, is employed to make sure all the beads are transferred to the reaction vessels. Upon completion of the rinsing process, all valves including valve 129 are returned to the default state at step 896a. The reaction vessel bank is then drained of all fluids at step 898a.
Fig. 20 is a flow chart showing the sequence of commands issued by the control computer to fill the reaction vessel with the desired reagent from the de~ivery system. The steps discussed in connection with Fig. 20 are also ~rh~rn ~ lly illustrated in Figs. 21A-21D. This process assumes that the lower manifold is filled only with inert argon at step 900. Fig. 21A graphicaLly shows a relevant portion of the reaction vessel bank having an empty manifold. The lower manifold is first filled with a reagent at step 902. Valve 100 opens to permit the reagent to enter the lower manifold, and valve 110 opens to vent the argon displaced from the lower manifold. When the reagent is detected by sensor llOS, all valves return to default at step 903.
In some instances, the sensors lOlS-109S may be tripped i-lauv~ .lLly or prematurely while filling the tubes connecting the reaction vessels with the lower manifold.
For example, a sensor may be actuated by a stray droplet of reagent before the reagent actually reaches it. This can cause an ,, ~,.11~;. .,l amount of reagent to be present in the tubes for delivery into the reaction vessels.
To reduce or eliminate problems associated with premature sensor actuation, the control computer, at step 904, can optionally be ~lu~ d to open valves 101-109 for a set amount of time in order to prefill the tubes. Generally, the time is set so as to prefill the tubes to about 75%, before being detected by the sensors lOlS-109S. As described, this step does not rely on the use of sensors lOlS-109S. Thus, preflling wo 95/12608 P~TIUS9~/123~7 ensures that there is at least a sufficient amount of reagent present in the tubes to inject into the reaction vessels to ade~uately perform mixing, even if the sensors are ~ dLul~ly actuated At step 905, the valves retum to default after the predefined time has expired in preparation for filling the tubes.
At step 906, the tubes connecting the reaction vessel with the lower manifold are filled to the sensors with reagent. The filling process may be carried out in parallel to save time or in series. Valve 100 opens to pemmit ~lc~ul;~l argon from the ~ICaaUli~,_i delivery system to enter the lower manifold. Selected valves 101-109 open, serially or in parallel, to permit the reagent to enter the tube connecting the reaction vessel with lower manifold. When the level of reagent in a tube reaches the upper light sensors IOlS-109S, the light sensors tum on, and the control computer promptly tums off an associated valve 101-109. When all sensors lOlS-109S are on, all valves are returned to the closed state at step 908. Fig. 21B srhrm ~ir~lly illustrates the result after this filling step is completed.
The bottom manifold is then cleared in the manner earlier discussed at step 910. Fig. 21C shows a relevant portion of the reaction vessel bank having a cleared manifold and a column of reagent inside the portion of the tube between a top optical sensor, e.g., lOlS7 and a valve, e.g., 101. After the bottom manifold is cleared, all valves are again retumed to default at step 912. The reagent in the tubes are then pushed up into the reaction vessels through the frits.
To push the reagent into the reaction vessels, Argon valve 122 opens to permit argon from the L,l~,u.i~ delivery system to pressurize the lower manifold. Vent valve 120 also opens.
At step 913, the vortex motor is activated to commence agitating the reaction vessel bank for a ~ i amount of time. The time period is sufficient long to permit the contents within the reaction vessels to mix completely. Generally, a time of about 4 has been found to be adequate, but may vary depending on the type of synthesis.
During the above mentioned mixing period, at step 914, valves 101-109 open for a ~ uy,ldllllll~ d period of time to flow a small amount of reagent into the reaction vessels. UsuaUy, the reaction vessels are filled and drained repetitively dunng a synthesis process. Each time the reaction vessels are drained, the beads therein become dry and clump together to form a "bead c~ke". Step 914 fluidizes the contents of the ~ WO 95/12608 2 1 7 5 5 ~ 7 PCTII~S9J1123.17 111 ~
reaction vessel and dissolves the bead cake. Since vortexing is most effective when the beads are at or near the bottom of the reaction vessel, only a small amount of fluid should be injected. Otherwise, the bead cake may float to the top of the reaction vessel, requinng more time to dissolve it. At step 915, the valves retum to default after the predefined time has expired.
At step 916, the remaining portion of the reagent is pushed up into the reaction vessel by opening valves 101-109. Each vessel is filled until its associated sensor 101S-109S detects the absence of a fluid and the control computer tums off that valve.
When all sensors 101S-109S are off, all reaction vessels are filled. To improve mixing, the vessel bank is agitated while being filled. As noted before, the reaction vessels may be u~ la~ d so as to fill the vessels in parallel or in series by ûpening all the valves 101-109 at once or sequentially.
Altematively, the reaction vessels may be filled without relying on sensors 101S-109S. For example, valves 101-109 may be opened for a pl~ ;ldlllll.Cd time period which is sufficient to fill the vessels to the desired level. A time period of 0.5 seconds to l second has been found to be ~ILi~ri~Luly. However, this time period may vary according to the number of vessels being used, i.e., the greater the number, the longer the time required. Fig. 21D shows a diagram of the reaction vessel after being filled~
Note that the volume of reagent to be pushed up into the reaction vessels also can be easily changed by varying the length or diameter of tubing between valves 101-109 and sensors 101S-109S. This change can be easily ~ ~c. ,~ "s,i by ~ the tube which connects a reaction vessel to an injection valve, e.g., valve 111, with a tube having a different length or cross-sectional dimension.
It may also be advantageous in some instances to increase the diameter of reaction vessels themselves. For instance, it may be desirable to ciTr~llt~ oucly mix the beads with two or more reagents. Such mixing can occur by following the steps descnbed in Figs. 21A-21D to introduce the first reagent to the reaction vessels. A second reagent is then introduced to the reaction vessel by repeating the steps described in Figs. 21B-21D.
In so doing, however, an argon bubble will be disposed between the bead suspension and the second reagent due to the argon left in the tubes 241-249 and 271-279 beforeintroduction of the second reagent. To remove the argon bubble from the reaction vessel, the inner diameter of the reaction vessel can be made larger to reduce the height of the wo 95/1260~ 2 1 7 5 5 8 7 PCT~US9~1123~7 ~

bead suspension within the reaction vessel, thereby making escape of the argon bubble through the bead suspension easier. After removal of the argon bubble, the bead suspension and the second reagent are mixed together by vortexing as previously described.
Fig. 22 is a flow chart showing the sequence of commands issued by the control computer to inject activated amino acid reagents into the reaction vessels. Figs.
23A-23C ~1,. ..~ ~ll. ^lly illustrate the relevant steps of the amino acid injection process.
Again, it is assumed that the lower manifold is cleared, i~e., contains only argon, at the start. Fig. 23A shows a diagram of the reaction vessel, the lower manifold, the valves, 10 the sensors, and associated tubes at the start.
An alternatiYe ~ n~--- for the reservoirs 231-239 is shown in Fig. 6A.
For . .,.1~.~.1",.. .,1~ E. a rotatable carousel for holding a plurality of groups of reservoirs, the carousel is rotated to align the tubes with the selected group of reservoirs at step 917. Once the ~ reservoirs are selected, the manifold is filled at step 91~ with amino acid activating reagents such as 0.2M HBTU and 0.6M DIEA in a so1ution of 3:1 DMF to DCM. The manifold is filled in the manner discussed in connection witn Fig. 20, i.e., open valves 100 and 110 until sensor 110S is turned on.
Thereafter, aU valves close at step 920.
The activating reagents then enter the tubes connecting the reaction vessels with the lower manifold. Valves 100 and 120 open to let ~ UI;L~i activating reagent enter the lower manifold at step gæ. Selected ones of valves 101-109 open until the lower optical sensors lllS-119S senses fluid presence. All valves again close at step 924. Fig.
23B graphically shows the presence of fluid in relevant portions of the reaction vessel bank after this initial filling step.
: To ~rCrl~rlich the injection, valves 100 and 120 again open to let 1"' ' activating reagents enter the lower manifold at step 926. Selected ones ofvalves 101-109 open in parallel to permit a column of l ~ activating reagent to advance up the ~u, .... ,1i.. ~.1 tube. c ' '~, associated ones of valves 111-119 open to inject amino acid into the upwardly advancing column of ~ LII;L~ activating 30 reagent and to mix with the activating reagent. Fig. 23C graphically shows this injection step.
When each ænsor 101S-109S detects a fluid presence, the control computer turns off a valve 101-109 which is associated with that sensor. When all valves 10 1 -1 09 ~ WO 95/12608 2 ~ 7 5 5 8 7 PCT/US9.1/123~7 close at step 928, all valves of the reaction vessel bank return to the default mode. The mixture of amino acid and activating reagent is preferably permitted to stay in the afor~m-~n~inn~A tube for about two minutes to ensure proper activation at step 930.
Thereafter, the bottom manifold is cleared at step 932 in the manner 5 discussed earlier in connection with Fig. 17. The column of mixture between valves 101-109 and upper sensors lOlS-109S are then pushed up into the reaction tubes in the manner discussed in connection with Fig. 20 at steps 913-916.
Fig. 24 shows the sequence of commands issued by the control computer for r~ the bead suspension within the reaction vessels back to the parent vessel. At10 the start, it is assumed that the reaction vessels have been drained, and the lower manifold is filled with argon. The reaction vessels are first filled with a solvent at step 936 in the manner discussed in connection with Fig. 20. Thereafter, all valves return to default.
Next, the mixture of beads and reagent is vortexed to create a suspension at step 938. AlL~ tiv~ly, the mixture of beads can be vortexed while the reaction vessels 15 are being filled. Such a process improves the speed of suspension and helps prevent the beads from clumping together at the bottom of the vessel. The contents of the reaction tubes are transferred to the parent vessel at step 940. Valve 122 opens to pressurize the lower manifold with argon. Valve 129 opens to permit the bead suspension to move from the reaction vessel bank to the parent vessel. Selected ones of valves 101-109 open, 20 preferably in series, to permit argon to blow the contents of each reaction vessel up toward the top common manifold and into the parent vessel. The contents of the reaction vessels are thus transferred to the parent vessel serially. Although the above transfer may also be performed in parallel by opening valves 101-lO9 ~ ,. Ju~ly~ serial transfer permits argon pressure within the reaction vessel bank to remain high and is therefore preferable.
25 FUILI~ U~, each of valves lOl-lO9 preferably remains open for about four seconds to ensure that s~bst~nti~lly all of the contents of a given reaction vessel are transferred to the parent vessel. During this process, valves 90, 122, and 129 remain open.
After the contents of all reaction vessels are transferred to the parent vessel,~ the reaction vessels may be rinsed and another transfer process may occur. To rinse the 30 reaction vessels, the above steps are repeated, starting with the refilling of the reaction vessels with DMF at step 936. As shown in steps 937 and 941, valve 129 is kept open during the line cycles to prevent damage to the beads and valve 129. The parent vessel preferably has volume for at least three transfers. At the end of the l~ul.lbi~ ion, the wo gS/1260~ ~ 1 7 ~ ~ 8 7 Pcrluss~ll23~7 0 parent vessel is preferably drained by opening valves 110 and 91 until the level of f~uid in the parent vessel reaches below lower capacitive sensor 90S and tums that sensor off.
Three cycles of rinse have been found to be satisfactory.
Thereafter, all valves including valve 129 return at step 942 to the default S state. The contents of the parent vessel are agitated at step 944 to mix the beads from the various vessels in the manner discussed in connection with Fig. 20. If the beads are to be removed from the parent vessel, the parent vessel is preferably drained at step 946 by opening valves 10 and 91 until the level of fluid in the parent vessel reaches below lower capacitive sensor 90S and tums that sensor off. All valves are ~ub,,~u~llLly returned at step 948 to their default state. The mixture containing beads may then be removed from the parent vessel for use.
Alternatively, the beads may be reaUocated to the reaction vessels in the manner discussed in connection with Figs. 21A-21B. FoUowing the rP~IIn~rinn all valves retum to the default off state.
G. Overall Diagram of Software Fig. 25 is a flow chart of the source code which is included herein as Appendix I. Module 950 represents the user. A command interpreter 952 accepts the textual commands from tbe user. Altematively, the user may enter commands to run the synthesizer using a menu system 953. The commands received by menu system 953 are either converted to a format usable by command interpreter 952, or call a support routine in support routines module 962 directly. Command interpreter 952 also parses thecommands entered, textually or otherwise, by the user. Thereafter, the parsed commands call and execute support routines in support routines module 962. ru-LI~ lulc, the parsed commands are formatted by a display formatter 954 and displayed on a display 762.
Module 958 contains a plurality of macro files. A macro file defines, for example, the sequence of steps that must actually take place to run a synthesis or build a library. At its most basic level, a macro file contains, for example, macros which in turn contains sets of discrete cûmmands for controlling valves and reading sensor information.
Macros may utilize other basic macros to perfomm higher level functions such as draining reaction vessels 201-209.
The macros received by command interpreter 952 from macro files 958 are passed into a synthesizer library controller 960. Synthesizer library controller 960 calls ~, WO 9S/12608 2 ~ 7 5 ~ 8 7 PCT~59~112317 the macros for actuai synthes~s. For example, one macro may specify the initial global variables that must be set before synthesis begins.
Fig. 25 shows a support routines module 962 for running a variety of support ~ubluuLill~s. One such subroutine is autofill, which is a subroutine for5 ~l~fom~tir~liy filling the reaction vessels until all sensors are on. Support routines 962 accept inputs from either command interpreter 952 or menu system 953. Option list 964 contain pointers to functions, etc. Fig. 26 shows the inputs and outputs of option list 964 and its,,1~ with command interpreter 952 and support routines module 962.
There are also; .;I; .I;,~ti"" files 966 for holding global variables and global10 settings. Tr~ li7~tilm hles 966 hold, for example, a value ~ ; e the amount of time during which a strike voltage is supplied to a valve to open a closed valve, etc. A lookup table file 968 cooperates with ~yllLII~;~, command library controller 960 to, for example, permit a monomer to enter ~ u~lidLe selected reaction vessels. Lookup table file 968 may contain, for example, a listing of each reaction vessel, its ~.."~ .on.l;l,~ tag monomer, and the list of monomers necessary for sy^~hPci7in~ the desired polymer.
Fig. 25 also shows a log file 970. Log file 970 accepts inputs from command interpreter 952 and ~l-tll~. . library controller 960. Log file 970 contdins npPrPtirn~l data for diagnostic purposes. An entry in log file 970 contains, for example, ;"r""" ~;.", relating to the macros cailed.
An associate file 972 contains a listing of each reaction vessel and its associated valves and sensors. Associate file 972 cooperates with both synthesizer library controller 960 and support routines 962 to simplify the task of addressing each reaction vessel and its associated valves and sensors.
The digital commands outputted by support routines 962 enter a parallel driver 974. Parallel driver 974 may be, for example, PCDIO120-P l/O board 766.
Parallel driver 974 outputs valve control signals 976 via its IlO channels to drive the solenoid valves. The vaive control signals, as discussed, are further processed by controller circuit 768. FulLil~ lui~, parallel driver 974 outputs stepping motor controller - signals 978 to control the vortexing stepper motor. Sensor inputs 980 from the optical sensors, the ultrasonic sensor, and the capacitive sensors of the ~yllLIl~ . are also received by parallel driver 974 for processing by support routines 962 via sensor checicing ~UIJlUULil.~s 982.

wo 95/12608 2 1 7 5 5 8 7 Pcr~S9J/123~7 ~

Fig. 27 illustrates the data structures necessary to control valves. A valve index VINDEX array 986 accepts a valve number 984 as input and provides a pointer to a VALVES array 988. ~ach element of VALVES array 988 contains a pointer to a data byte 990. Each data byte 990 contains 8 bits of valve data i"r ,""~ The bit containing valve data i--rulll~Liu-- for a given valve is accessible by the address of its data byte 990 and a shift value It~ g the relative location of that bit within dat~ byte 990. Each bit of data byte 990 may be m~nir~ t~fi to dp~Jlul~lidL~ly turn on or off a valve. The valve data i"r,~ ;Oll in each bit corltrols a (;~II~,.JUlldil~g valve via output port 992.
Fig. 28 iilustrates the data structures necessary for receiving sensor i"r~,l...d~ from input port 994. The ;,.r,,"~ " representing the binary state of each sensor is stored in one bit in a data byte 996. To access the information in data byte 996, a sensor number is used to access SENSOR array 998. Each element of SE~SOR array998 contains a pointer to an d~ JlidL~ data byte. Each data byte 996 contains 8 bits of 15 sensor data information. The bit containing valve data ;r~-"~ ,. for a given valve is accessible by the address of its data byte 996 and a shift value representing the relative location of that bit within data byte 996.
H. Windows Interface The control software may illl,Ol~ a Windows-type interface or workspace. Generally, the Windows interface is a l~ ~ ' , graphical user interface (GUI) providing one or more windows for display on the screen. Additional windowobjects may be displayed in various si~es and formats (e.g., tiled or cascaded), as desired.
At the top of the window is a menu bar with a plurality of user-command choices, each of which may invoke additional submenus and software tools for use with application objects.
The window also includes an area for displaying and n ~nirlll~in~ screen objects. This area is a workspace or viewport for the user to interact with data objects which reside in the memory of the control computer system.
The windows interface includes a screen cursor or pointer for selecting and otherwise invoking screen objects of interest. In response to user movement signals from a pointing device such as a mouse, the cursor floats (i.e., freely moves) across the screen to a desired screen location. During or after cursor movement, the user may generate user-event signals (e.g., mouse button "clicks" and "drags") for selecting and manipulating ~ WO 95/12608 2 i 7 5 5 8 7 PCT/US9~1123.17 objects, as is known in the art. For example, the window may be closed, resized, or scrolled by "clicking on" (selecting) screen ' ""'l'') " Keystroke equivalents, including keyboard a 1 or "hot keys", are provided for pcl~ull~ g these and other user operations through the keyboard. Thus, a Windows interface provides a more intuitive 5 approach to interacting with the control computer.
Underlying the Windows interface is a message or event-driven architecture.
This model is perhaps best described by contrasting its operation with that of a modal or sequential al~ ll;t~ult; that has been traditionally employed, as ~ ~",l liri~l by the command interpreter in Fig. 25. In this manner, the reader may appreciate the added 10 flexibility as well as complexity of an event-driven system.
A modal program comprises a series of discrete operating blocks or modes having a well-defined beginning, middle, and end. Thus, the program follows a fairly rigid sequence of operation with each step necessarily being completed before the program proceeds to the next step.
While a modal program is relatively easy to design and implement, it is generally not easy to use. The design certainly ensures that all required information is entered, but only at the expense of forcing users to operate in a manner dictated by the program. Specifically, since the program is built around a pre-arranged set of modes, a user cannot get from one mode to another without first completing a previously-required 20 mode. Any deviation from this sequence by the user is simply not permitted. This inflexibility of the modal programs may be inefficient for handling real-world tasks.
On the other hand, an event-driven ~ u,~ eschews a pre-selected sequence, opting instead for an "event loop. n The event loop is a centralized mechanism for processing messages about user and system events. It includes an event queue and 25 "~ for retrieving and ', ~ messages to various window classes.
Messages are how the operating system manages and ~ llul~ multiple - C and hardware events, such as clicks of a mouse or presses of a keyboard, which in MS-Windows are converted to messages by Windows event handlers. From a ^- UII ~ , a message is simply a data structure containing information 30 about a particular event. The message structure may include a message identifier which serves as a symbolic constant for a particular event. For example, messages from a window object might include i r.~ ;.... about creating, closing, moving, and re-sizing the window. Additional event data are available as message r:~r~m-trr~ the exact WO 95/12608 2 1 7 5 5 8 7 PCTIUS9~/123~7 ~

illL~I,ul~;L~Liull of a given parameter varies with each event type ~,UI~ d Input messages are coLected in a system-wide queue and then directed to the proper window.
These messages, along with timer and screen paint (screen refresh) messages, are passed to the target application(s) of interest.
A m,~nh~nicm is provided for retrieving messages from the system queue and rii~r~t~hin~ them to the appropriate application which, in turn, may proceed to process any message that arrives. Each window belongs to a particular window type which defines certain ch~r~-~t~ri5fir~ common to all windows of that type. Associated with each type is a Windows function which processes all messages sent to windows of its type. An lû application queue is provided where Windows may place messages that belong to a specific ~rrli~"ti"n When the application is ready to receive input, it simply reads the awaiting messages. If none are found or if there exists a message for other ~rFlir~-innc Witl~ higher priority, Windows passes control to the other -l,r,li. ~li...,~
The general mechanism for retrieving and ~ messages in an event-15 ~ased system, such as Microsoft~D WindowsW, is known in the art; see, e.g., Petzold, C., Plu,slu.,."..ng Wi~dûws, Second Edition, Microsoft Press, 1990 and Custer, H., Inside Windows N7, Microsoft Press, 1993. Additional inf~lrm~tirm can be found in Microsoft's Window Software D~velo~ lL, available from Microsoft Corp. of Redmond, WA. The disclosures of each of the foregoing are hereby illCullJuldL~I by reference for all purposes.
Fig. 33 illustrates a GUI as ;, ~ on the control computer. The CUI
includes a rectangular window 1301 with a workspace 1303. At the top of the window is a menu bar 1305 with user command choices 1306-1313. Each of these command choices include additional submenus containing commands for controlling the operations of the synthesizer. These command choices offer a user the flexibility of either pc~lrollllil~g a synthesis ~llt~m~fir~lly or manually by invoking the ,~ lu, commands with the mouse.
The GUI is designed with the intention of being a user friendly ~IIV;~UI~ , thus ",;,.;",;,;"~ efforts required for ~IU~ g the synthesizer. For example, a dialog box object or a set of dialog box objects is associated with each command. When a command is invoked, the ~,U~UIU~IidL~ dialog objects are displayed in the workspace and interactively prompt the user to enter the necessary il~rû~ldliull. A
Help command 1313 provides ill~U~ Liull to assist a user through the process. Using the WO 9~/12608 PCT/US9-11123~7 dialog objects, the user may program the synthesizer without using traditional text r,omm:~n~lc Fig. 34 iliustrates a submenu 1320 that is associated with the Macros option.
A user may invoke either a Learn or Run command by clicking the mouse on submenuitem 1321 or 1322, respectively. In the Windows ~llvilUll~ , a macro is an object that contains a set of discrete comm~nl1c such as those discussed in connection with Figs. 16-24, for controlling the synthesizer. Using the Learn command 1321, the user can define a macro to perform specific functions. The submenu may also identify the keystrokes assigned to invoke the available rl.mrn-.n~C For example, "Alt+L" is used to execute the Learn command.
Once the macro is "learned," the Run command 1322 may be selected to execute the learned macro or any other macros which have been previously defined. Fig.
35 exemplifies a dialog box object that is displayed when the Run command is invoked.
The dialog box object includes an area 1325 (combination box) which lists the available macros. To select a macro, the user enters the name of a macro in a Select Macro space 1324. Alternatively, the user may scroll, by clicking and dragging the mouse, until the desired macro flle in space 1325 is selecoed. The user then enters the number of times the macro is to be repeated in space 1326. Finally, to run the macro, the user clicks the mouse on a RunMacro button 1327 or a RunSMacro button 1328. The RunSMacro command instructs the system to perform the macro functions serially, i.e., one reaction vessel at a time. The Cancel choice 1329, when selected, exits the dialog box object 1326.
A Help choice 1330 provides i~lru~ iul~ regarding the different choices in the dialog box object.
Fig. 36 illustrates a submenu 1335 which is displayed when the Groups option 1310 on the menu bar is chosen. Submenu 1330 includes a Define command 1331 which is employed to define a set of valves associated with a group of specific reaction vessels. Once defined, the valve group is stored as a group object in memory. The computer's memory may contain many group objects, each defining a unique valve group.
Submenu 1330 also includes an Open/Pulse command 1332 to fill and drain the selected reaction vessels for a predefined time period. When invoked, a dialog object box associated with the Open/Pulse command is displayed. The dialog object box, somewhat akin to the one illustrated in Fig. 35, contains a ~,UIIliJ;l~Lioll box that lists the SUBSTITUl~ SHEET (RUi~ 26) Wo 95/12608 2 t 7 5 5 8 7 PCT~lSg~1l23~7 ~

available group objects from which to choose. The user selects the desired group and inputs the desired time period to pulse the selected valves in an assigned space proYided by the dialog object. To fill the reaction vessels, the user clicks an Open button to indicate that the valves are to be opened. Next, the user initiates the filling process by clicking either a Pulse or SPulse (to fill the reaction vessels serially) button. To drain the reaction vessels, the user clicks a Close button and either the Pulse or SPulse button.
The user, using a Fill/Drain command 1333, can fill or drain the vessels ~llSnrr~sir~lly using sensors. The Fill/Drain command, when selected, displays a dialog box object similar to that of the Open/Pulse command. The user selects the group of valves and clicks either an AutoFill or SAutoFill button to perform a fill function or an AutoDrain or SAutoDrain button to empty the reaction vessels. In some rmhotlin~.on~c, a Time Delay option may be provided to delay the valves from being closed or opened after triggering the sensors. This function is p~uLi~uld ly useful in situations where the reaction vessels are not quite at their desired levels when the sensors æ activated. By setting the delay option with a specific delay period, the reaction vessels can be filled d~lU,UlidL~Iy.
As can be seen, the commands associated with the Group menu afford the user flexibility in choosing ~n"-l,i"~ , of reaction vessels to employ during synthesis.
Fig. 37 illustrates a submenu 1340 containing the options available for the Variables menu selection. A create command 1341 defines a variable which may be 1l"~ 1 in the macros. Variables are typically employed, for example, in situations where the value, such as time, may vary from one synthesis to another. Instead of creating a macro for each time value, a variable is simply defined to correspond to time.
The variables are set to the desired value before each synthesis cycle using the set command 1342.
Fig. 38 illustrates a submenu 1345 that is associated with the Diagnostics option. Submenu 1345 includes Valves 1346, Sensors 1347, and Mix 1348 commands to gives a user intimate control of the synthesizer and access to inform~Sinn regarding Ihe synthesizer for diagnostic purposes. The Mix command 1348, when selected, activates the vortex motor to mix the reaction vessels for a period of time as specified by the user.
Referring to Fig. 39, a Valve Diagnostic dialog box object 1390 is displayed when the Valves command is selected. The user, via dialog box object 1390, may contro]
the operations of any valve in the synthesi~er by selecting the entry with which th~ desired valve cull~uul.d~. For example, Valve 100 in Bank I is opened by clicking the cursor on WO 9S/12608 2 1 7 ~ 5 8 7 PCTIUS9~1123-11 box 1391. For ~u.,~ , all the valves may be closed by selecting the Close All command 1397. A Cancel command 1398 closes the dialog box object 1390.
Fig. 40 illustrates a Sensor Diagnostics dialog box object 1391 CUI~ pOlldil~g to the sensor command. As shown, Dialog box object 1391 contains a box 1396 associated with each sensor. Boxes 1396 inform the user of the status of the 1ull~ uildillg sensors. For example, if a box has an "X" in it, this would indiQte that the sensor with which it is associated is on. Conversely, an empty box would indiQte that the sensor is off.
Fig. 41 illustrates a submenu 1350 that is displayed when the File option is selected. A New command 1351 creates a new synthesis setup file for Qrrying out a synthesis and a Modify command 1352 allows a user to select a preexisting synthesis file for editing. Once the synthesis setup file is completed, the user invokes either the Save 1354 or Save As command 1355 for saYing the file in memory. A Print command 1357prints the selecoed synthesis file. A Print Setup command 1358 configures the printer to desired mode, such as printing the file in landsQpe mode. An Exit command 1359 is invoked to leave the File option.
In some instances, such as prior to each synthesis, or when a new valve group is selected, the user may wish to configure the system by invoking the Load CFG
files command 1356. The system loads the d~ U~ t~, files to inform which are thed~lU~Jl valves to use. In effect, CFG files map or "associate~ the Yalves with each selected reaction vessel.
Figs. 42-44 illustrate the dialog objects used in creating and modifying a synthesis setup file. Referring to Fig. 42, a Set Associate dialog box object 1360 allows the user to select the desired reaction vessels by checking the dl)~lUIJl ' boxes contained in space 1361. For Uu~ , a Check All button 1362 and Uncheck All button 1363 are provided to easily select or de-select all the reaction vessels. Check Bank buttons 1364a-1364d allow the user to select all the reaction vessels belonging to a specific bank.
A Cancel button 1368, when selected, aborts the synthesis setup process. A Help button 1369, as previously explained, provides information to assist the user through the process.
To continue the synthesis setup process, the user clicks the OK button 1365 which closes the Set Associate dialog box object and displays a Synthesis Setup dialog box object.
Fig. 43 illustrates the Synthesis Setup dialog box object 1370 with which a user defines a Start Macro 1371, a Loop Macro 1372, and an End Macro 1373 for the SUBSTITUTE SHEET (RULE 26) wo 95112608 2 ~ 7 5 5 ~ ~ Pf~/Us9~,l23~7 ~

synthesis. The Start Macro and End Macro, for example, include commands for washing the reaction vessels before and after each synthesis process. The Loop Macro contains commands to perform a synthesis. These commands include injecting the selected reaction vessels witb amino acid building blocks and oligon~f leotiflrc~ pooling the contents of the reaction vessels in the parent vessel and mixing them to form a bead Sll~r~n~ n, and fi~ the bead suspension to the selected reaction vessels. The injecting, pooling, and ~ ;b~ steps constituoe one synthesis cycle. The synthesis cycle is repeated according to the value enoered in the Number Synthesis Steps parameter 1374. Once the Macros are defined, the user saves the conoents of the Synthesis Setup dialog box object and continues the setup process by clicking an OK button 1375. Again, the user may abon the process by clicking a Cancel button 1376.
Fig. 44 illustraoes the Amino ~ Oligo Setup dialog box object 1380. As shown, the box contains entries 1381 associaoed with each reaction vessel. The user enoers the desired amino acid symbol and f~ fln~ f~otifif~ code in the entries. For example, if the entry for reaction vessel 1 (RV01) contains "V ATGCCGA", this causes the synthesizer to inject amino acid V and I;L, '~ . ' ATGCCGA into reaction vessel 1. After the a~ r codes are entered, the user clicks the OK button 1382 to compleoe the setupprocess. A Cancel button 1383 is provided to abon the process. As can been seen, a synthesis library can easily be creaoed using the synthesis setup procedure.
Once the synthesis setup is compleoed, the user may initiaoe the synthesis process. Referring to Fig. 45, the user first selects the Synthesis option 1308 and then the Go command 1391 to begin the process. As an aloernative, a user may build a single macro to perform functions similar to those saved in the synthesis files.
Referring to Flg. 46, the GUI displays a status screen 1400 during the synthesis or macro execution. As shown, the status screen is divided into two separate areas 1401 and 1402. The first area 1401 displays information relating to the synthesis.
For example, the names of the Stan Macro, Loop Macro, and End Macro are lisoed.
Additionally, a Loop Number line 1408 informs the user as to the number of loopsremaining in the synthesis.
The second ar a 1402 displays the filename of the Macro currently being execuoed. As previously described, a macro may be nesoed with other macros to perform higher level functions. The starus screen may be designed to list up to 10 nested levels 1409a-1409j of macros being called. A Command line 1410, a Timing line 1411, Message SUB~TITUTE SHEET ~RUL~ 26) ~ WO 95/12608 2 ~ 7 5 5 8 7 PCTIUS9 11123~7 line 1412, and RV-s line 1413 may be provided to display additional status or c~nfl~l~r?ri--r~
information, For example, the Command line may show which mæro command is being executed; the Message line, when applicable, displays a text message as ~lc~lu~ .lcd by the user. The Timing line displays the amount of time that remains in which the valves are 5 opened or closed. The RV's line informs the user which reaction vessels are used. A
Time to Complete bar 1414 informs the user as to the percentage of time remaining before the synthesis is completed.
At anytime during synthesis or macro execution, the user may switch into the "User Abort" mode by pressing a preassigned function key, i.e. F12. The User Abort 10 mode allows the user to pause and execute macros that are not defined as part of the synthesis without having to abort the synthesis process. When invoked, the sysoem temporarily pauses execution and displays the User Abort dialog box object 1420, as illustrated in Fig. 47. At this point, the user may insert any macro for execution. This can be done by typing the name of the desired macro in a Select Macro box 1421 and 15 clicking the mouse on a Run Macro button 1422.
The User Abort dialog box object also provides an Ignore button 1424 which enables the user to continue the synthesis process as if the system had never entered into the User Abort mode. A skip option 1423 instructs the system to first skip over the current command in the macro before continuing the synthesis. A Retry button 1425 20 causes the system to execute the current macro from the beginning. An Abort button 1426 allows the user to cancel the synthesis.
Fig. 48 illustrates a submenu 1430 associated with the Edit command. The Edit command permits the user to easily access and modify the various objects by selecting the dp~lu~JI items listed in the submenu. An Associate command 1431, when selected, 25 displays the dialog box object which lists the Set Associate objects stored in memory. By selecting the desired object, the Set Associate dialog box object is displayed. At this point, the user may edit the contents of the dialog box object with the mouse. When finished, the user clicks the OK button and the ".~l;ri. ,.li.",~ are saved. Likewise, the user may edit the Group, Macro, Variable, and Code objects by selecting the desired object. The selected 30 objects are then placed in an editor, allowing the user to modify the text.
As previously mentioned, the sensors may be inadvertently triggered by the presence of a drop of liquid. This may be a problem, particularly when the solution used SUBSTITUTE SH~ET ~U~E 2~3 WO 95/12608 2 1 7 ~ 5 ~ 7 PCT/IIS9.1112317 ~

dunng the synthesis cycle contains a high rnn~Pntr:~tinn of bubbles. To avoid or mitigate t .,1~ 1 triggering of the sensors, their sensitivity may be ~ P~I
The sensors are IJ.u~l~u~ d using a Machine Config command 1456. This command displays a Config dialog object box containing seYeral entries, Fill%, Drain%, 5 TimeOut%, amd PtsAve. The Fill% specifies the percentage that the sensor remains on to determine when the reaction vessels are full. For example, if 80% is entered, the sensor must be on 80% of the time that it is read. The Drain% specifies the percentage that the sensor remains off to determine when the reaction vessels are empty. As an example, if 20% is entered, the sensor must be off 80% of the time that it is read. Timeout specifies 10 the time period to delay before the sensors are switched on or off. PtsAve specifies the number of points or readings to use to determine the percentage of time that the sensors are on or off. The user may also specify the sensor or group of sensors from which to read. Thereafter, the user cliclcs an OK button which ~lltnm~ti(~ y configures the system accûrding to the p~r~mP~Prs.
Fig. 49 is a flow chart illustrating the event-driven ~Ul,~ UIt of the control sûftware as described in Figs. 33-48. As shown, an l/O Object module 1450, which is the heart of the ~yllLl.~ s GUI, facilitates c~ ..,. among the various object modules comprising the GUI. When the control software is initiated, a mûdule 1460 loads the u.Jl~ ;ul~lLiull files into the I/O Object module. These files are used to ~0 configure a Variable Objects module 1456, Lookup Table Objects module 1457, Macro Objects module 1458, Grûup Objects module 1459, Valve Object Array module 1461, and Sensor Object Array module 1462.
The Lookup Table Objects module contains a file used for mapping the valves and sensors to their ~ ~ull~ ; reaction vessels so as to eliminate the need to 25 manually address each individual valve or sensor relating to a specif~c reaction vessel.
The Macro Objects module stores the list of defined macro; the Variable Objects module stores the defined variables while the defined group objects are stored in the Group Objects modules.
The Valve Object Array module stores an array identifying each individua~ ~
30 valve in the system. To close or open a valve, the I/O Object module scans the Valve Object Array module until if finds a match. When a match is found, the Valve Object Array module outputs a signal tû control that specific valve. Tû cûntrol a grûup ûf valves, -~ WO95/L2608 21 7~587 PCTIUS9.11123.17 the I/O module cooperates with the Group Objects module to sc;m the Valve Object Array, causing it to send the d~lU~ L~ control signals to the selected valves.
The Sensor Object Array module stores an array identifying each individual sensor in the system. The 1/0 module may read a sensor by scanning the Sensor Object Array module until a match is found, causing it to read the specified sensor. To read a t group of sensors, the I/O and Group Objects modules scan the Sensor Object Array module to determine the d~JlU~lidt~ sensors to read.
The GUI also includes a Dialog Box Objects module 1453 and a Synthesis Object module 1454. The Dialog Box Objects module contains the dialog box objects which are displayed when certain commands are invoked. The Synthesis Object module stores the current synthesis setup file. To perform a different syntlnesis, the GUI reads the desired synthesis setup file from memory into the Synthesis Object module. Conversely, the contents in the Synthesis Object module are written to memory to save a synthesis setup file.
A Main Window Object (MWO) module 1452 ro~nml~ni~ with a View Object module 1455 which displays the GUI's main window (Fig. 33) on the screen. A
Message, in response to a user command, is sent tû the MWO. This message is parsed to determine the ~ Jl command to execute. For example, if a Macros command is received, the MWO instructs the I/O object to retrieve the macrûs dialog box object from the Dialog Box Objects module and the lists of macrûs from the Macrûs Objects module.
The View Object module receives this ;"r," ", ~ "- frûm the I/O module and displays it on the G~JI.
In one ~ . the I/O module contains a Watchdog routine to shut down the ~y~ if the computer should m~lfiln~ tinn For example, the 1/0 object 25 module may be ~.u~ n~ to send a pulse every 2 seconds to the ~yllLllC~ If for any reason the ~yll~ siL~,l fails to receive these pulses, it will assume that the control computer has msllfilnrtionf-d and will power down.
~XAMPT F~
3û The following examples are provided as further illustration of the present invention and not as a limitation.

wo 95112608 2 1 7 ~ 5 8 7 PCT/US9~123~7 ~

EXAMPLE 1: LIBRARY PREPARATION AND SCREENING
This Example illustrates how the products of a ulllbill~Lulidl peptide synthesis on resin beads can be explicitly specified by attaching an ~ lrlrul;~lP
identifler tag to the beads coincident with each amino acid coupling step in the synthesis.
5 Each tag conveys which amino acid monomer was coupled in a particular step of the synthesis, and the overall sequence of a peptide on any bOEd can be deduced by reading the tag(s) on that bead. The collection of beads can be screened for binding to a lluu~ lLly-labeled anti-peptide antibody using a lluulc~ activated cell sorting (FACS) instrument. Those bOEds to which an antibody binds tightly can be isolated by 10 FACS, and the ,.li~,..",. lr.,li~lr- identifiers that j~re attached to individual sorted bOEds can be amplifled by the PCR. The sequences of the amplified DNAs are determined to reveal the identity of the peptide sequences which bind to the antibody with high affinity. By combining high capacity, l~lir,~"".~ code-based i- r."" ~ storage, amrlihr~til-n mrthrl~lrlngy, and lluuic,--.l- e-based sorting, the present method provides a means for 15 specifying the identity of OEch member of a vast library of molecules ~y~ from both natural and unnatural chemical building blocks and for quickly and efficiently isolating individua~ bOEds that bOEr high affinity ligands for biological receptors.
In this Example, single stranded ~ ,Lides are used to encode a .ulllbilldLu-i~l peptide synthesis using both L- and D-amino acid building blocks and 10 ~m 20 diameter ~oly~y~ beads. The ~ "~ .Jl;~rl~ tags have a high information content, are amenable to very high sensitivity detection and decoding, and, with the present method, are stable to reagents used in peptide synthesis. Peptides and n~ ti~i~-s are assembled in parallel, alternating syntheses so that each bead bOErs many copies of both a single peptide sequence and a unique oligon~lrlPoti~ identifier tag. The olieom-rl~tides share common 25 5'- and 3'-PCR priming sites, and thus the bOEds can serve as templates for the PCR. The encoded synthetic library contains about 8.2 x 105 hepta-peptides and is screened for binding to an anti-dynorphin B ,.,~ 1 antibody D32.39 (see Barrett & Goldstein, 1985, Neurûpeptides : 113-120, illl,Ul,UI ' ' herein by reference), using a lluu-c:s-c,.
activated cell sorting (FACS) instrument to select individual beads that strongly bind the 30 antibody. After PCR ~mrlifir~tir~n of the ,~ ullllrl~lLide tags on sorted bOEds, the DNA
is sequenced to determine the identity of the peptide ligands.

~ WO 95/12608 2 1 7 5 5 8 7 PCT/US91/123.17 A. Reagents and General Methods The Illu~lodi~zc~ 10 ,um diameter bead materiai used in this work was a custom-sy-lLl,~,;~d "~a~lul~uluus styrene-divil.y~ lle copolymer filnrlirn~li7P~i with a 1,12-.l;~ ln~lf~ - linker purchased from Pharmacia. The beads are Pharmacia S MflnnhP~fl~u that have not been derivati_ed with Pharmacia's Gene Assembler Support t linker. See Ugelstad and Mork, 1980, Adv. ~Q~ 101-140, i". u",, ~ herein by reference.
All protected amino acids were obtained from Bachem Bioscience Inc. PCR
and sequencing primers were ~yllLll..,;~J with an Applied Biosystems model 394 10 ~ ..";.1P ~yll~ .. Authentic samples of certain peptides were ~yllLll~ .d with an Applied Biosystems model 431A peptide ~llLi.~,;~l using Fmoc-protected amino acids, HBTU/HOBt in situ activation chemistry, and d~lut~Liull with 40:1:1 TFA/water/r~ l.;r,l. These peptides were purified by HPLC (>95% purity) on a Rainin Cl8 reverse phase column using 'WdiCI/i" ~ P/0, 1 % TFA as eluant, and 15 structures were verified by mass ~ UIIl~Lly.
B. Parallel Synthesis of a 69-base Ol;~ ;flP and the Opioid Peptide Dynorphin B
The C-terminal seven amino acid fragment of the opioid peptide dynorphin 20 B H-Arg-Gln-Phe-Lys-Val-Val-Thr-NHz (RQFKVVT) (SEQ ID NO:2) was ~y-l~l-e~i~l in parallel with a 69-mer oliLudw~yl.J~l~;uLidc (ST08) on 10 ~m diameter beads. Thesequence of ST08 was 5'-ATC ('AA TCT CTC CAC (ATC TCT ATA CTA TCA) TCA
CC iTA TC CT AT TT TT AC] CTC ACT CAC TTC CAT TCC AC-3' (SEQ ID
NO:20) . Underlined portions of this sequence correspond to PCR-priming sites whi~e the 25 region in L~u~ es is l~u..lulo~;uu~ to the primer used fûr sequencing this template. The 14-base sequence enclosed in brackets represents the coding region of the template.
The beads were first treated with a mixture of succinimidyl 4-O-DMT-u~ybu~yldL~ (Molecular Probes) and the l-u~yb~ P ester of either N-Fmoc-2,4-dimethoxy-4'-(~bu~y.l.~Li.ylo~:y)-b~l.Ll.yd,yla...;..~ (i.e. the acid-cleavable 30 Knorr ~ubu~d~;d~ linker) or N-Fmoc-Thr('Bu)-OH (for non-cleavable ~ s). The ratio of Fmoc-protected amino groups to DMT-protected hydroxyl residues on the beads was determined ~L..,~ y to be ~ .u,~..n~t~.ly 20:1. The beads were subjected to 20 cycles of Dliel.l. lflr~liflP synthesis on an automated ~yllLI~ using Wo 95/12608 2 ~ 7 5 5 8 7 Pcr/uss~ll23~ ~

3'-O-methyl-N,N-diisopropyl P~ A~ PC of the following nl~rlPo~i~Pc N6-Bz-5'-O-DMT-('7-dea~a)-2'-deoxyadenosine (Berry and Associates, ~nn Arbor, Michigan), N~-Bz-S'-O-DMT-2'-dcv,.y~ -e, and 5'-O-DMT-thymidine (Glen Researchl-The beads were then removed from the instrument and treated for 5 min.
5 with 10% piperidine in DMF to remove the Fmoc protecting group. After coupling the first amino acid residue (N-Fmoc-Thr('Bu)-OH), the beads were treated with a DME~
solution of acetic anhydride and 1-methylimidazole to cap any unreacted amines. All peptide coupling rcactions were run for 20 min. and contained 0.11 M Fmoc-amino acid, 0.1 M HBTU, 0.1 M HOBt, and 0.3 M DIEA in DMF. The beads were then subjected to 10 two cycles of nucleotide addition on the synthesizer (detritylation with TCA;tetrazole-catalyzed ~ u~l-;L~l.lLiu-~; capping with acetic anhydride; oxidation with iodine in acetonitrile/water). Sequential steps of amino acid coupling and din~ e addition were repeated until synthesis of the peptide sequence RQ~KWT (S~Q ID NO:2) and ~UIlsLlu- ~io.. of the oli~;~,-"~ P coding region had been completed. After p~lru~ g an 15 additional 35 cycles of oli~j~",~ lPul;-iF synthesis, the beads were treated sequentially with piperidine~DMF (1:9 for 8 min), thiophenol/L.;~ ullillc/dioxane (1:2:2 for 4 hr), ethyl. f-l; "..,.,r/ethanol (1:1 for 5 hr at 55 C), and TFA/water (20:1 for 1 hr) to deprotect fully both the peptide and ~ F~ f chains. In ~ F ` using the acid-cleavable linker, the ~ from the TFA d-~.,lu._Liu.~ reaction was conrrntr~tP~i 20 ~n vacuo, and the isolated crude peptide was then analyzed by HPLC.
C. Construction of an Encoded Library The parallel synthesis chemistry outlined above was used in the construction of the library. The sites of peptide synthesis were ~ir~ from DNA synthesis sites 25 in this P~rPrimrnt by coupling to all the beads a mixture of N-Fmoc-Thr~Bu)-OBt and suc~i-,illlidyl 4-O-DMT-u~.ybuLyl~Lc; as described above. Sequences of oli~;ullucleuLide tags in the library deviated from ST08 only within the coding region. The 3'-conserved region of the ,~lig~ FvLidc ST08 was first ayllLII.,;~ on a total bead mass of 35 mg (-- 1.75 x 10~ beads). The E~moc protecting group was removed and the bead mass was divided 30 into seven equal parts. To each aliquot was coupled one of seven different alpha-N-Fmoc-protected amino acids (side chain protecting groups are shown in p~ut llLIl~ sia): Arg(Nr-Pmc), GlnF~Trt), Phe, Lys('Boc), Val, D-Val and Thr(tBu). Each part was then subjcctcd to two rounds of automated oli~u,.~ P synthesis. The ~ WO95112608 2 1 75587 PCT/US9~/123-17 respcctive sef~uences of the appended (~ r J~ that specified uniquely each different amino acid residue were TA, TC, CT, AT, TT, CA and AC The beads were then pooled, mixed thoroughly, and the entire bead mass subjected to Fmoc d~luLc~Liu-l.
This cycle of bead partitioning, peptide coupling, nli~nnllrlf~)tiflf dimer 5 synthesis, bead l~r ,.~ i.... and Fmoc removal was repeated for a total of seven times.
The final Fmoc protecting group was not removed. Rather, the pooled bead mass was subjected to 35 cycles of oli~nn-lrlfl~tifif synthesis. The library was then fully dc~ut~lcd as describcd above.
D. Library Staining and FACS Analysis A portion of a library (typically 0.5-2 mg of beads) was suspended in blocking buffer ~PBS, 1% BSA, 0.05% Tween-20) and incubated at room t~llpcldlulr for 1 hr. The beads were pelleted by - .I ir~ ;-.,. and ~ lrll in a solution of mAbD32.39 (10 mg/mL in blocking buffer). The suspension was incubated on ice for 30 min., 15 pelleted by ,f ,t, i rl,~f l i..", and washed with blocking buffer. The beads were then suspended in a solution of pl~y~ u~ly~ -conjugated goat anti-mouse antibody (Molecular Probes) for 20 min. on ice. The beads were washed in blocking buffer and diluted in PBS
for delivery into the nuulc~ activated cell sorting (FACS) instrument (Bccton Dickinson FACStar Plus). Beads which had bound the mAb D32.39 were identified by20 their acquired nUUlL~ CllCe. Individual beads from both the most brightly stained û. 17%
of the library and from the region having the lowest lluu.c~ ~, ce (ca. 98%) were sorted into PCR microfuge vials. Specific binding of D32.39 to the beads was blocked byplr;l~ ll of the mAb with the soluble peptide Ac-RQFKWT-OH (SEQ ID NO:2) at a final - ..,. f ~Ill,U;l~ll of 10 ~M.
E. PCR of Bead-Bound Template PCR ~, l.lir; ~ c were performed in the ... r Il~r~ supplied buffer system (50 mM KCl, 10 mM Tris-HCI, pH 9.0, 0.1% Triton X-100, 2 mM MgCI2) with 0.2 mM dATP, dCTP, and dGTP, 0.8 mM dUTP, 2 mM each primer, 3 units TaQ
30 polymerase (Promega), and 1 unit of uracil DNA glycosylase (Gibco BRL) (total volume 70 L). The primer scquences, 5'-ATC CAA TCT CTC CAC-3' (SP13) (SEQ ID NO:21) and 5'-f~biotin)-GTG GAA TGG AAG TGA-3' (SP14) (SEQ ID NO:22) were respectively hnmnlf~go~ls and ~""1~1 ."~ ly to the template ST08. PCR reactions consisted of 45 WO 95112608 2 ~ 7 5 5 8 7 PCT/IJS9~ -5.17 ~

cycles of d~,,dLuld~iull at 95C for 30 sec., primer annealing at 50~C for I min., and extension at 72C for I min. Reactions were analyzed by clc~luyllulc,;s in 20%
acrylamide or 2% low melting point agarose gels.
F. Sequencing of PCR Product BiuL;Ily- ' PCR product from individual reactions was isolated with streptavidin-coated magnetic beads (Dynal, Inc.). After alkaline elutiûn of the non-biotinylated strdnd and washing, each bead sample was treated with sequencing cocktail. Dideoxy sequencing was performed using the primer 5'-ATC TCT ATA CTA
TCA-3' (SP15) (SEQ ID NO:23) and Bst L)olylllrldac (Bio-Rad) according to the r~ f~ tllrpr'5 ill~LIul,~iul-~, with the exception that a 1:100 ratio of deoxy- to d;dco~y~ lcuLide Lli~llu~lJlldL~a (Pharmacia) was emplûyed.
G. Dr~ inl~ ûf Peptide Binding Affinities The binding affinities ûf variûus peptides fûr the mcnn~lnn~l antibûdy D32.39 were measured in a I ,-"~ inl~ binding PYrPrimpnt A tracer peptide (I.RRASLGGGRRQFKWT (SEQ ID NO:24); 50 pM) containing the known epitope for D32.39 fused to a consensus substrate sequence for cAMP-dependent protein kinase was radiolabeled to high specific activity with [g -33P]ATP (see Li et al., 1989, Prûc. Natl.
Acad. Sci. USA 86: 558-562, iul~_UIAuo ' herein by reference) and mixed with various cnnrPntr~tinnc of the peptide of interest (10 ~M-I pM). The peptide mixtures were added to pOlyaLylcllc wells coated with D32.39 ( 0.1 Gmg/mL). Samples were incubated 2 hr. at 4C, the wells washed with PBS, and the radioactivity associated with each well was counted and used to generate a CulllpCLi~ivc binding eurve. Under the conditions of the assay the IC50 should be close to the 11;~ l const~nt (K~ for the peptide.
EXAMPLE 2: SYNTHESIS AND STABILITY STUDIES OF THIAZOLIDINONES
The following examples relate to the synthesis of thi~7nlitlinnnPc using the methods ûf the present invention. This synthesis is described in greater detail in U.S.
Patent Application Nû.081265,090, filed June 23, 1994, and il,cull,uldLcd herein by reference for all purposes.

~ Wo 95/12608 2 1 7 5 5 8 7 PCr/uss~ll23~7 A. P~ dldLiUII of Double-Labeled Thi~7r~ innnr-H2N-S-~entaGel (500 mg), a cu~ "_;dlly available polystyrene based resin (Rapp Polymere, Tubingen, Germany, lg, 0.30 mmol/g loading), was elaborated withFmoc-Gly-OH labeled at the r -carbon (2-l3C, 99% from Cambridge Isotope Laboratones, 5 Inc., Andover, MA). The resin was capped with Ac20, d~luL~d with piperidine, and the Fmoc-rh~t~ nkpr coupled as its OBt-activated ester. The resin was again capped, J~1uL~d, and reacted with unlabeled Fmoc-Glycine-OH as its anhydride. An additional round of capping amd J~lu~:lio-l generated the free amine rc-sin. Reaction with 0.75 M
PhCHO labcled at the carbonyl (carbonyl-l3C, 99% from Cambridge Isotope Laboratones, 10 Inc., Andover, MA) and 2.0 M I~ dlJ~Ud. ~ liC acid in ACN containing 3A molecular sieves for 2 hours at 70C generated the double labeled thi~7nlirlinrmr- resin. The resin was washed extensively (3xs ml CH2Cl2 3X5 ml DMF, 3X5 ml CH2CI2, 3X5 ml MeOH, 3X5 ml CH2CI2, 3X5 ml Et2O) and dried under vacuum.
15 B. TFA Stability Studies A portion (20mg) of the resin was treated with 95% TFA/5% H20 For I
hour followed by washing with CH2CI2, MeOH and Et2O. Gel-~3C NMR analysis of theresin indicatcd no loss of thi~l7rl1irlinrmP, as evidenced by relative integration of the two labeled carbons. Sce Panel B, Fig. 30. Any destruction of either the photolinker or 20 thi37l~ 1inr~ne would be expected to result in the integration of the benzylic carbon to decrease. This ~ 1 d--- ' that both the ll- -,.,li~l;....nr and the rhrltrllinkr-r were stable to TFA treatment.
C. DNA Synthesis Stability Studies A portion (20 mg) of the resin was loaded into the standard DNA synthesis cartridge and subjected to 40 cycles of DNA synthesis with A, C and T n~mlr~ irlP~
employed as their rl~c,~ followed by iodine oxidation after every cycle.
"Mock" dimethoxytrityl (DMT) removal was ~(.,,,.l.l;~h-`il by treating the resin 2%
- TFA/CH2CI2 at tbe start of every cycle. The resin was removed from the cartridge, washed with DMF, and analyzed by gel-l3C NMR *~L u~,u~,y. See Panel A, Fig. 30.
The spectrum obtained revealed little or no destruction of either the photolinker or II,;,.,.,li,l;"~",e molecules. A portion (2 mg) of the resin was also photolyzed for 3 hours in pH 7.4 PBS buffer and the liberated thi~7nlirlinr~nP analyzed by HPLC. See Panel A, Fig.

WO 95/12608 ~ 7 7 5 5 8 7 PCTIUS9~1113~7 31 and Fig. 32. The data revea'ed that the thi~7~ inrm~ was released in high punty and that both the photolinker and thi~7,~ 1inone were not significantly altered upon treatment with standard DNA synthesis reagents.
5 EXAMPLE 3: COME,INATORIAL SYNTHESIS
A ~.,,.,1,;.. ~,.;,-1 synthesis of YGGFL was performed using the synthesis device. The synthesis was done in reaction vessels 1-6; 7-9 were ~ 1 The six amino acids added to the beads were L, E, G, Y, A, and F. YGGFL was specified along with other peptides. Beads were added to the parent vessel (29.5 mg) and suspended in 10 DMF~ Each synthesis cyc~e included steps of rerli~t7ih~ ,n, peptide coupling, capping, amine d~lu~r~LiO-I, collection of dr~lut~Liull for FMOC, rinsing with DMF, and c~ . in the parent.
Following synthesis, the labeled Hert7 antibody was introduced to the mixed beads. The Hertz antibody binds mostly with YGGFL. FACS ana'lysis identified the15 presence of YGGFL, provJtg that this specified .-,~ 7- was synthesized by thesynthesizer. The ,-Yrr7-im!-nt shows that a diverse collection ot- peptides, including the YGGFL chain, can be specified and 7yllL~I~,,~..I via the synthesizer.
Although the present invention has been described in some detail by way of illustration and example for purposes of clarity and ~ , it will be apparent that certain changes and ."~ may be practiced within the scope of the appended claims.
EXAMPLE 4: DETERMINATION OF BEAD DISTRIBUTION USING THE
APPARATUS OF THE INVENTlON
To determine if mixed beads from the parent vessel were being evenly distributed to the reaction vessels, some beads were biuLulyldlrd. The biotinylated beads were manua',ly deposited in one reaction vessel. Non-'u;oLi"~' J beads were manually deposited in the other 8 reaction vessels. The synthesi_er transfers all beads from 9 reaction vessels to the parent vessel. A sample was taken from the parent vessel, and fluoresced streptavidin was allowed to bind with biotin on the l,;o~ hl~d beads.Florescence Activated Cell Sorter (FACS) analysis shows that ~yluHIl~ ly 9. l % of the beads in the parent vessel were b;uLilly ' The beads were then rea',located to 9 reaction vessels, and the percentage of biotinylated beads to tota'~ beads in each vessel was wo gs/l2co8 2 1 7 5 5 ~ 7 PCT/USg~123~7 deternlined by a FACS analyzer. Table ~ shows that the mixed beads in each reaction vessel have d~u~luxi~ .,ly the same ratio of biotinylated beads to total beads as the parent vessel.

% Bright Beads Parent 9.1 9.7 2 9.7 3 9.4 4 8.7 9.4 6 8.9 7 9.1 8 8.9 9 9.3 Average 9.2 Standard dev. 0.32 It is to be understood that the above description is intended to be illustrativeand not restrictive. Many f ,~l~o~;",~ will be apparent to those of skill in the art upon reviewing the above ~iPcrrir~irm The scope of the invention should, therefore, be deterrnined not with reference to the above ~if~ rirtion~ but should instead be ~f ~f rnninf~l with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.

WO95112608 2 i 7 55 ~ 7 PCT~S9~/123~7 ~

SEQUENCE LISTING
(1) GENERRL INFORMRTION:
(i) APPLIQNT: AFFYMRX ,~, ,rrrr'fi N.V.
(ii) TITLE OF INVENTION: Synthesizing ~nd ScreenLng Molecular Diver5ity ( iii ) NUMBER OF SEQUENCES: 24 ( iv ) ~:-JKeu~ ADDRESS:
A PnnDT`CqET': Townsend and Townsend Ehourie and Crew B STREET: One Market Plaza, Steuart Tower, Suite 2000 C CITY: San Francisco D STATE: Cali~ornia E COUNTRY: USA
F ZIP: 94105 ( v ) COMPUTER RERDABLE FORM:
(A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC _ ~hl..
(C) OPERRTING SYSTEM: PC--DOS/MS--DOS
(D) SOFTWRRE: PatentIn Relea~e ~1.0, Version #1.25 ~vi) CURRENT APPLICRTION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE:
(C) CLASSIFIQTION:
(vii) PRIOR APPLIQTION DATA:
(A) APPLICATION NUMBER: Us 08/146,886 (B) FILING DATE: 02--NOV-1993 (vii) PRIOR APPLIQTION DATA:
(A) APPLICATION NUMBER: US 08/149,675 (B) FILING DATE: 02--NOV-1993 (viii) ATTORNEY/AGENT INFOPMRTION:
(A) NAME: Norviel, Vernon R.
(B) REGISTRRTION NUMBER: 32,4B3 (C) REFERENCE/DOCICET NUMBER: 16528J--000740PC
(ix) TP'Tr'r`tMMllNrCATION INFORMRTION:
(A) TELEPHONE: 415--326--2400 (B) TELEFAX: 415-326--2422 (2) INFORMATION FOR SEQ ID NO:1:
(i) SEQUENCE -DPDarT~DT~TIcs:
(A) LENGTE~: 13 amino acids ( B ) TYPE: amino acid (C) STDP~ FI'~'~qS; aingle (D) TOPOLOGY: linear (iL) MOLECULE TYPE: peptide ~ WO 95112608 2 t 7 ~ 5 8 7 PCTIUS9~ 3-17 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l:
Tyr Gly Gly Phe Leu Arg Arg Gln Phe Lys Val Val Thr 2 ~ INFOR~5ATION FOR SEQ ID l O: 2:
(i) SEQUENCE rWl~RArT~RT.~TICS
A LENGTH: 7 a_ino acid~
B TYPE: arnino acid , C STRr'~ n`----C ~ingle D, TOPOLOGY: linear ( ii ) MOLECULE TYrE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:
Arg Gln Phe Lys Val V~l Thr (2) l~rl mTr-N FOR SEQ ID NO:3:
(i) SEQUENCE rl~o~rT~RTqTICS
(A) LENGT~I: 8 unino acid~
(B) TYPE: amino ~Cid (C) STR~Nnl;!nM~C ~ingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE l/~.~r~luN: SEQ ID NO:3:
Thr Phe A~g Gln Phe Lys Val Thr (2) INFORMATION FOR SEQ ID NO:4:
( i ) SEQUENCE r~l~o~ lU n (A) LENGTH: B amino ~cids ( B ) TYPE: ar~ino acld (C) sTR~Nn~nM~.~c ~ingle ID~ TOPOLOGY: linear (ii) MOLECULE TYPE: peptLde ( xi ) SEQUENCE ~ lUli: SEQ ID NO: 4:
Thr Thr Arg Arg Phe Arg Val Thr 2 ~ 755~7 WO 95112608 PCTIUS9~/123~7 (2) INFOR~ATION FOR SEQ ID NO:5:
(i~ SEQUENCE ri~R~r~TpRTcTIcs:
(A) LENGTH: 8 amino acid~
(B) TYPE: a:nino acid (C) s~rP~M~lPnNPCC: single ID) TOPOLOGY: line~r ( ii ) ~OLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:
Thr V~l Arg Gln Phe Lys Thr Thr (2) INFORMATION FOR SEQ ID NO:6:
(i) SEQUENCE rN~R~rTpRT~TIcs (A) LENGTH: 8 amino ~Cid5 ( B ) TYPE: ~mino acid (C) .cTR;~npnNpcc: single (D) TOPOLOGY: linear (ii) ~IOLECULE TYPE: peptide (xi) SEQUENOE DESCRIPTION: SEQ ID NO:6:
Gln Val Arg Gln Phe Ly~ Thr Thr (2) INFOR~LaTION FOR SEQ ID NO:7:
(i) SEQUENCE CE~ARACTERISTICS:
(A) LENGTH: 8 ~nino ~cids (B) TYPE: amino ~cid (C) S~R~MI~pnNpcc- single (D) TOPOLOGY: line21r (ii) ~OLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:
Arg Gln Phe Arg Thr Val Gln Thr WO 95/12608 Pi'T/lJS9.1/123~7 i2) INFORMATION FOR SEQ ID NO:8:
(i) SEQUENCE ~ ARArT~T.~iTIcs (A~ LENGTE~: 8 amino acids (B) TYPE: amino acid (C) 5'rRANn~nNl;'~.C: 5inyle (D1 TOPOLOGY: linear ( ii ) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:
Lys Gln Phe Lys Val Thr Lys Thr (2) INFORMATION FOR SEQ ID NO:9:
( i ) SEQUENCE CEIARACTERISTICS:
(A) LENGTH: 8 amino acidu (B) TYPE: amino acid (C) 5~12P~mFnM~CC single (D) TOPOLOGY: lLnear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:
Gln Gln Phe Lys Val Val Gln Thr (2) INFORMATION FOR SEQ ID NO:10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGT~: 8 amino acids ( B ) TYPE: amino acid (C) S~P~ nMI;qc: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:
Lys Gln Phe Lys Val Thr Gln Thr -2~755 WO95/12608 ~7 PCTIUS9~/123.17 (2) INFORMATION FOR SEQ ID NO:ll:
(i~ SEQUENCE CE~ARACTERISTIC5:
. A) LENGTH: B amino acids B) TYPE: amino acid C) STRANnEnMTi:cc: Dingle D ) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID No:ll:
Thr Gln Phe Lys Val Thr Lyn Thr (2) INFORMATION FOR SEQ ID NO:12:
( i ) SEQUENOE CBARACTERI ST I CS:
(A) LENGTB: 8 amino acids (3) TYPE: amino acid (C~ sT~ANn~nN~c~: single (D) TOPOLOGY: linear (il1 MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:
Thr Phe Arg Val Phe Arg Val Thr (2) INFORMATION FOR SEQ ID No:13:
( i ) SEQUENCE rTTARAoTERTcTIcs A) LENGTB: 8 amino acids , B) TYPE: amino acid , C) STRANDEDNESS: Gingle D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:
Phe Arg Arg Gln Phe Arg Val Thr 2 1 75~87 WO 9~/12608 PCT/US9 1/123~7 (2) INFORMATION FOR SEQ ID NO:14:
(i) SEQUENCE rTlARPr~RTRTICS:
(A) LENGTH: 8 amino acl~
(B) TYPE: amino acid (C) STRpMn~nMF~-R: ~ingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide r (xi) SEQUENCE DESCRIPT~ON: SEQ ID NO:14:
Arg Gln Phe Lys Gln Val Gln Thr (2) INFORI~ATION FOR SEQ ID NO:15:
(i) SEQUENCE ~ pRAr~ERT~TIcs:
(A) LENGTH: 8 amino acids (B) TYPE: amino acid (C) STRrMnT~nN~Rs: single (D) TOPOLOGY: linear (ii1 MOLECULE TYPE: peptide (xi) SEQUENCE LI~CRl~.lu~: SEQ ID NO:15:
Gln Thr Val Thr Val Lys Ly~ Thr ( 2 ~ INFORMATION FOR SEQ ID NO: 16:
~i~ SEQUENCE ~'FlPRA-''rli:RTS~ICS:
~A~ LENGTH: 8 amino acid~
( B ~ TYPE: amino acid (C~ s~RrMnRnNrqR: ginyle (D~ TOPOLOGY: linear (ii) MOLECULE TYPE: peptide ~xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:
Gln Gln Val Gln Arg Gln Thr Thr WO 9~/12608 ~ I 7 5 5 8 7 pCT~S9~1123~7 ~
l~o (2) INFORXATION FOR SEQ ID NO:17:
(i) SEQUENCE oll~RprTFR~cTIcs A LENGTH: 8 nmino ~cid~
B TYPE: amino ~cid C I RTPP`~lFnNF~q: single ~ D TOPOLOGY: linear (ii) MOLECIJLE TYPE: peptide (xi) SEQUENCE L~:nlr~14N: SEQ ID NO:17:
Ly~ Thr Gln Val Val Gln Phe Thr ~2) INFOR~TION FOR SEQ ID NO:18:
(i) SEQUENCE r'l"P'rTFR~.CTICS-. A) LENGTH: B ~ino acids B) TYPE: ~mino ~cid .C) STRr --lFn~TE~C: ~ingle , D ) TOPOLOGY: linear (ii) MOLECIJLE TYPE: peptide (xi) SEQUENCE ~5~.nl~,l4N: SEQ ID NO:18:
Gln Val Thr Gln Val Ary Val Thr (2) INFORMPTION FOR SEQ ID NO:19:
( i) SEQUENCE r~PPrTFRTCTICS
(A) LENGTH: 8 amino ~cid~
(B) TYPE: amino acid (C) STRP~)FnrlFCC: ~ingle (D) TOPOLQGY: linear (ii) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:lg:
Phe Vnl V~l Thr Val Arg Val Thr WO 95112608 5 8 7 PCT/US9~/123~7 (2) INFOR~5ATION FOR SEQ ID No:20:
(i) SEQUENCE rTT~rT~RTgTICS
(A) LENGTH: 69 base pairs (B) TYPE: nuclelc acid (C) sTI:r~Mr~pnNrqs: L;ingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (olignn11~1~nfi,i ) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:

(2) INFORMATION FOR SEQ ID NO:21:
( i ) SEQUENCE CEaRACTERISTICS:
(A) LENGTH: lS baue pairs (B) TYPE: nucleic acid (C) STR~NI~nNT~c5: single (D) TOPOLOGY: linear ( ii) MOLECULE TYPE: DNA (ol i ~nnllrl ~cf i ~ic.) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:
ATCCAATCTC TCCAC lS
(2) INFORMATION FOR SEQ ID NO:22:
( i ) SEQUENCE r~l~T~rTT'RT.qTICS:
(A) LENGTP.: 15 ba~e paini (B) TYPE: nucleLc acid (C) STR~nFl~T'eS: f~ingle ( D ) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (~ qnn ~ ~ntide) (xi) SEQUENCE DESCRIPTION: SEQ ID No:22:
GTGGAATGGA AGTGA l S
(2) INFORMATION FOR SEQ ID NO:23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: lS baie pairi (B) TYPE: nucleic acid (C) STT~ ~MnT~n~lT~cc: iingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (primer) (xi) SEQUENCE DESCRIPTION: SEQ ID No:23:

ATCTCTATAC TATQ lS

WO 95/12608 2 ~ 7 5 5 8 7 PCT~ ~S9~1123~7 ~

(2) INFoRMaTIoN FOR SEQ ID NO:24:
(i~ SEQUENCE CHARACTERISTICS:
(A) LENGTd: 17 amino ~cLds (B) TYPE: /ullino ~cld (C) STRaNDEDNESS: single (D) TOPOLOG~: linear ( ii ) MOLECULE TYPE: peptide (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:
Leu Ary Arg Ala Ser Leu Gly Gly Gly Arg Arg Gln Phe Lys Val Val Thr

Claims (39)

WHAT IS CLAIMED IS:
1. A method of synthesizing diverse molecules on a plurality of substrates comprising the steps of:
distributing said substrates to a plurality of reaction vessels;
coupling a first portion of said diverse molecules to said substrates in said reaction vessels with different reagents in each of said reaction vessels;
moving said substrates through flow lines to a mixing vessel and mixing said substrates;
redistributing said substrates through said flow lines from said mixing vessel to said reaction vessels; and coupling a second portion of said diverse molecules to said first portion of said diverse molecules to form diverse molecules on said substrates.
2. The method of claim 1 wherein said redistributing step includes the step of redistributing at least a portion of said substrates through a common manifold.
3. An apparatus for parallel coupling reactions on solid supports, comprising:
a parent vessel;
at least one reaction vessel bank coupled to said parent vessel, said reaction vessel bank comprising a plurality of reaction vessels for performing said coupling reactions in parallel;
a plurality of flow lines between said parent vessel and said reaction vessels, said flow lines forming a flow path between said reaction vessels and said parent vessel;
a delivery system for delivering reagents to said reaction vessel bank; and a programmable computer for coordinating transfer of said solid supports betweensaid parent vessel and said at least one reaction vessel bank.
4. The apparatus of claim 3 further comprising a common manifold, said common manifold being connected to at least one of said plurality of flow lines.
5. The apparatus of claim 3 wherein said delivery system further comprises meansfor delivering said reagents from a first portion of the apparatus to a second portion of the apparatus, said first portion having a higher pressure than said second portion.
6. The apparatus of claim 3 wherein said reaction vessel bank further comprises means for agitating in parallel the contents of said plurality of reaction vessels.
7. The apparatus of claim 3 wherein said reaction vessel bank further comprises valve means, responsive to command signals from said programmable computer, for delivering in a parallel manner said reagents to selected ones of said plurality of reaction vessels in a first mode and for serially delivering said reagents to selected ones of said plurality of reaction vessels serially in a second mode.
8. The apparatus of claim 3 wherein said parent vessel, said reaction vessel bank, and said delivery system are sealed from the atmosphere during said parallel coupling synthesis reactions.
9. The apparatus of claim 4 further comprising a valve for shifting said solid supports between said parent vessel and said plurality of reaction vessels, said valve being the only valve through which solid supports traverse during the shift between said parent vessel and said plurality of reaction vessels.
10. The apparatus of claim 9 wherein said reaction vessel bank further comprisesvalve means, responsive to command signals from said programmable computer, for delivering in a parallel manner said reagents to selected ones of said plurality of reaction vessels in a first mode and for serially delivering said reagents to selected ones of said plurality of reaction vessels serially in a second mode.
11. A method for performing coupling reactions on beads in parallel, said methodcomprising:
transferring said beads in a suspension from a parent vessel to a plurality of reaction vessels;

performing said coupling reactions in parallel inside said plurality of reactionvessels on said beads;
transferring said beads from said plurality of reaction vessels to said parent vessel; and mixing said beads.
12. The method of claim 11 wherein said steps are repeated a predetermined number of times.
13. The method of claim 11 wherein said transferring step further comprises the step of transferring at least a portion of said beads through a common manifold.
14. An optical alignment block for use with an optical detector in detecting thepresence of a liquid within a substantially translucent tube, said optical alignment block comprising:
means for directing a beam of light from the transmitter of said optical detector through the center of said tube onto a portion of the collector of said optical detector; and means for inhibiting light, other than said beam of light, emitted from the transmitter of said optical detector from reaching a portion of the collector of said detector.
15. The optical alignment block of claim 14 wherein said directing means comprises a pinhole aperture through said optical alignment block.
16. The optical alignment block of claim 15 wherein said optical detector comprises two forks, the transmitter being located at a first fork, and the collector being located at a second fork, said optical alignment block further comprises:
means for frictionally engaging said optical alignment block between said two forks; and means for positioning said tube such that the longitudinal axis of said pinhole aperture intersects the radial axis of said tube at a 90-degree angle.
17. The optical alignment block of claim 14 wherein said directing means furthercomprises means for positioning said tube between the transmitter and the collector of said optical detector.
18. A delivery system for delivering reagents, comprising:
a 2-port valve having a first port and a second port;
a 3-port valve having a first through channel and a third port;
means, responsive to a programmable computer, for selectively permitting said third port to communicate with said first through channel;
means, responsive to said programmable computer, for selectively permitting saidfirst port to communicate with said second port; and means for sealingly coupling said first port to said first through channel, thereby forming a manifold.
19. The system of claim 14 wherein said third port is coupled to a first tube carrying a reagent, and the other of said first port and said second port is coupled to a second tube carrying argon, and wherein said first tube carries said reagent either toward or away from said manifold.
20. A combinatorial synthesis device for performing coupling reactions on beads,comprising:
at least one reaction vessel bank, said reaction vessel bank comprising a plurality of reaction vessels and a plurality of monomer reservoirs, each said reservoir associated with one of said reaction vessels; and a common reagent reservoir, said common reagent reservoir coupled to said at least one reaction vessel bank for delivering a common reagent to said plurality of reaction vessels through a common manifold.
21. A method for synthesizing a tagged molecular library, wherein each differentmolecule in the library is covalently attached to a solid support and is tagged with one or more different tags, wherein each of said one or more different tags comprises a variable hydrocarbon region and a molecular hook, which tags are also covalently attached to said solid support, said method comprising: (a) apportioning the supports in a stochastic manner among a plurality of reaction vessels; (b) exposing the supports in each reaction vessel to a first chemical building block; (c) pooling the supports; (d) apportioning the supports in a stochastic manner among the plurality of reaction vessels; (e) exposing the supports in each reaction vessel to a chemical building block; and (f) repeating steps (a) through (e) from at least one to twenty times.
22. The method of Claim 21, wherein said solid support is a linker.
23. The method of claim 21, wherein said solid support is a MonobeadTM.
24. The method of Claim 21, wherein said molecule is attached to said solid support by a linker.
25. The method of Claim 24, wherein said linker is cleavable.
26. The method of claim 21, wherein each of said one or more different tags comprises a cleavable linker attaching each of said one or more different tags to said solid support;
a molecular hook; and a variable length hydrocarbon chain connecting said linker to said molecular hook.
27. The method of claim 21, wherein each of said one or more different tags comprises the formula:
wherein n is from 1 to 10, X is a cleavable linker and R is a molecular hook.
28. The method of claim 26, wherein X is a photocleavable linker.
29. The method of claim 21, wherein said molecular hook is selected from the group consisting of biotin, an activatable group and a high association peptide.
30. A method of screening a tagged molecular library of Claim 25, wherein said molecule is cleaved from said solid support and then incubated with a receptor under conditions conducive to binding of a ligand to said receptor.
31. The method of claim 30, wherein said molecule is a peptide, said solid support is a bead from about 50 to about 500 µm in diameter, said cleavable linker is a mixture of cleavable linkers, and only a portion of said molecules on said beads are cleaved prior to said incubation step.
32. In a method of synthesizing a synthetic peptide library comprising a plurality of different members, each member comprising a peptide composed of a sequence of amino acid monomers linked to a bead to which is also linked one or more oligonucleotide identifier tags identifying the sequence of monomers in said peptide, wherein said amino acid monomers are protected with Fmoc and piperidine is used to remove the Fmoc protecting group, the improvement comprising effecting Fmoc removal by treatment with 5 to 15% piperidine for 5 to 60 minutes or 15 to 30% piperidine for 1 to 30 minutes.
33. The improvement of Claim 32, wherein said bead is about 10 µm in diameter and composed of a macroporous styrene-divinylbenzene copolymer derivatized with a dodecylamine linker.
34. The improvement of Claim 32, wherein said bead is a MonobeadTM.
35. The improvement of Claim 32, wherein said amino acid monomers have side 'Bu side chain protecting groups, TFA is used to remove said 'Bu side chain protecting groups, and said olilgonucleotide tags comprise 7-deaza-2'-deoxyadenosine.
36. A method of detecting the presence of one or more different tags in the method of claim 26, said method comprising:
cleaving said one or more different tags from said solid support;

immobilizing said one or more different tags;
coupling an amplifiable, detectable group to said molecular hook on said one or more different tags;
amplifying said amplifiable, detectable group; and detecting the presence of said amplifiable detectable group, wherein the presence of said amplifiable, detectable group is indicative of the presence of said one or more different tags.
37. The method of claim 35, wherein said amplifiable, detectable group comprises an oligonucleotide sequence capable of binding to said molecular hook.
38. A method of determining the synthesis sequence of a molecule attached to a solid support in the tagged molecular library of claim 21, said method comprising individually detecting the presence of said one or more different tags attached to said solid support, the presence or absence of said one or more different tags being indicative of the occurrence of a particular synthesis step in the synthesis sequence of said molecule.
39. The method of claim 38, wherein said individually detecting of said one or more different tags comprises:
physically separating said one or more different tags according to their structure whereby a separation pattern is obtained for said one or more different tags;
immobilizing said one or more different tags so as to preserve said separation pattern;
treating said tags with an oligonucleotide sequence whereby the oligonucleotide sequence selectively binds to said one or more different tags;
amplifying said olignonucleotide sequence;
detecting the presence of said oligonucleotide sequence, wherein the presence orabsence of said oligonucleotide sequence is indicative of the presence or absence of said one or more different tags;
identifying said one or more different tags present by the relative position of said one or more different tags in said separation pattern; and correlating said presence or absence of said one or more different tags with theoccurrence of a particular synthesis step in the synthesis sequence of said molecule.
CA002175587A 1993-11-02 1994-11-02 Synthesizing and screening molecular diversity Abandoned CA2175587A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/146,886 1993-11-02
US08/149,675 1993-11-02
US08/149,675 US5503805A (en) 1993-11-02 1993-11-02 Apparatus and method for parallel coupling reactions
US08/146,886 US5639603A (en) 1991-09-18 1993-11-02 Synthesizing and screening molecular diversity
PCT/US1994/012347 WO1995012608A1 (en) 1993-11-02 1994-11-02 Synthesizing and screening molecular diversity

Publications (1)

Publication Number Publication Date
CA2175587A1 true CA2175587A1 (en) 1995-05-11

Family

ID=26844384

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002175587A Abandoned CA2175587A1 (en) 1993-11-02 1994-11-02 Synthesizing and screening molecular diversity

Country Status (9)

Country Link
EP (1) EP0726906A4 (en)
JP (1) JPH09508353A (en)
CN (1) CN1134156A (en)
AU (1) AU703472B2 (en)
BR (1) BR9407947A (en)
CA (1) CA2175587A1 (en)
GB (1) GB2298863B (en)
NZ (1) NZ276860A (en)
WO (1) WO1995012608A1 (en)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817751A (en) * 1994-06-23 1998-10-06 Affymax Technologies N.V. Method for synthesis of diketopiperazine and diketomorpholine derivatives
JP3398749B2 (en) * 1994-11-10 2003-04-21 オーキッド バイオ サイエンシズ, インコーポレイテッド Liquid distribution system
US5632876A (en) * 1995-06-06 1997-05-27 David Sarnoff Research Center, Inc. Apparatus and methods for controlling fluid flow in microchannels
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5888830A (en) * 1995-09-22 1999-03-30 Berlex Laboratories, Inc. Apparatus and process for multiple chemical reactions
KR19990063660A (en) * 1995-09-22 1999-07-26 벌렉스 래보라토리즈, 인크. Apparatus and Method for Multiple Chemical Reactions
CA2230592A1 (en) * 1995-09-29 1997-04-03 Ian Henderson A solid phase synthesis reaction vessel and method of using the same
DE19609272C2 (en) * 1996-02-27 2000-05-25 Schering Ag Process for the parallel synthesis of large numbers of 2,6-disubstituted quinoline derivatives
GB2326152B (en) * 1996-03-07 2000-06-28 Imperial College A composite for combinatorial organic synthesis
US5942443A (en) * 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
WO1997040385A1 (en) 1996-04-25 1997-10-30 Bioarray Solutions, Llc Light-controlled electrokinetic assembly of particles near surfaces
US5872015A (en) * 1996-05-10 1999-02-16 Board Of Trustees Of The University Of Illinois Molecular diversity screening method
NZ333346A (en) 1996-06-28 2000-03-27 Caliper Techn Corp High-throughput screening assay systems in microscale fluidic devices
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
NO304355B1 (en) 1997-02-20 1998-12-07 Sinvent As Multi-autoclave for methodical, automated synthesis of zeolites and other compounds
US7622294B2 (en) 1997-03-14 2009-11-24 Trustees Of Tufts College Methods for detecting target analytes and enzymatic reactions
US20030027126A1 (en) 1997-03-14 2003-02-06 Walt David R. Methods for detecting target analytes and enzymatic reactions
US5874589A (en) * 1997-07-18 1999-02-23 Glaxo Wellcome, Inc. Methods for synthesizing diverse collections of tetramic acids and derivatives thereof
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
GB2336327B (en) * 1997-12-15 2000-03-08 Kalibrant Limited Method and apparatus for chemical synthesis
GB9726482D0 (en) * 1997-12-15 1998-02-11 Kalibrant Limited Method and apparatus for chemical synthesis
US6455263B2 (en) 1998-03-24 2002-09-24 Rigel Pharmaceuticals, Inc. Small molecule library screening using FACS
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
DE19819735A1 (en) * 1998-05-02 1999-11-04 Novartis Ag Device and method for producing an arrangement of chain molecules on a carrier material
CA2339163C (en) * 1998-08-10 2010-01-12 Genomic Solutions, Inc. Thermal and fluidic cycling device for nucleic acid hybridization
US6132685A (en) 1998-08-10 2000-10-17 Caliper Technologies Corporation High throughput microfluidic systems and methods
US6306658B1 (en) * 1998-08-13 2001-10-23 Symyx Technologies Parallel reactor with internal sensing
WO2000031536A2 (en) * 1998-11-23 2000-06-02 President And Fellows Of Harvard College Detecting structural or synthetic information about chemical compounds
AU772164B2 (en) * 1998-11-30 2004-04-08 Nanomics Biosystems Pty Ltd Carriers for combinatorial compound libraries
AUPP737298A0 (en) * 1998-11-30 1998-12-24 University Of Queensland, The Combinatorial libraries
US20020015957A1 (en) 2000-04-29 2002-02-07 Hageman Gregory S. Diagnostics and therapeutics for macular degeneration-related disorders
UA81216C2 (en) 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
NO312921B1 (en) 1999-07-05 2002-07-15 Sinvent As Multitest compilation for evaluation, detection and monitoring of processes at elevated pressure
GB0002389D0 (en) 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
ATE483970T1 (en) 2000-02-08 2010-10-15 Sangamo Biosciences Inc CELLS FOR DRUG DISCOVERY
AU2001255748B2 (en) 2000-04-28 2006-08-10 Sangamo Therapeutics, Inc. Methods for binding an exogenous molecule to cellular chromatin
AU2001257331A1 (en) 2000-04-28 2001-11-12 Sangamo Biosciences, Inc. Methods for designing exogenous regulatory molecules
US7923542B2 (en) 2000-04-28 2011-04-12 Sangamo Biosciences, Inc. Libraries of regulatory sequences, methods of making and using same
AU2001257421A1 (en) 2000-04-28 2001-11-12 Sangamo Biosciences, Inc. Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
AU2001255870B2 (en) 2000-04-28 2006-07-13 Sangamo Biosciences, Inc. Databases of regulatory sequences; methods of making and using same
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US20030045005A1 (en) 2000-10-17 2003-03-06 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
EP2381116A1 (en) 2000-11-16 2011-10-26 California Institute of Technology Apparatus and methods for conducting assays and high throughput screening
US6955888B2 (en) 2001-06-11 2005-10-18 Xenoport Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
EP1401850A1 (en) 2001-06-20 2004-03-31 Nuevolution A/S Nucleoside derivatives for library preparation
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
US20040002073A1 (en) 2001-10-15 2004-01-01 Li Alice Xiang Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
IL163822A0 (en) 2002-03-15 2005-12-18 Nuevolution As An improved method for synthesising templated molecules
EP1539980B1 (en) 2002-08-01 2016-02-17 Nuevolution A/S Library of complexes comprising small non-peptide molecules and double-stranded oligonucleotides identifying the molecules
JP4895608B2 (en) 2002-10-30 2012-03-14 ヌエヴォリューション・アクティーゼルスカブ Synthesis method of bifunctional complex
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
WO2008103472A2 (en) 2007-02-23 2008-08-28 Elan Pharmaceuticals, Inc. Prevention and treatment of synucleinopathic and amyloidogenic disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
AU2003298655A1 (en) 2002-11-15 2004-06-15 Bioarray Solutions, Ltd. Analysis, secure access to, and transmission of array images
EP1756277B1 (en) 2002-12-19 2009-12-02 Nuevolution A/S Quasirandom structure and function guided synthesis methods
RU2390350C2 (en) 2003-02-01 2010-05-27 Ньюралаб Лимитед Active immunisation for creating soluble a-beta antibodies
WO2004074429A2 (en) 2003-02-21 2004-09-02 Nuevolution A/S Method for producing second-generation library
EP2236606B1 (en) 2003-03-20 2013-11-06 Nuevolution A/S Ligational encoding of small molecules
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
ES2632216T3 (en) 2003-05-19 2017-09-11 Prothena Biosciences Limited Truncated fragments of alpha-synuclein in Lewy body disease
US8153410B2 (en) 2003-07-07 2012-04-10 Fox Chase Cancer Center Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
US20060162014A1 (en) 2003-07-07 2006-07-20 Jaffe Eileen K Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
WO2005026387A1 (en) 2003-09-18 2005-03-24 Nuevolution A/S A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
EP1664722B1 (en) 2003-09-22 2011-11-02 Bioarray Solutions Ltd Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
WO2005042763A2 (en) 2003-10-28 2005-05-12 Bioarray Solutions Ltd. Optimization of gene expression analysis using immobilized capture probes
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
MY144231A (en) 2003-12-17 2011-08-15 Wyeth Corp Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
EP1694693A2 (en) * 2003-12-17 2006-08-30 Praecis Pharmaceuticals Inc. Methods for synthesis of encoded libraries
SG149013A1 (en) 2003-12-17 2009-01-29 Wyeth Corp Immunogenic peptide carrier conjugates and methods of producing same
DE602004009710T2 (en) * 2003-12-31 2008-08-07 F. Hoffmann-La Roche Ag METHOD OF PEPTIDE SYNTHESIS USING A REDUCED AMOUNT OF DETERGENT
ATE463584T1 (en) 2004-02-19 2010-04-15 Helicos Biosciences Corp METHOD FOR ANALYZING POLYNUCLEOTIDE SEQUENCES
DK1730277T3 (en) 2004-03-22 2010-03-01 Nuevolution As Coding by ligation using building block oligonucleotides
US7341872B1 (en) 2004-04-29 2008-03-11 Uop Llc Multiautoclave with set of vessels for combinatorial synthesis of zeolites and other materials
US20060063208A1 (en) 2004-08-02 2006-03-23 Woolf Clifford J DRG11-responsive (DRAGON) gene and uses thereof
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US7572600B2 (en) 2004-08-04 2009-08-11 Chemocentryx, Inc. Enzymatic activities in chemokine-mediated inflammation
EA013752B1 (en) 2004-08-09 2010-06-30 Элан Фармасьютикалз, Инк. Prevention and treatment of synucleinopathic and amyloidogenic disease
US20060182664A1 (en) * 2005-02-14 2006-08-17 Peck Bill J Flow cell devices, systems and methods of using the same
WO2006088950A2 (en) 2005-02-14 2006-08-24 University Of Iowa Research Foundation Methods and reagents for treatment and diagnosis of age-related macular degeneration
ES2547866T3 (en) 2005-02-16 2015-10-09 The General Hospital Corporation Use of hemojuvelin fusion proteins to regulate iron metabolism mediated by hepcidin
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
WO2007030560A2 (en) 2005-09-08 2007-03-15 Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents
DK1957644T3 (en) 2005-12-01 2011-03-28 Nuevolution As Enzymatic coding methods for efficient synthesis of large libraries
US8357781B2 (en) 2006-06-01 2013-01-22 Janssen Alzheimer Immunotherapy Neuroactive fragments of APP
PT3067066T (en) 2007-02-23 2019-06-17 Univ California Prevention and treatment of synucleinopathic and amyloidogenic disease
US8895002B2 (en) 2007-04-09 2014-11-25 The General Hospital Corporation Hemojuvelin fusion proteins and uses thereof
WO2009078799A1 (en) 2007-12-17 2009-06-25 Marfl Ab New vaccine for the treatment of mycobacterium related disorders
EA028356B1 (en) 2007-12-28 2017-11-30 Протена Байосайенсиз Лимитед Treatment and prophylaxis of amyloidosis
CA2713423A1 (en) 2008-01-18 2009-07-23 North Carolina State University Peptides and methods of use as therapeutics and screening agents
JP5628807B2 (en) 2008-08-18 2014-11-19 ソウル ナショナル ユニバーシティー インダストリー ファウンデーション Method for regulating cancer metastasis or cancer cell migration by regulating intracellular levels of lysyl tRNA synthetase
ES2638324T3 (en) 2009-02-13 2017-10-19 X-Chem, Inc. Methods of creating and examining DNA-encoded libraries
EP2443459B1 (en) 2009-06-19 2018-12-26 The Arizona Board of Regents, A Body Corporate Of the State of Arizona acting for and on behalf Of Arizona State University Compound arrays for sample profiling
DK2558577T3 (en) 2010-04-16 2019-04-01 Nuevolution As Bi-functional complexes and methods for the preparation and use of such complexes
US8975293B2 (en) 2011-05-26 2015-03-10 Regents Of The University Of Michigan Epigenetic co-repressors of the gamma-globin gene and methods of using same
JP6674738B2 (en) 2011-09-07 2020-04-01 エックス−ケム インコーポレイテッド Method for tagging a DNA code library
WO2013043012A2 (en) 2011-09-22 2013-03-28 Medicinal Bioconvergence Research Center Novel use of leucyl trna synthetase
EP2748307A4 (en) 2011-09-23 2015-08-19 Univ Louisville Res Found Methods and compositions for expanding cells and improving engraftment
KR101398079B1 (en) 2011-10-10 2014-05-27 재단법인 의약바이오컨버젼스연구단 method for screening an agent preventing or treating cancer using glycyl-tRNA synthetase and cadherin
WO2013078138A1 (en) 2011-11-21 2013-05-30 OSI Pharmaceuticals, LLC Proton nmr spectroscopy for biochemical screening
CA2879018A1 (en) 2012-07-13 2014-01-16 X-Chem, Inc. Dna-encoded libraries having encoding oligonucleotide linkages not readable by polymerases
WO2014145123A2 (en) 2013-03-15 2014-09-18 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State Unversity Peptide array quality control
WO2014144383A1 (en) 2013-03-15 2014-09-18 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Non-covalent patterned chemical features and use thereof in maldi-based quality control
CN105102427B (en) 2013-03-21 2018-09-07 赛诺菲-安万特德国有限公司 The synthesis of peptide prod containing cyclic imide
CA2907454C (en) 2013-03-21 2021-05-04 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
CA2959045A1 (en) 2014-09-12 2016-03-17 The University Of Washington Wnt signaling agonist molecules
US10196613B2 (en) 2014-12-19 2019-02-05 Regeneron Pharmaceuticals, Inc. Stem cells for modeling type 2 diabetes
LT3262059T (en) 2015-02-24 2022-02-25 City Of Hope Chemically encoded spatially addressed library screening platforms
WO2016169894A1 (en) 2015-04-20 2016-10-27 F. Hoffmann-La Roche Ag Specific peptide binders to proteins identified via systemic discovery, maturation and extension process
US10758886B2 (en) 2015-09-14 2020-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Conditioned surfaces for in situ molecular array synthesis
EP3210667A1 (en) * 2016-02-29 2017-08-30 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Modular continuous flow device
WO2017208210A1 (en) 2016-06-03 2017-12-07 Prothena Biosciences Limited Anti-mcam antibodies and associated methods of use
KR20190020106A (en) 2016-06-20 2019-02-27 헬스텔 인크. Differential diagnosis method of autoimmune disease
JP2019526786A (en) 2016-06-20 2019-09-19 ヘルステル・インコーポレイテッドHealthtell Inc. Methods for diagnosis and treatment of autoimmune diseases
AU2017292172A1 (en) 2016-07-06 2019-01-03 Prothena Biosciences Limited Assay for detecting total and S129 phosphorylated alpha-synuclein
CN109803530A (en) 2016-07-29 2019-05-24 瑞泽恩制药公司 Mouse comprising causing the mutation of the truncated old information model expression of C-
EP3526346A1 (en) 2016-10-12 2019-08-21 Janssen Biotech, Inc. Methods for screening for modulators of gdf15-like biological activity
WO2018089858A1 (en) 2016-11-11 2018-05-17 Healthtell Inc. Methods for identifying candidate biomarkers
EP3619534A1 (en) 2017-05-05 2020-03-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
EP3687687A4 (en) 2017-09-25 2021-11-17 Plexium, Inc. Oligonucleotide encoded chemical libraries
US20190141966A1 (en) 2017-11-10 2019-05-16 Regeneron Pharmaceuticals, Inc. Non-Human Animals Comprising SLC30A8 Mutation And Methods Of Use
CN107881102B (en) * 2017-11-23 2021-04-09 希施生物科技(上海)有限公司 Automatic synthesizer for nucleic acid DNA/RNA production
MA53158A (en) 2018-07-20 2021-05-26 Aicuris Gmbh & Co Kg METHODS FOR SCREENING AND IDENTIFYING AGENTS INHIBITING OR MODULATING THE NUCLEAR EXIT COMPLEX OF THE HERPES VIRUS
CN109192250B (en) * 2018-08-01 2021-12-07 华东理工大学 Accelerated simulation method for overcoming rapid migration of surface species in heterogeneous catalysis
CN113966401A (en) 2019-04-10 2022-01-21 犹他大学研究基金会 HTRA1 modulation for the treatment of AMD
US20220402895A1 (en) * 2019-10-23 2022-12-22 National University Of Singapore Method and System for Synthesising Compounds
US20220387957A1 (en) * 2019-11-04 2022-12-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Microwave-assisted method for synthesis of oligo- and polysaccharides on solid phase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60105691A (en) * 1983-11-14 1985-06-11 Nippon Zeon Co Ltd Apparatus for synthesizing polynucleotide
US4701304A (en) * 1985-04-19 1987-10-20 Applied Protein Technologies, Inc. Apparatus for automated synthesis of peptides
US5252296A (en) * 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
WO1991017873A1 (en) * 1990-05-23 1991-11-28 Robin Mcgarvie Protection means for handsaw
EP0544809B1 (en) * 1990-08-24 1998-12-16 Ixsys, Inc. Methods of synthesizing oligonucleotides with random codons
US5264563A (en) * 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
JPH0720546B2 (en) * 1991-08-26 1995-03-08 株式会社島津製作所 Multi-item simultaneous chemical reactor
WO1993006121A1 (en) * 1991-09-18 1993-04-01 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers

Also Published As

Publication number Publication date
NZ276860A (en) 1997-09-22
AU1128095A (en) 1995-05-23
GB9609254D0 (en) 1996-07-03
GB2298863A (en) 1996-09-18
AU703472B2 (en) 1999-03-25
JPH09508353A (en) 1997-08-26
EP0726906A4 (en) 1998-10-07
WO1995012608A1 (en) 1995-05-11
BR9407947A (en) 1996-11-26
GB2298863B (en) 1998-03-11
EP0726906A1 (en) 1996-08-21
CN1134156A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
CA2175587A1 (en) Synthesizing and screening molecular diversity
US6165778A (en) Reaction vessel agitation apparatus
US5639603A (en) Synthesizing and screening molecular diversity
EP0604552B1 (en) Method of synthesizing diverse collections of oligomers
Lebl et al. One‐bead–one‐structure combinatorial libraries
US5646285A (en) Combinatorial non-peptide libraries
Lam Mini-review. Application of combinatorial library methods in cancer research and drug discovery
US5541061A (en) Methods for screening factorial chemical libraries
Terrett Combinatorial chemistry
US5891737A (en) Combinatorial non-peptide libraries
EP1042060B1 (en) Method and apparatus for chemical synthesis
PL169616B1 (en) Method of determining biooligomeric ligand sequence for an acceptor molecule
US6395559B1 (en) Multiple fluid sample processor with single well addressability
JPH09512036A (en) Method and apparatus for labeled combinatorial chemical library synthesis
Salmon et al. High-volume cellular screening for anticancer agents with combinatorial chemical libraries: a new methodology
CN101583580A (en) Make and use of surface molecules of varied densities
US6864048B2 (en) Factorial chemical libraries
WO2000066360A1 (en) Multiple fluid sample processor with single well addressability
US20050100968A1 (en) Self-encoded combinatorial synthesis of compound multiplets
Liu et al. Design, synthesis, screening, and decoding of encoded one-bead one-compound peptidomimetic and small molecule combinatorial libraries
Seneci Encoding techniques for pool libraries of small organic molecules
Meyers Chemical and biological approaches to molecular diversity: Applications to drug discovery

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued